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ABSTRACT
Three approaches to understanding peripheral pain pathways are described in this thesis. 
Cre-loxP technology has been used to delete genes specifically in specialised sensory 
neurons that respond to tissue damage (nociceptors). The sodium channel selective Nay 1.8 
promoter is used to drive Cre expression. I used a mouse expressing diphtheria toxin A- 
chain downstream of a floxed stop signal, crossed with the Nayl.SCre mouse to delete all 
cells expressing this channel. This lead to massive cell loss of nociceptive neurons, 
associated with altered pain behaviour. The mice lost cold, mechanical and inflammatory 
pain, but not thermal or neuropathic pain behaviour. These observations are consistent with 
modality specific pain pathways in the peripheral nervous system. Microarray analysis was 
used to identify the transcripts selectively expressed in the lost sensory neurons, providing 
potential new analgesic drug targets for inflammatory pain.
In a further study exploiting knock out mice, I identified a line that had lost sensitivity to 
light touch, but was otherwise normal in terms of pain pathways. This sensory loss was due 
to the insertion of a LacZ cassette in a gene encoding Papin, a PDZ-protein of unknown 
function. Further analysis showed a loss of interactions between sensory neurons and 
mechanosensitive Merkel cells, and a loss of sensory neuron numbers.
Finally, conditional deletion of Nayl.7 in mice, and global loss of Nay 1.7 in man have been 
shown to lead to a loss of pain sensitivity. I used a recently discovered peptide blocker of 
Nayl.7 to examine the role of this channel in normal mice. I found that Nayl.7 block leads 
to a loss of mechanical, inflammatory and neuropathic pain, making this sodium channel a 
very attractive analgesic drug target.
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1 EVTRODUCTION
1.1 P a in
Pain, defined as an emotional and sensory experience caused by potential or actual tissue 
damage (lASP, 1994), is one of the most common clinical conditions. According to a 
survey from the British Pain Society, almost 10 million people in the UK suffer some sort 
of pain every day (BPS, 2005). Physiological pain refers to pain evoked by a painful 
stimulus e.g. a needle prick. The information from the insult will go to the brain and act as 
a warning to prevent tissue damage. Pathophysiological pain is due to a condition such as 
inflammation, nerve damage or nerve dysfunction. The current pharmacological pain- 
treatment is non-opioid based (paracetamol, cyclo-oxygenase inhibitors etc.); opioid based 
(codeine, morphine, deamorphine etc.) as well as agents whose primary indication is for 
conditions other than pain, but have proven useful in the treatment of pain conditions 
(anticonvulsants, antidepressants, steroids and others).
An improvement in the treatment of pain is needed, as the daily experience of pain can 
have a devastating effect upon individuals’ quality of life and the current options for 
treatment often fail. A way to achieve this is to investigate the molecular mechanisms of 
pain to obtain a better understanding and through that find ways to develop better 
treatments.
1.2 Pr im a r y  se n so r y  n e u r o n s  a n d  n o c ic e p t o r s
The primary afferent sensory neurons. Dorsal Root Ganglion (DRG) neurons and 
trigeminal neurons terminate in the periphery and work as sensors, transducing noxious and 
non-noxious stimuli into action potentials. The signal is carried by the axon to the central 
synapse where secondary and tertiary neurons project the signal for further processing in 
the brain where pain is perceived.
The primary sensory neurons are myelinated to different degrees: the most heavily 
myelinated are the Ag-fibres, followed by the Aô-fibres that are only lightly myelinated and 
the C-fibres are unmyelinated. These neurons can also be characterised by their conduction
velocity: Ap>10 msec'\ A5 at 1.2-10 msec'*, and C-fibres at <1-2 msec'*. The AP-fibres 
respond very fast and mainly to innocuous stimuli. It has been reported, however, that a 
small population of the Ap-fibres might be involved in nociception (Djouhri and Lawson, 
2004;Lawson, 2002). In contrast, the Aô-fibres and C-fibres exhibit a much slower 
conduction of information. The C-fibres respond to noxious insults, transducing thermal, 
mechanical and chemical stimuli into trains of action potentials and are called nociceptors. 
Under normal conditions nociceptors may be inactive but if the tissue is exposed to 
stimulation strong enough to introduce damage nociceptors will be activated. A large group 
of specialised receptors and proteins transduce and regulate the sensitivity of nociceptors -  
see fig.l.
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Figure 1. The primary sensory neurons.
Information from the nerve terminals are transduced into 
electrical signals and carried by the dorsal root ganglia to 
dorsal horn of the spinal cord where the neurons synapse 
onto the secondary neurons from where the signal is 
carried to the sensory cortex. At the nerve terminal a 
number of receptors are located sensing tissue damage 
and controlling the flux of ions over the membrane 
generating action potentials. Adapted from Anemone 
Labs(2007)
At the dorsal horn of the spinal cord, termination of 1^  ^order neurons occurs at different 
depths. The dorsal horn is divided into laminae I-X (see fig.2), with the five most 
superficial layers involved in transmission of sensory information. The Ap-fibres terminate 
in the deep laminae III and IV, whereas the Aô-fibres terminate in laminae I and V. Finally, 
the C-fibres terminate in the superficial lamina I and II (Snider and McMahon, 1998). The 
sensory neurons can synapse with two different sets of projection neurons, nociceptor- 
specific (NS) or wide dynamic range (WDR) neurons. The NS respond only to high-
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intensity stimulation, whereas the WDR respond to a variety of intensities with a graded 
response. In the outer laminae, the projecting neurons are NS, whereas lamina V contains 
primarily WDR neurons. As described, Af-fibres innervate lamina V, but intemeurons 
from other lamina also deliver input to lamina V.
Peptidergic C fibre
L'n myelinated, 
pcripberin, trkA, 
BDNF, CGRF.SP, 
TRPVI
A6-fibre
Myelinated, NF200, 
trkA, trkC, BDNF, 
CGRP, TRPVI
Skim
\nm peptidergic C-fibre
L’amyelinated, 
peripheria. Ret, IB4, 
P2X3, TRPVI A f i b r e  (mon-nociceptive)
NS
NS
Lamina IV
WDR
Lamina V
Spinal Cord
Figure 2. The termination of sensory neurons on the dorsal horn. 
Adapted from Foulkes and Wood, 2008.
1 .3  N o c i c e p t i o n
The Aô-fibres and C-fibres, the two subpopulations of primary afferent neurons that 
primarily are involved in nociception, are polymodal. When noxious insults are introduced, 
specialised receptors expressed in the nerve terminal become activated and allow the 
movement of ions over the membrane, which produces a depolarisation resulting in the 
generation of action potentials.
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The endings of the nerves differ between the different subpopulations. The Ap-fibres ends 
in specialised organs whereas the majority of the Aô and the C-fibres terminate as free 
nerve endings in the skin (Maclver and Tanelian, 1993).
Histochemically, the A-fibres can be identified using antibodies against 200kDa 
neurofilament subunit (Lawson and Waddell, 1991), whereas the small nociceptors (C- 
fibres) are identifiable using antibodies against the intermediate neurofilament peripherin.
1.3.1 Development of nociceptors
During embryonic life the nociceptive sensory neurons express the receptor Tyrosine 
Kinase A (TrkA) and are dependent on the retrograde transport of NGF. During the first 
two post natal weeks, the neurons are divided into two subpopulations, peptidergic and 
non-peptidergic. The expression of TrkA is downregulated and remains expressed only in 
the peptidergic subpopulation, which remains sensitive to NGF (Molliver and Snider,
1997). The peptidergic subpopulation synthesises neuropeptides such as calcitonin gene- 
related protein (CGRP) and Substance P (SP). Antibodies against CGRP, TrkA or 
Substance P can be used to identify the peptidergic subpopulation of sensory neurons.
The non-peptidergic subpopulation becomes sensitive to the neurotrophic factor glial cell- 
derived neurotrophic factor (GDNF), the endogenous ligand of the tyrosine kinase receptor, 
RET. As the TrkA receptor is downregulated, the non-peptidergic neurons also become 
insensitive to NGF (Molliver et al., 1997). The cells possess cell surface glycol-conjugates 
that can be identified by binding of the lectin Isolectin B4 from Griffonia simplicifolia 
(Silverman and Kruger, 1990).
1.3.2 Mechanical nociception
Mechanosensation is part of human daily life giving the ability to sense touch, texture, 
sound etc. Mechanosensation is regulated through two different sets of mechanoreceptors, 
low threshold mechanoreceptors (LTM) that respond to innocuous stimuli and high 
threshold nociceptors that respond to noxious mechanical stimuli. The following part will 
focus on high threshold mechanosensation (HTM).
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A conopeptide, NMB-1, was shown by Drew et al. (2007) to block pressure evoked pain in 
rats. When biotinylated NMB-1 was co-stained with Peripherin nearly all cells that had 
bound MNB-1 also expressed peripherin, linking the expression to the nociceptive 
population of sensory neurons (Drew et a l, 2007). Many hypotheses of possible 
transducers of intense mechanical stimulation have been tested, but so far very few proteins 
have proven to be strongly involved in mechanical nociception. Among the candidates are 
certain cation-permeable ion channels belonging to the large family of Transient Receptor 
Potential channels (Trp).
One of the Trp-channels suggested to be involved is TrpV4. It is expressed mainly in the 
small C-fibres (Nagata et a l, 2005) and in free-nerve endings (Suzuki et al., 2003b). A 
TrpV# knockout mouse did show impaired response to noxious tail pressure (Suzuki et al., 
2003a). Another Trp-channel possibly involved in mechanical nociception is TrpAi. Two 
different TrpAi knockout mice have been generated, but only one mouse was tested for 
noxious mechanical responses. Unfortunately the testing of the TrpAi KO mouse was done 
in a slightly unconventional way, so it makes it difficult to compare the data (Kwan et a l, 
2006). The study used von Frey filaments, finely graded filaments applied to the paw, and 
the Randall Selitto apparatus, a blunt incremental pressure applied to paw or tail, to test the 
mechanical responses. In particular for the von Frey tests, a range of filaments was applied 
to the paw a total of eight times ( 1/second) and if the mouse responded more than twice it 
was considered as a positive response. The Randall Selitto apparatus was used to apply 
noxious pressure to the paw of the mouse. The applications of von Frey filaments differed 
from most other studies and the application of Randall Selitto apparatus to the paw of the 
mouse is a very difficult task. Results appeared to show a resistance to noxious mechanical 
stimulation (Kwan et a l, 2006).
1.3.3 Thermal nociception
For the transduction of thermal stimuli non-specific cation channels belonging to the super 
family of Trp-channels have so far been the primary candidates. TrpV;-V4, together with 
TrpMg and TrpAi, have been named the “ThermoTrps”. In general the TrpVw - channels 
share a high sequence homology of about 40-50 percent. They exist as homomultimers
14
although the existence of heteromuitimers of the TrpVi-TrpV] has been reported (Hellwig 
et a l, 2005).
TrpVi has long been thought to be the transducer of noxious thermal heat. The channel is 
located in the small and medium diameter sensory neurons and recent studies have shown 
low levels of expression in the brain and in non-neuronal tissue (Caterina, 2007). Initially, 
the ion channel was cloned characterised as the receptor for the vanilloid. Capsaicin (chilli 
pepper). Using HEK293 cells expressing TrpVi, a large increase in calcium influx after 
raising the temperature from 22°C to 45 °C suggested involvement in heat sensation 
(Caterina et a l, 1997). A few years later functional data from a TrpVi KO was published 
giving further evidence of involvement in heat sensation. The KG mouse showed a very 
significantly impaired response to thermal stimulation both acute and after induction of 
inflammation (Caterina et a l, 2000). Interestingly, no acute pain phenotype was recorded 
from a second TrpVi KG mouse, merely confirming the electrophysiological data and 
thermal phenotype seen after induction of inflammation (Davis et a l, 2000).
Using the TrpVi sequence for screening, another ion channel was identified and cloned: 
TrpVi (Griginally called VRLi). The distribution was restricted to the medium and large 
diameter neurons and electrophysiological data from HEK293 cells and Xenopus oocytes 
showed activation at temperatures higher than 53°C (Caterina et a l, 1999). So far, no data 
from a TrpV] null mouse has been published, but a full investigation of thermal responses 
would be very interesting.
More recent discoveries have identified a further two Trp-channels contributing to 
sensation of heat. TrpV] showed a different profile to that of TrpVi and TrpV2 as it is 
predominantly expressed in the kératinocytes and not in the sensory neurons, suggesting the 
skin can detect heat and synapse between kératinocytes and the primary neurons (Xu et a l, 
2002;Peier et a l, 2002b). The activation of TrpVg occurs already at innocuous temperatures 
around 33°C. The TrpV] KG mouse showed a strong resistance to innocuous heat and a 
very strong resistance to noxious heat measured above 50°C (Moqrich et a l, 2005). 
Interestingly, responses to noxious heat after inflammation showed no differences.
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Further, TrpV4 was identified as sharing its characteristics with TrpV], being mainly 
expressed in kératinocytes and not sensory neurons, and becoming activated at innocuous 
temperatures. In both HEK293 cell systems and Xenopus oocytes, TrpV4 heat-evoked 
currents are detectable at temperatures above 27°C. (Guler et a/., 2002). As with TrpVi, a 
strong reduction in responses to noxious heat after inflammation was also reported 
(Alessandri-Haber et a l, 2006)
P2X3, belonging to the purinergic receptor family and is activated by ATP and expressed in 
small sensory neurons (Chen et a l, 1995), has been shown to have a possible role in 
thermal sensation. Performing electrophysiology on the P2X3 knock out mouse showed a 
significant deficit in thermal sensations but this was not reproduced in vivo, testing thermal 
responses using the hot-plate and tail flick (Souslova et a l, 2000). Electrophysiological 
testing of DRG neurons confirmed that P2X-receptors expressed in DRG are responding to 
temperature dependent ATP release, but the range of temperatures applied were between 
25-40°C and not in the noxious range (Khmyz et al., 2007).
With low temperature stimuli, innocuous and noxious cold sensation, two other Trp- 
channels have been identified; TrpMg and TrpAi. Both are expressed in the small neurons 
in the DRG and are activated at temperatures below 25°C and 18°C respectively (Story et 
a l, 2003). After the cloning of TrpMg by Peier et al 2002, TrpMg was expressed in CHO 
cells and showed, using calcium imaging, that lowering the temperature to 15°C increased 
the calcium levels in TrpMg- expressing cells (Peier et al., 2002a). Functional data from 
transgenic TrpMg knockout mice from two independent groups demonstrated resistance to 
temperatures below 15°C (Colburn et a l, 2007;Dhaka et a l, 2007). TrpAi has, as 
mentioned above, shown a possible involvement in mechanical nociception. Another 
interesting role for TrpAi could be in cold nociception demonstrated by cold activation of 
TrpAi when expressed in CHO cells anà.Xenopus oocytes (Story et a l, 2003). Two 
knockout mouse lines were generated and interestingly, conflicting observations in 
response to cold were recorded (Bautista et a l, 2006;Kwan et a l, 2006). Kwan et al. found 
differences between WT and KG in two models of cold stimulation, using cold plate and 
cooling by evaporating of acetone applied to the paw. In contrast, the KG from Bautista et 
al. found no differences at all due to cold, but a different regime of studies was applied. 
Bautista et al. used the latency in cold plate behaviour to determine a difference between
16
control and KO mice compared with Kwan et al’s approach where measuring the number of 
pain behaviours over a period of 5 minutes was applied. The evaporation study by Kwan et 
al. involved application of the acetone and counting pain behaviour immediately for two 
minutes; Bautista et al. measured the cumulative time spent licking and biting.
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1.3.4 Inflammatory pain
After a noxious insult strong enough to introduce tissue damage, an inflammatory response 
will normally occur. Inflammatory modulators are released from the surrounding tissue 
activating and sensitising the sensory neurons leading to Allodynia, a painful feeling from a 
stimulus that would not normally be painful, or Hyperalgesia, where an increased response 
is seen to a painful stimulus.
C-fibre
Membrane
Phospholipids
Arachidonic
Acid
Na- C « -
N«* C « -
(^^^dykin i^
Substance P 
and CGRP
HistamineDegranulabon 
Platelet
Na„1.8
► PKA
PGE2. PGU
pro-inflammatory cytokines
TNF, IL-1B, IL-6
Figure 3. Overview of the inflammatory response.
Due to tissue damage released compounds works through 
their respective receptors activating or sensitizing the 
neuron.
TTXs/r; Tetrodotoxin sensitive/resistant 
Modified from (Coutaux et al., 2005)
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1.3.4.1 Inflammatory modulators
ATP is released from the cytosol of damaged kératinocytes and acts on P2X purinoceptors 
(Cook and McCleskey, 2002). Similar to ATP, hydrogen ions (H^), also released upon 
tissue damage, can also generate action potentials if injected on their own. A lowering of 
the pH activates Acid Sensing Ion Channels (ASIC) of which isoforms 1-3 are expressed in 
the sensory neurons. Knockouts of ASICl and ASIC2 showed no deficit in nociception, 
whereas deletion of the ASIC3 demonstrated a clear pain resistant phenotype to 
intramuscular injected acidic saline, suggesting an involvement in inflammatory 
nociception (Sluka et al., 2003). Hydrogen ions can also activate the TrpVi cation channel 
(Welch et a l, 2000).
Bradykinin (BK) can both sensitise the neuron and generate action potentials when 
injected. BK is released by the damaged tissue and works through the G-protein coupled 
receptor Bradykinin B2 (B2), initiating a cascade of reactions involving Phospholipase C 
(PLC) and Phospholipase A2 (PLA2). BK is metabolised to des-[Arg^]-bradykinin which 
acts on the B1-receptor (Bl). After activation B2 is desensitized, endocytosed and 
resensitised whereas expression of Bl is induced after tissue damage (Prado et a l, 2002). 
Pharmacological block (des-Arg^ -[Leu*]-bradykinin) as well as gene disruption of Bl in 
mice reduces the formalin-induced inflammatory response (Rupniak et a l, 1997;Pesquero 
et a l, 2000), whereas transgenic B2-KO mice showed a normal response to formalin 
(Boyce et a l, 1996). Cytokines, a group of many different proteins, can be released by 
many different cell types after tissue damage and immunological responses. The pro- 
inflammatory cytokines (IL-ip, IL-6  and TNF), released from macrophages, lymphocytes 
and monocytes, have been shown to up-regulate the inflammatory response by stimulating 
the release of prostaglandins (Copray et a l, 2001;Cunha et a l, 2005b). Prostaglandins are 
known to sensitize sensory neurons via specific receptors. Due to inflammation, 
phospholipase A2 hydrolyses membrane phospholipids and arachidonic acid is released. It 
is further converted by cyclooygenases (COX) into a prostaglandin intermediate, and 
specific isomerases generate the different prostaglandins. The prostaglandins PGE2 and 
PGI2 work through the EPl, EP2 and IP receptors (Zeilhofer, 2007) or potentiate other 
receptors such as TrpVi (Moriyama et a l, 2005). The neurotransmitter Serotonin is found 
both in the CNS and PNS and in the sensory neurons; studies have shown strong 
involvement in nociception via the 5HT3 receptor. Zeits et al. analysed the 5-HT3 null
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mouse and found that the 5-HT3 receptor is expressed in both small C-fibres and in some 
medium and large fibres. Further, in the formalin test they showed that deletion of the 5- 
HT3 receptor reduced the response in the second phase (Zeitz et al., 2002). The action of 
histamine in the CNS is most interesting as all three identified and cloned histamine 
receptors (HI-3) are distributed throughout the CNS. Blockade and transgenic deletion of 
the HI receptor showed reduced sensitivity to both acute nociception and inflammatory 
nociception (Mobarakeh et ah, 2000;01sen et a l, 2002). Studies of the H2 receptor null 
mouse show some involvement of the receptor in acute nociception, but not in 
inflammatory nociception (Mobarakeh et a l, 2006). H3 is expressed in the sensory 
neurons, located on the small and medium fibres (Cannon et a l, 2007a). Interestingly, 
pharmacological blockade of H3 has an antinociceptive effect, reducing swelling and 
nociceptive responses (Cannon et a l, 2007b). Neurotrophins work through the Tyrosine 
Kinase Receptors (Trk) expressed on the terminals of sensory neurons which activate 
different signalling pathways. NGF works through the TrkA receptor and regulates 
expression of many proteins such as SP and CGRP, ion channels and receptors. NGF levels 
are increased under inflammatory conditions and several studies show the involvement of 
NGF in inflammatory nociception (Reviews; (McMahon, 1996;Pezet and McMahon,
2006). Synthesis of BDNF is also upregulated in the DRG after inflammation, but it is 
transported to the nerve terminals in the dorsal horn where it works on TrkB (Lee et a l, 
1999). The neuropeptide Substance P is expressed by C-fibres and released into the dorsal 
horn not only in inflammation, but in most nociceptive modalities. It acts centrally on the 
NK-1 receptor and regulates the excitability of the dorsal horn neurons. Studies on the NK- 
1 knockout mouse showed a strong reduction in responses to inflammation (Kidd et a l, 
2003). CGRP is expressed abundantly in the sensory neurons, transported to the nerve 
terminals and released into the dorsal horn synapse (Gibbins et a l, 1987;Gibson et a l,
1984) and acts through a seven transmembrane GPCR multi subunit complex (McLatchie et 
a l, 1998). After inflammation CGRP levels have been shown to be increased (Hanesch et 
a l, 1993).
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1.3.5 Important ion channels in inflammatory pain
1.3.5.1 Nayl.7
A tissue-specific DRG knockout of the Nayl.7 showed a large reduction in the response in 
the second phase of the formalin test. When exposed to long term inflammation using CFA 
no change in response to either thermal and mechanical stimulation was recorded 
suggesting a major role of Nayl.7 in inflammatory pain (Nassar et a l, 2004).
1.3.5.2 Nayl.8
Inflammatory modulators can increase the activity of PKA and PKC and it has been shown 
that both kinases can regulate Nayl.8 (Vijayaragavan et al., 2004), but the responses from 
the Nayl.8 null mouse tested after induction of inflammation using carrageenan and 
Formalin, recorded only a delay in developing hyperalgesia was recorded in the KO 
compared with controls (Akopian et a l, 1999;Nassar et a l, 2005)
1.3.5.3 TrpVi
One important ion channel in inflanunatory pain is the TrpVi. In two transgenic mouse 
TrpVi knockout lines, thermal responses after inflammation were significantly reduced 
(Davis et a l, 2000;Caterina et a l, 2000). The channel is sensitised (phosphorylated) by 
PKC and PKA (Bhave et al., 2002;Premkumar and Ahem, 2000), desensitised by cAMP 
dependent protein kinases (Mohapatra and Nau, 2005) and activated directly by a number 
of inflammatory mediators such as protons and prostaglandins.
1.3.5.4 TrpV]
As TrpVi is so strongly activated by inflammation and contributes to increased thermal 
sensations, TrpV] could also be involved. Even though little data is available and no 
knockout mouse has been generated, data from a selective activator of TrpVi, Probenocid, 
was published recently. Wild type mice treated with Probenecid showed a very strong 
inflammatory reaction after injections of carrageenan compared with controls injected only 
with carrageenan (Bang et a l, 2007). This suggests that TrpV2 does contribute to 
inflammatory pain.
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1.3.5.5 TrpAi
As mentioned above, TrpAi is expressed in the small C-fibres. Specific prostaglandins, 
PGE2 and PGD2, have been shown to activate TrpAi (Taylor-Clark et al., 2007). An even 
stronger reduction in the formalin test was seen in the TrpAi KG mouse. In the first phase 
of the formalin test, the TrpAi KG mouse showed around 80 percent reduction in response. 
In the second phase, which is considered an inflammatory response (Jeong and Holden,
2007), the nociceptive behaviour was almost ablated (McNamara et a l, 2007).
1.3.5.6 P2 X3
In sensory neurons, P2X2 and P2Xs are both expressed (Chen et a l, 1995;North, 2004). 
They can exist as homomeric ion-channels or as a heteromeric P2X(2/3) (Grubb and Evans, 
1999). Electrophysiological studies proved a role for P2X receptors in the nociceptive 
responses to inflammation and also showed that both P2X2 and P2X] were upregulated 
after inflammation, potentiated by ATP and Bradykinin (Paukert et al., 2001;Xu and 
Huang, 2002). The transgenic P2X] null mutant mouse showed a reduced response in the 
formalin test together with reduced responses to noxious thermal stimulation (Souslova et 
a l, 2000 ).
1.3.6 Neuropathic pain
Pain perception initiated or caused by primary lesions or dysfunction in the nervous system 
is defined as neuropathic pain and results in the development of spontaneous and abnormal 
activity in injured and uninjured afferent neurons (Ji and Strichartz, 2004).
The characteristics of neuropathic pain are an persistent pain characterised by burning pain, 
electric shock-like pain and pain paroxysms including allodynia, hyperalgesia and 
secondary hyperalgesia, hyperalgesia in non-injured tissue surrounding the injury (Jensen et 
a l, 2001 ;Nozaki-Taguchi and Yaksh, 1998). This is caused by host of events including 
inflammatory mediators released shortly after the neuronal damage, and the central changes 
induced caused by changes in the retrograde supply of neurotrophic factors GDNF and 
NGF.
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Early work by Bennett et al. tested the effects of intrathecal NGF and GDNF on nerve cells 
at DRG and spinal level after axotomy (excision of the nerve). GDNF was shown to 
suppress the reduction in IB4-positive profiles, whereas NGF, to a lesser extent, was shown 
to suppress a reduction in TrkA positive cells. This suggest that the loss of GDNF and NGF 
supply after nerve injury is responsible for the phenotypic changes observed in the injured 
and uninjured nerve that contribute to the generation of ectopic discharges (Bennett et al.,
1998). Ectopic discharges are massive spontaneous impulse discharges in mainly Ag-fibres, 
but also Aô-fibres, developing shortly after injury to nerves (Liu et al., 1999).
Long term changes include down regulation of the N ayl.8 and N ayl.9 in the injured nerves, 
but an up regulation of N ayl.8  in uninjured nerves in surrounding tissue has been reported 
(Gold et al., 2003). The change in gene expression and thereby regulation in expression of 
ion chaimels, receptors etc. have been investigated by microarray with several hundreds of 
genes found to be up- or downregulated (Costigan et a l, 2002). Even though changes in 
gene expression have been reported for a number of the voltage gated sodium channels, 
none of the DRG tissue-specific transgenic mouse lines with deleted sodium channel(s) 
have shown any reduction in the development of neuropathic pain. Blockade of N ayl.8  has 
however, shown a decrease in the development of neuropathic pain (Ekberg et al., 2006). 
The development of allodynia has been hypothesised to be mediated by increased activity 
in the AP-fibres. Touch-evoked activity has been shown to be increased in the superficial 
dorsal horn laminae suggesting that Ap-fibres deliver non-nociceptive central information 
to the normally nociceptive laminae I+II (Bester et a l, 2000).
1.3.7 Important changes in gene expression due to neuropathic pain
The expression of several proteins, in particular Nay 1.3 and the Voltage Gated Calcium 
Channel (VGCC) subunit a20-l have been proven to change in neuropathic pain conditions.
1.3.7.1 Nayl.3
Most of the voltage gated sodium channels expressed in the DRG become downregulated in 
neuropathic pain (Rogers et al., 2006). N ayl.3  however, is almost absent in the adult mouse
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DRG, but was shown to be upregulated after nerve injury, both in the DRG and CNS 
(Hains et a l, 2003;Waxman et a l, 1994). Later on, it was shown that down regulation of 
the Nayl.3 using antisense oligonucleotides could reverse neuropathic pain (Lindia et a l, 
2005). In contrast, when another group used antisense to knock down Nayl.3 after having 
introduced neuropathic pain, no differences were observed between the antisense and the 
mismatch group (Lindia et a l, 2005). A separate analysis of the DRG tissue-specific 
knockout of the Nayl.3 failed to show any differences in the development of neuropathic 
pain (Nassar et a l, 2006).
1.3.7.2 Voltage gated calcium channel snbnnit aiô-l
The VGCC a 20-l subunit has been shown to be involved in the regulation of neuropathic 
pain (Newton et a l, 2001;Luo et a l, 2001). Following peripheral nerve injury, using 
several neuropathic pain models, two groups demonstrated an upregulation of both 026 
mRNA and protein expression in small and medium diameter DRG neurons. The 
upregulation was highest in the DRG, but also observed in the dorsal horn of the spinal 
cord. Further, Chun-Ying Li et a l  used intrathecal administration of antisense 
oligonucleotides to knock down the 026-1 in nerve-injured rats, and reported a reversal of 
the expected upregulation of a2Ô-l in both DRG and spinal cord. It was apparent that 
antisense was involved in a reversal of mechanical allodynia to some degree, but the 
authors reported that the antisense treatment resulted in an incomplete knock down and 
large variations between treated animals were observed (Li et a l, 2004). From a 
pharmacological perspective, the anticonvulsant Gabapentin/Pregabalin binds to «20-1 and 
has since then shown a better than existing drug profile for the treatment of neuropathic 
pain (Gilron, 2007).
1.3.7.3 Bradykinin Bl
The Bradykinin Bl receptor is induced as a consequence of inflammation and plays an 
important role in inflammatory nociception. Recent studies have shown that Bl expression 
is upregulated in DRG after nerve injury (Levy and Zochodne, 2000), suggesting a role for 
Bl in the development of neuropathic pain. Work by Ferreira et al. 2005 showed a 
significant resistance to the mechanical allodynia and thermal hyperalgesia normally
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observed after nerve injury. Further, using a B1 receptor antagonist made it possible to 
reverse the hypersensitivity observed in wild-type mice with nerve injury induced by partial 
sciatic nerve ligation (Ferreira et al., 2005;Levy and Zochodne, 2000).
1.3.7.4 Microglia/BDNF
A publication from Watkins et al. reported that microglia, a type of glia cells, play a role in 
the development of pathological pain (Watkins et al., 2001) and in particular in neuropathic 
pain a robust change was seen (Griffin et a l, 2007). A blocker of microglial activation, 
minocycline, was shown to either prevent or delay the development of different models of 
neuropathic pain (Raghavendra et al., 2003). BDNF has shown to play a crucial role in the 
communication between the microglia and the neuron. A study showed that ATP activated 
microglia caused a shift in the GABA-A mediated inhibition to excitation in the spinal 
dorsal horn superficial neurons resulting in the release of BDNF. Using siRNA to block the 
release of BDNF from ATP activated microglia, suppressed both the current shift and 
allodynia. Similarly, blockage of the receptor for BDNF (TrkB) was shown to prevent both 
current shift and allodynia suggesting that BDNF is the main signalling molecule released 
fmm activated microglia contributing to allodynia after nerve injury. (Coull et al., 2005).
1.3.8 Dorsal horn termination after neuropathic pain
The central termini of sensory neurons, at the point where they synapse onto the secondary 
neurons in the spinal dorsal horn, exhibit numerous changes after nerve injury. It has been 
claimed that A-fibres, under normal circumstances terminating in lamina I and HI-VI, 
injury can sprout into lamina II after nerve injury (Woolf et al., 1992). As described in 
section 1.2 lamina II normally receives information predominantly from C-fibres and the 
theory suggests that the sprouting may be one of the causes for the development of 
allodynia, one of the characteristics of neuropathic pain. The sprouting of A-fibres has also 
been shown not to be permanent and after a period of months the previously sprouted A- 
fibres are withdrawn from lamina II (Woolf et al., 1995).
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1.4 C e n t r a l  p r o c e ss in g  o f  n o c ic e p t io n
As described, primary neurons synapse onto secondary neurons, from where the 
nociceptive information is carried through to the sensory cortex. The main neurotransmitter 
released after moderate stimulation of the primary neurons is glutamate, which generates a 
fast synaptic response in the second order neurons mediated by the ionotropic N-methyl-D- 
aspartate (NMDA), a-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) and 
Kainate receptors as well as the G-protein coupled glutamate receptors. More intense 
nociceptive stimuli trigger the release of several neuropeptides such as SP, CGRP, iC, ATP 
and BDNF into the synapse cleft.
The nociceptive signals pass through two different pathways to the brain. These pathways 
are referred to as the lateral polysynaptic pathway and the medial polysynaptic pathway. In 
the lateral pathway the signals reach the brain regions via the lateral thalamic nuclei. This 
pathway encodes the sensory discriminative properties of painful stimuli, which are 
perceived in the primary and secondary somatosensory cortices as pain. Only then are they 
localised to a specific region of the body. Signals transmitted through the medial thalamic 
nuclei reach the prefrontal and anterior cingulated cortices of the brain. This pathway is 
involved in encoding the motivational affective properties of pain stimuli, and here the 
stimuli are recognised as unpleasant and defence responses are mediated.
1.5 V o l t a g e  g a t e d  s o d iu m  c h a n n e l s
Voltage Gated Sodium Channels (VGSC) are involved in modulating the resting membrane 
potential (Herzog et al., 2001)) and sub-threshold oscillations, and in the generation and 
conduction of action potentials. They can be divided pharmacologically into two groups 
depending on their sensitivity to the guanidinium compound Tetrodotoxin (TTX), found on 
puffer fish 'Fugu' where it is produced by bacteria. The VGSCs consist of the pore forming 
a-subunit and one or more auxiliary p-subunits (see fig.4). The p-subunits stabilise the 
channel in the plasma membrane and modulate the properties, but are not essential for the 
channel function (Isom et al., 1994). In total ten different isoforms of the a-subunit 
(Nay 1.1-1.9+Nax) and five p-subunits (Pi-P4+Pia) have been identified and cloned. The 
TTX-sensitive Nayl.l, Nay 1.2, and Nay 1.6 are all expressed in the CNS and primary
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sensory neurons. Another TTX-sensitive sodium channel, Nayl.7 is expressed in 
sympathetic neurons, Schwann cells and primary sensory neurons (Toledo-Aral et a l,
1997;Sangameswaran et a l, 1997). Finally, Nayl.S and Nay 1.9 are expressed exclusively in 
sensory neurons and are resistant to TTX (Dib-Hajj et al., 1998).
/T >Hj+
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Figure 4. Structure of the Voltage Gated Sodium Channel.
From (Scheuer and Catterall, 2006)
The role for N ayl.S  in nociception was based on its exclusive expression in over 85% of the 
small sensory neurons (nociceptors) (Akopian et a l, 1996;Okuse et a l, 1997). In the 
Nay 1.8 null mouse, a phenotype to noxious mechanical and some differences to thermal and 
inflammatory stimulation were found (Akopian et a l, 1999).
A double KO of both N ayl.7  and N ayl.8 showed no difference in the development of 
neuropathic pain, but a very significant reduction in the second phase of the formalin 
model, slightly stronger than the reduction seen with the N ayl.7  KG alone (Nassar et a l, 
2005). Interestingly, when exposed to thermal stimulation the double KG showed a greater 
latency in response compared with both the N ayl.8  KG and the N ayl.7  KG. This suggests
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that each channel has an individual role in pain, but possible a combined role which is not 
completely understood.
Navl.9 is also expressed exclusively in nociceptors in the DRG, but data from a transgenic 
mouse line with a disrupted Nay 1.9 channel showed little involvement of the channel in 
either mechanical or thermal acute nociception. Only after inflammatory induced pain did 
the mouse show some reduction in hyperalgesia (Priest et al., 2005). Evidence from another 
Nay 1.9 knockout mouse confirmed previous observations that Nay 1.9 does not contribute to 
acute nociception, but showed a strong involvement in inflammatory pain. When exposed 
to several different inflammatory agents, the Nay 1.9 null mouse showed attenuated 
responsiveness to both thermal and mechanical stimuli, suggesting that Nay 1.9 acts as 
effector of the hypersensitivity seen after inflammation (Amaya et a l, 2006). A third 
Nayl.9 knock out mouse has since then been generated and electrophysiological studies 
confirmed the involvement of the ion channel in inflammation (Ostman et al., 2008).
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2 EXPERIMENTAL APPROACHES
2.1.1 Electrophysiology
Electrophysiological recording of either cells or tissue preparations is a well-established 
method enabling investigation of ion-channel related electrical current over the cell 
membrane. Historically, sophisticated methods have been developed making it possible to 
record from WDR neurons. The patch clamping technique is one of the most recognised 
methods for scientific investigations of cellular currents and many different techniques 
have emerged to test the effect upon current, after physical stimulation of the cell such as 
heat, pressure etc. Also, recordings from WDR neurons make it possible to measure central 
input after peripheral stimulation.
2.1.2 Extracellular electrophysiology
Using electrophysiological recording from single unit WDR neurons makes it possible to 
investigate the modulations in nociceptive pathways at the dorsal horn level after 
stiipulation of the periphery. This technique is mostly used on rats, but Dickenson et al 
have modified it for use in mice (Urch and Dickenson, 2003;Foulkes et a l, 2006). After the 
electrode has been placed (extracellularly) in the WDR neuron in a deeply anaesthetised 
animal, recordings are made after electrical, mechanical or thermal stimulation of varying 
magnitude to the intact hind paw.
The latency relative to initial stimulus makes it possible to distinguish between A- and C- 
fibre mediated responses. A whole range of responses is normally recorded and used to 
characterise the properties at dorsal horn level, examples of which include the analysis of 
two different DRG tissue-specific knockouts. Nay 1.7 (Nassar et a l, 2004) and Annexin 2 
light chain PI 1 (Foulkes et a l, 2006).
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Figure 5. Single unit electrophysiology.
The electrical information generated from stimulation of 
the peripheral nerves is identified by the electrode and 
amplified.
2.1.3 Patch clamp electrophysiology
The patch clamp technique makes it possible to record electrophysiological characteristics 
from either small numbers of ion channels located in the cell membrane or from the whole 
cell. A small glass pipette with a very narrow diameter is attached to the cell with light 
suction. The solution in the pipette is prepared to match the intracellular solution as closely 
as possible. An electrode in the pipette conducts the electrical changes in the membrane 
potential after changes to the extracellular solution or physical stimuli. If the cell membrane 
is broken the recordings will be from the whole cell giving a much larger current. A review 
of different patch clamp techniques is described by (Neher, 1992).
2.2 M icroarray
Functional genomic studies, where mRNA expression is analysed under defined conditions 
(e.g. healthy and diseased), allow us to compare different sets of genes under given 
conditions. Microarray is a tool to measure the expression level of thousands of genes by 
determining the amount of mRNA that is present e.g. differences in gene expression 
between KO and WT.
The Affymetrix gene chip is manufactured by using photolithography combined with 
combinatorial chemistry to produce short strands of oligonucleotides, representing the 
mouse genome, synthesised onto a silica slide.
The method works in principle by making labelled cRNA from cDNA, synthesised from 
mRNA extracted from the desired tissue using poly-T-primers, reverse transcriptase and
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labelled nucleotides. The labelled cDNA is fragmentised and loaded onto the gene chip 
where the fragments will hybridise with their corresponding oligonucleotides. By scanning 
the chip a visual picture can be obtained showing which genes are represented and by 
comparison between the control-baseline and the knock out a list of up- or downregulated 
genes can be generated.
Affymetrix G enechip
1 2 $  cm
Hybridized probe feature ^
Image of hybridized probe array
Figure 6. The Gene chip technology.
Thousands of short sequence oligonucleotides (probes) 
are representing different genes. The hybridization of the 
sample to the probes can be detected by fluorescence.
Microarray technology has been used increasingly over the last 5-10 years. Among the first 
microarray data to be published was the measurement of differences in gene expression 
from 45 Arabidopsis thaliana genes (Schena et a l, 1995). Since then the availability and 
affordability together with reliability has promoted the use of microarray to one of the most 
commonly used methods for the study of gene expression. There remains a dearth of 
published microarray studies related to pain, but among some of the more recent papers is a 
comparison of gene regulation at spinal horn level between three neuropathic pain models 
(Griffin et a l, 2007) and another comparison at dorsal horn level of the regulation of genes 
after CFA induced inflammation (Geranton et a l, 2007).
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One of the things microarray will not reveal is any difference in the translation of mRNA 
into functional protein. Analysis by Western blot would be able to show changes in protein 
levels.
Another important thing is the possibility of false positive genes. Even though more than 
half the probes on the chip is controls a risk is always there and confirmation using qRT- 
PCR is required to validate the microarray data.
2.3  G e n e t ic  m a n ip u l a t io n
By nature, when two sets of genes are combined a subset of both is, then replicated in the 
new organism. Sometimes this leads to ‘mistakes’ -  naturally occurring genetic mutations - 
and fortunately scientists have over the years, discovered a number of mouse lines that are 
useful for research. One example is the “ducky mouse” which carries a mutation resulting 
in loss of the full length calcium channel subunit azÔ-l and is used nowadays as a model for 
absence epilepsy (Brodbeck et al., 2002).
In more recent years genetic manipulation techniques have been used to generate 
genetically modified animals and a more systematically approach is the Munich ENU 
Project (MEP). Here chemical mutagenesis using the alkylating agent 'N-ethylnitrosourea 
(ENU) is used to introduce mutations as a model system for hereditary human diseases.
2.3.1 RNA interference
The use of antisense is thought to be able to ‘switch ofT genes and block protein 
expression. By injecting RNA sequence complementary to mRNA transcribed from the 
gene of interest, the antisense RNA would hybridize to the mRNA and block translation. 
Difficulties with delivery, stability and specificity have limited the use of antisense, 
particularly in vivo.
A more recent discovery from work on C.elegans (Montgomery et al., 1998) investigated 
the effect of short double stranded RNA sequences and how they could trigger the natural 
degradation of homologous mRNA. Since then, it has been demonstrated that double 
stranded RNA of more than 30 nucleotides initiates an interferon based inflammatory 
response that causes unspecific translational suppression involving the dsRNA RNAse III
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enzyme DICER (Elbashir et al., 2001). Today, most studies use 21-23 nucleotide 
synthetically RNA duplexes. The duplex assembles with a multiprotein nuclease complex, 
RNA-Induced-Silencing-Complex (RISC), which unwinds the dsRNAs and degrades target 
mRNAs homologous to the single-stranded siRNA in a sequence-specific manner.
2.3.2 Targeted gene deletion by homologous recombination
Reliability and reproducibility are very important in any research, and the use of transgenic 
animals can be an immensely powerful tool, both reliable and reproducible, to investigate 
the function of a particular protein. Since its first use in the early eighties, reliability was a 
problem due to the ‘random insertion’ after pronuclear injection into fertilized single cell 
mouse embryos (Palmiter et al., 1982). There was no control over insertion site or number 
of copies, so each transgenic line generated could have its own pattern, making it difficult 
to distinguish the desired pattern (Feng et al., 2000).
Using homologous recombination to ‘knock in’ the transgene into a specific locus increased 
the reliability of the procedure, and with the use of tissue-specific recombinase systems 
early embryonic lethality could also be prevented by restricting the gene deletion to the 
tissue expressing the enzyme. Nonetheless, some issues remained as the enzyme must be 
driven by a specific promoter, which means the gene deletion would only happen when this 
promoter was active. To resolve this problem, several drug-inducible and tissue-specific 
Cre mouse lines were developed using different drugs to switch on the recombinase 
enzyme (Feil et al., 1997).
2.3.2.1 The Recombination system CrdloxP
This system consists of the Cyclization Recombination protein (Cre) of the PI 
bacteriophage and its short DNA recognition sequence loxP:
ATAACTTCGTATAATGTATGCTATACGAAGTTAT. The recombination protein Cre 
catalyses the recombination of the sequence between the loxP sites, depending on the 
orientation of the sites. If the loxP sites are placed in opposite directions, the sequence 
between the loxP sites will be inverted by Cre. If sitting in the same direction, the flanked 
sequence will be excised.
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Two different transgenic mouse lines are needed to use this system. One mouse expresses 
the recombination protein Cre and the other has been modified so loxP sites are flanking 
the gene of interest. In general, a plasmid has to be constructed that will integrate into the 
genome when transfected into embryonic stem cells.
For the floxed mouse, the construct contains loxP sites flanking the sequence of interest and 
next to them sequences homologous to the genomic sequence promote homologous 
recombination, the event where DNA from donor and host is exchanged. For positive 
selection a neomycin cassette is inserted between the loxP site and the 3’arm. For negative 
selection, a thymidine kinase cassette is inserted downstream of the 3’arm. This is useful to 
detect random insertion errors occurring in the homologous recombination.
The Cre-construct contains the chosen promoter followed by the coding sequence for Cre 
starting with ATG. The sequences of homology and selection cassettes are as for the floxed 
construct.
After successful recombination has been confirmed the stem cells are introduced into 
blastocysts and inserted into “pseudo-pregnant” mice for gestation. The CrdloxP system is 
now a well established system and several reviews exist describing the development, 
mechanisms and possibilities using the recombinase systems (Nagy, 2000) and 
(Lewandoski, 2001)
2.3.2.2 Flp-FRT system
This system is based on the budding yeast Saccharomyces cerevisiae and works like Cre as 
a site specific recombinase. The Flp recognition target FRT repeats which have similar size 
properties as the loxP sites with the following sequence: 
GAAGTTCCTATTCTCTAGAAAGTATAGGAACTTC.
Due to its origin in yeast, the Flp is optimal at 30°C and has been subsequently modified to 
optimise its performance at 37°C.
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Figure 7. The Ctq/IoxP system.
The Cre expressing mouse is crossed with a floxed 
mouse to generate the tissue-speciflc KO mouse. Cre will 
recognise the loxP sites and delete the sequence flanked 
by the sites.
2.3.2.3 The Navi.8Cre mouse line
A Cre recombinase mouse line was generated by Stirling et al. linking the expression of Cre 
to the N ayl.S promoter (Stirling et al., 2005). The Voltage Gated Sodium Channel Nayl.S  
was identified by Akopian et al. and its distribution limited to a subset of sensory neurons 
of which >S5% are nociceptors (Akopian et a l, 1999;Djouhri et a i, 2003). Knock-In 
technique was used place the Cre-recombinase coding sequence at the ATG initiator of the 
Nayl.S. The expression pattern of Cre was confirmed to mimic the pattern of N ayl.S and
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motor function, behaviour and electrophysiology were characterised as normal. Onset of 
Cre expression is at embryonic day 14 in small diameter DRG, trigeminal and nodose 
neurons. The electrophysiological properties of heterozygous Nayl.SCre DRG were 
compared with Nayl.S wild type DRG. The loss of a single copy of the Nayl.8 gene did not 
affect the TTX-resistant current density in DRG neurons (Stirling et a l, 2005).
The Nayl.SCre mouse line has been used successfully to investigate several genes such as 
Nay 1.3, Nayl.7, Brain derived neurotrophic factor (BDNF) and annexin light chain PI 1 
(Foulkes et al., 2006;Nassar et a i, 2004;Nassar et a i, 2006;Zhao et a i, 2006)
In the Nayl.SCre mouse line described above, the Flp-Frt system was used to excise the 
Neo cassette used for positive selection.
2 .4  I n  v iv o  b e h a v io u r a l  a sse ssm e n t  o f  n o c ic e p t io n
Reliance upon behavioural testing is inevitable when investigating mechanisms for 
nociception using transgenic mouse lines. For the investigator it is of great importance to be 
aware of the possible pain and stress the mice can be under during any experiments. For 
this reason, good planning, training and knowledge of available test models are important 
in order to minimise any risk of unnecessary harm to the animals, because this not only 
results in unreliable data, but more importantly put the animal’s welfare at risk.
A general overview of animal behaviour is described in (Hogan, 2002).
2.4.1 Mechanical
The two preferred methods of mechanical testing to mimic innocuous and noxious 
mechanical stimuli are von Frey filaments and the Randall Selitto apparatus. A number of 
other methods have been reported and will be discussed below.
2.4.1.1 von Frey filaments
Von Frey testing is one of the most widely used methods by which to assess mechanical 
response threshold. Calibrated nylon filaments deliver a graded mechanical force to the 
hind paw of the mouse. The filament is applied for around 2-3 seconds and a positive 
response is recorded if the mouse lifts its paw during application.
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One way the experiment can be performed is by applying a set of hair filaments, ranging 
from 0.07g to 1.4g, 5 times each and recording any positive responses, as described by 
Fuchs et al (Fuchs et al., 1999). The analysis is based on the percentage of positive 
responses for each hair and the 50% threshold can be determined.
Another method is the up-and-down method described by Chaplan et al. which benefits 
from using fewer applications of filaments, but still calculates the 50% threshold. The 
filament expected to give a positive response 50 percent of the time is applied. This 
application is followed by a filament of weaker strength if the mouse did respond or of 
stronger rigidity if it did not respond. This is repeated several times either side of the 50% 
threshold. The pattern of positive responses together with the force of the last hair applied 
is used to calculate the 50% threshold (Chaplan et al., 1994).
2.4.1.2 Randall Selitto apparatus
The Randal Selitto test was developed by Randall and Selitto in 1957 and originally 
developed and used on rat paws, but has since then been modified to use on mouse tails 
(Takesue et al., 1969).
When using the Randall Selitto apparatus an increasing mechanical pressure from a blunt 
probe is applied to the tail of the mouse until a withdrawal response is registered and the 
final weight is recorded. When using the test on rats the experimenter has to train the rats so 
the instrument can be applied to the paw. When using on mice, a Perspex glass restrainer is 
used to access the tail.
Using von Frey, a blunt thin filament is applied. The response is believed to be due to touch 
sensitive neurons. It is not a noxious stimulus, but an irritant sufficient to evoke a response. 
The Randal Selitto apparatus applies an increasing pressure from a 3mm^ blunt probe 
activating high-threshold mechanoreceptors in the C-fibres and is considered to be a 
response to a noxious insult (Hogan, 2002).
2.4.2 Thermal
A host of different thermal stimulation methods exist and five are described briefly in the 
following paragraphs.
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2.4.2.1 Hargreaves’ test
The Hargreaves instrument allows the mouse to settle in a small chamber on top of a glass 
surface, before thermal responses are tested using a focused light beam applied to the hind 
paw through the glass plate. The latency in seconds until the mouse first responds to the 
heat is monitored. The test was described by (Hargreaves et al., 1988) and is considered to 
be a spinal reflex due to the fast paw withdrawal.
2.4.2.2 Hot plate
Using the hot plate test, the mouse is placed on a hot plate between 50-55°C until any 
licking, biting or flinching in the hind paws is observed. The response is considered a 
supra-spinal response involving higher centres (Jensen and Yaksh, 1984) and was first 
described by Woolfe and MacDonald (WOOLFE, 1943).
The different techniques used in the two thermal tests evoke a different type of response in 
the mouse. The Hot plate exposes the paw (and mouse) to a constant thermal stimulus, 
whereas the Hargreaves is a radiant heat source only applied to the paw. As noted above 
this results in different patterns of withdrawal.
2.42.3 Tail-flick test
This test is today performed by exposing the tail to a radiant heat source and measuring the 
latency in seconds before the tail flicks away from the heat. The mouse is placed on a base 
with its tail placed on top of a focused beam. When the mouse has settled the beam is 
activated and delivers a strong noxious thermal stimulus. Historically this test had been 
performed by immersing the tail in warm or cold water.
2.4.2 4 Cold pain
Few models for the investigation of noxious cold have been described. Among them, the 
most typical way is to use a temperature-controlled plate cooled to 0°C. After the mouse is 
placed on the plate, lifts of the paws are counted for 5 minutes. This test is repeated twice 
with at least one hour in between (Zimmermann et a l, 2007).
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Another test, the temperature preference test, uses the same principles, but has two plates in 
conjunction with each other and is probably a non-noxious test. Using this set-up two 
different temperatures can be programmed and if the mouse does not respond to the cold, 
the time spent on each plate should be the same (Colburn et al., 2007). Finally, the 
application of a volatile liquid, such as acetone, undergoes an endothermie reaction in the 
change of phase from liquid to gas. The time the mouse spends licking and biting the 
affected paw is measured.
2.4.3 Inflammatory models
Inflammatory models can be wide-ranging depending on the compound inducing the 
response. Formalin is a very short-lasting model with the response ending after less than an 
hour. The response to Carrageenan lasts for several hours whereas CFA gives rise to a long- 
lasting inflammatory response that can be followed for days. Specific receptors or ion 
channels can be tested by using different compounds such as Substance P (NK-1),
Capsaicin (TrpVi), NGF (TrkA) etc.
2.4.3.1 Formalin
Injecting 5% formalin into the plantar surface of the paw results in tissue damage and a 
typical and widely described behavioural pattern in the mouse. The response can last up to 
one hour and is divided into two phases: the first 5 minutes are considered direct chemical 
stimulation of the free nerve endings; the response from 10-60 minutes is considered 
inflammatory as modulators are released in the affected tissue.
2.4.3 2 Complete Freund’s Adjuvant (CFA)
Complete Freund’s Adjuvant consists of dried and inactivated Mycobacterium butyricum 
emulsified in mineral oil, inducing an inflammatory response. Compared with injection of 
Formalin, CFA, when injected into the plantar surface of the hind paw, generates a long 
term inflammatory response resulting in both mechanical and thermal hyperalgesia tested 
using von Frey filaments and Hargreaves’ instrument respectively. The model, described
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for use in rats by (Millan et ai., 1988) results in an inflammatory response developing 
within 24 hours and lasting for longer than one week.
2.4.33 Carrageenan
Carrageenans are a complex group of polysaccharides, extracted from red seaweed, made 
up of repeating galactose-related monomers, which form thermo reversible gels. There are 
three main types -  lambda (A.), kappa ( k )  and iota (i) -  each with different characteristics, 
k-carrageenan does not form a gel at room temperature and can therefore be used for 
injection, resulting in a reproducible inflammatory response that is maximal 3-5 hours 
following injection (WINTER et al., 1962). Thermal hyperalgesia is measured using 
Hargreaves’ instrument.
2.4.3 4 Nerve Growth Factor
Nerve Growth Factor expression is upregulated due to inflammation (Woolf et al., 1994) 
and can be assessed by injection of NGF direct activation of the TrkA receptor, expressed 
in nociceptors (Fang et al., 2005). Injection of NGF is widely used to further characterise 
the inflammatory response. The hyperalgesic response after NGF injections is tested using 
thermal stimulation.
2.4 3.5 Capsaicin
TrpVi is activated by Capsaicin and specific responses to capsaicin can be performed by 
injecting Capsaicin (0.5-2.5pg/paw) into the plantar surface of the paw and monitoring the 
licking/biting behaviour for up to 5 minutes (Dhaka et a l, 2007).
2.4.4 Spontaneous pain
Models for spontaneous pain are not very well established, but recently Djouri et al. 
described a model for rats using injection of CFA (Djouhri et al., 2006). After injecting 
CFA, both in the paw and to the side of the knee joint, behavioural observations were 
performed on day 1, 2, 3 and 7. The spontaneous pain was reported as the cumulative time
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the rats spend having spontaneous foot lifting over two periods of 5 minutes. This model of 
spontaneous pain has not previously been reported for use in mice.
2.4.5 Neuropathic pain models
There exist a variety of animal models for neuropathic pain that interfere with the sciatic 
nerve and as such attempt to be analogous to human neuropathic pain. Fig. 8 gives an 
overview of some of the models.
2.4.5.1 Chung
The Chung models, described in rats by Kim and Chung (Kim and Chung, 1992) are two 
different models of ligation of the spinal nerve innervating the hind paw. The first model 
involved tight ligations of L5 and L6; the second only a tight ligation of L5. Substantial 
innervation fi*om the remaining spinal neurons to the hind paw would still exist, allowing 
testing for hyperalgesia. Behavioural analysis revealed development of mechanical 
hyperalgesia lasting many weeks with thermal hyperalgesia also developing, but more 
short-lived than the mechanical. Since then. Honore et al. (2000) have tested the second 
model on mice and evidence suggests that they develop the same characteristics as those 
observed in rats (Honore et al., 2000).
2.4.5 2 Seltzer (PSNL)
Partial Sciatic Nerve Ligation (PSNL) is a ligation of of the sciatic nerve and was 
described by Seltzer et al. in rats in 1990 (Seltzer et al., 1990) and modified to mice by 
Malmberg and Basbaum in 1998. The surgery results in a reproducible syndrome in the 
mouse, where a decrease in thermal and mechanical nociceptive thresholds is observed as 
well as prolonged changes in neurotransmitter and receptor expression (Malmberg and 
Basbaum, 1998).
2.4 5.3 Other neuropathic pain models
The Chronic Constriction Injury (CCI) model was developed and described by Bennett and 
Xie involving four loose ligations around the sciatic nerve (Bennett and Xie, 1988).
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The spared nerve injury model (SNI) is based on axotomisation of the tibial and peroneal 
nerves sparing the sural nerve (Decosterd and Woolf, 2000).
For all models using ligations it is important to be consistent with the tightness of the 
ligations. For SNI and CCI and PSNL the surgery is simple, but to reproduce the thickness 
of the sciatic nerve ligated can be difficult due to the size. With the CCI the tightness of the 
ligations also has to be reproducible as up to four of them are placed around the sciatic 
nerve. Chung (SNL) on the other hand, is very reproducible, but is much more invasive and 
the surgery itself is more delicate and can take up to 30 minutes per animal.
Spinal cor<
[SNL model
ain
^  PSNL model
CCI model i 
Peripheral model
Common peroneal I' Sural 
Tibial
Figure 8. Models of neuropathic pain.
SNL; Sciatic Nerve Ligation (Chung),
PSNL; Partial Sciatic Nerve Ligation (Seltzer) 
CCI; Chronic Constriction Injury 
SNI; Spared Nerve Injury.
From (Ueda, 2006)
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P r o je c t  o u t l in e
A brief introduction to each part of my project will be included for the respective chapters. 
The main parts include:
Tissue-specific deletion of Navl.8-expressing sensory neurons
Using the tissue-specific Nayl.SCre mouse line crossed with the Diphtheria toxin fragment- 
A floxed mouse line, a nociceptor specific transgenic mouse line with all Nayl .8-expressing 
neurons deleted was generated making investigations into the role of Nay 1.8-expressing 
neurons possible. As described above, behavioural assessment, immunohistochemical 
description and single unit electrophysiology was used to characterise the mouse. Finally 
microarray was used to identify transducers for different pain modalities.
Behavioural investigation of the Papin knockout mouse
A knockout mouse line mutant for the Plakophilin-related Armadillo repeat Protein- 
Interacting PDZ protein (PAPIN) identified in a yeast-two-hybrid screening using Nayl.8 as 
bait was investigated for responses to mechanical, thermal and inflammatory stimulation. 
Immunohistochemistry was used to characterise the cell expression in the DRG tissue.
Pharmacological characterisation of the Nayl.7 selective blocker, PhlTxl
Nayl.7 has been proven increasingly to be involved in the development of several pain 
modalities. A recent identified blocker, PhlTxl isolated from the Tarantula spider, specific 
for the Nayl.7 ion channel was tested on wild type mice on responses to mechanical, 
thermal and inflammatory responses and after the introduction of neuropathic pain.
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3 MATERIALS AND METHODS
3.1 M olec u la r  BIOLOGY
3.1.1 Genotyping
Mice of at least 4 weeks of age were marked using an ear puncher. The tissue samples from 
the ear were used for genotyping. Tissue samples from the tail was in some cases obtained 
for genotyping as described below.
3.1.1.1 DNA extraction
From tail sample:
2-3 mm of tail was snipped from each animal according to the Animals (Scientific 
Procedures) Act 1986. The tissue was incubated in a microfuge tube holding 500 pi of 
lysisbuffer for 6-12 hours at 55°C.
DNA Lysis buffer
100 mM Tris-HCl (pH 8.0)
5 mM EDTA 
0.2% SDS 
200mMNaCl 
(Stored at RT)
To each tail sample Proteinase K (PK) was added in 1:200
After incubation the solution was vortexed and any undigested tissue was isolated by 
spinning at 14.000 rpm for 5 min before the supernatant was transferred to a new microfuge 
tube.
One volume of isopropanol was added and the tube inverted to precipitate the DNA, 
followed by centrifugation at 14.000 rpm for 15 min.
The supernatant was discharged and the pellet was washed in 500 pi 70% ethanol twice. 
After removing the supernatant the pellet was air dried for 2-5 min before the DNA was 
resuspended in 200 pi TE buffer.
The PK was inactivated for 15 min at 65°C.
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If further purification was needed, the supernatant from the extraction was mixed with 
phenol/chloroform, vortexed and spun for 2 min at 14.000 rpm. The supernatant was 
transferred to a new tube and 1 volume of isopropanol was added. After inverting the tube a 
few times, the tube was spun for 5 min at 14.000 rpm. The cleaning of the DNA was 
performed as above.
From ear tissue sample:
Alternatively, DNA from a small piece of ear tissue was extracted using the following 
protocol:
3.60ml lOXGB
0.72 ml 25% TritonX-100
0.36 ml b-mecaptoethamol
31.32 ml H2O
36.00 ml
For each 475 pi PCR lysis buffer, 1 pi of 19.7 mg/ml Proteinase K (Roche 03 115n844) 
was added before use.
lOX GB (store at -20 degree)
4.47 ml 1.5MTrispH8.8
1.66 ml 1.0M(NH4>2S04
0.67 ml l.OMMgCh
3.20 ml H2O
10.00 ml
The samples were incubated at 55°C for 1 hour followed by 95° for 5 min to inactivate the 
Protenaise K. The samples were vortexed briefly and kept at -20°C.
3.1.1.2 PCR
Polymerase chain reactions were used to genotype the DNA from each animal.
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DTA-control (no floxed band) Tm Product
S 5’-AAGTCGCTCTGAGTTGTTAT-3’
AS 5’-GGAGCGGGAGAAATGGATATG-3’
58°C 600 bp
DTA-floxed (floxed band) Tm Product
S 5’-AAGTCGCTCTGAGTTGTTAT-3’
AS 5 -GCGAAGAGTTTGTCCTCAACC-3
59°C 300 bp
Cre recombinase Tm Product
S 5 -AAATGTTGCTGGATAGTTTTTA-3'
AS 5 -AAATTTGCCTGCATTACCGGTCGA-3
64°C 450 bp
PAPIN-WT Tm Product
S 5 -CAAGAGTCACTTATCTTTGTAAGACCTCTA-3'
AS 5 -ACTTATGGAACAGAATATAAAAGGCAAG-3'
58°C 420 bp
PAPIN-KO Tm Product
S 5 -CAAGAGTCACTTATCTTTGTAAGACCTCTA-3 ’
AS 5 -GGATAAGTATGACATCATCAAGGAAAC-3'
58°C 570 bp
In general the following conditions for the PCR reactions were used:
0.5 pg template DNA
2.5 pi 10 X PCR Buffer
1.5 p lM g C l2 (2 5 m M )
1.0 pi dNTP (5 mM)
1.0 pi of each primer (50 pM)
"H 2O up to 24.7^1
0.3 pi Taq polymerase 
Voltot: 25 pi
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3.1.1.3 PCR protocol:
Dénaturation at 94°C for 3 min.
Dénaturation at 94°C for 30 sec.
Annealing at 58-66°C for 40-70 sec (Tm).
Extension of the product at 72°C for 1-2 min.
Repeating step 2-4 29-34 times 
Keeping the PCR product at 10°C oo.
3.1.2 Gel electrophoresis
For separation of RNA or DNA bands by size, agarose gel electrophoresis was used 0.8-1.5 
percent agarose gels, depending on the sizes of fragments, were prepared by dissolving 
agarose (Sigma, UK) in TAB IX buffer IXTAE (40mM Tris-acetate, ImM EDTA). After 
cooling Ethidium bromide was added (0.5pg/ml) before the gel was loaded onto the gel tray 
and left to set. The samples were loaded into separate wells together with a 1-3 pi of 
loading buffer. From a power supply 80-120 volts were used to separate the bands. Bands 
were visualised using UV, UVP Biodoc-It™ Systems, and a picture printed from a thermal 
printer (Mitsubishi Video Copy Processing)
3.2  A f f y m e t r ix  M ic r o a r r a y
3.2.1 RNA isolation
DRG from DTA-control and DTA CRE animals were dissected and kept in RNAlater 
(Qiagen, UK). From each animal one DRG was kept for immunohistochemistry control.
The tissue was pooled in groups of two mice and the tissue homogenised using glass 
homogeniser cleaned with ddH20 followed by DEPC treated water (Ambion, UK) and 
finally once in 1 ml Buffer RLT. The tissue was kept on ice throughout the procedure. The 
tissue samples were passed through a QIA shredder column (Qiagen, UK) and spun down 
for 2 min at 14K rpm. The supernatant was transferred to a clean tube and 1 volume of 70% 
ethanol was added and mixed. The mixture was added to an RNeasy column and spun for 
15 sec. at 14K rpm. Buffer RWland twice Buffer RPE was added in turn, spun and the
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flow-through added, followed by the next buffer was added. Finally the column was placed 
in a collection tube and the column spun for 1 min at 14K rpm. The column was then 
placed in another collection tube and RNase free water was added to the column membrane 
before being spun again at 14K rpm for 1 min.
The concentration and quality of the RNA was measured using Nanodrop (BiotechLab,
UK) and a minigel (Experion, Bio-Rad) was run to check the 28s and 18s ratio. A 28s/18s 
ratio around 2 is considered very good, but less than 2 is also acceptable. Finally the sample 
was stored at -80°C.
3.2.2 First strand cDNA Synthesis
One-Cycle cDNA Synthesis kit (Affymetrix) was used for first and second strand cDNA 
synthesis.
The RNA eukaryotic sample (2pg), poly-A RNA controls and T7-oligo(dT) primer were 
mixed with RNase fiee water. The tubes were gently mixed and spun down for 5 sec. 
before being incubated for 10 min at 70°C. The tubes were cooled down and spun briefly 
again to collect the sample.
In parallel the First-Strand Master Mix was prepared. 7pl was added to each tube of 
RNA/poly-A/T7 mixture before the tubes were incubated for 2 min at 42°C.
1 pi of SuperscriptU was added and the contents of the tubes gently mixed before 
incubating for a further 60 min. at 42°C. The tubes were cooled to 4°C and spun to collect 
the sample and stored at 4°C for the second-strand cDNA synthesis.
3.2.3 Second-strand cDNA synthesis
The Second-strand Master Mix was prepared and added to each first-strand synthesis 
sample. The tubes were briefly spun before incubating for 2 hours at 16°C. T4 DNA 
Polymerase was added and incubated for 5 min further at 16°C. After incubation 0.5M 
EDTA was added and the sample was cleaned.
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3.2.3.1 Cleanup of Double-Stranded cDNA
To each cDNA tube 600pl cDNA ‘Binding Buffer’ was added. The solutions were mixed 
and added to a cDNA Cleanup colunm placed in a collection tube. The column was spun 
down for 1 min at lOK rpm and the flow-through discharged.
The column was washed using cDNA Wash Buffer and spun for 1 min at lOK rpm 
followed by a further 5 minutes spun at 14K rpm. cDNA Eluation Buffer was added to the 
column membrane and collected by spinning the column at 14K rpm for 1 min.
3.2.3.2 In vitro transcription of Biotin-Labelled cRNA Synthesis
To the template cDNA a mixture of labelling buffer, labelling NTP mix and labelling 
enzyme mix (TVT Labelling Kit, Affymetrix) was added and gently mixed before 
incubating at 37°C for 16 hours. The labelled cRNA was stored at -80°C.
3.2.3.3 Clean-up of Biotin labelled cRNA
Gene chip Sample Cleanup Module (Affymetrix) was used for the cleanup of cDNA
The labelled cRNA was cleaned using Affymetrix Clean-up Module (Affymetrix, US). To 
each tube RNase free water. Binding buffer and ethanol were added, mixed, and the total 
transferred to a cleanup spin column. The column was spun briefly before wash buffer was 
added and followed by another brief spin.
The cRNA quality and concentration was checked using the Nanodrop (BiotechLab, UK) 
instrument.
3.2.3 4 Fragmentation
20|ig of labelled cRNA was mixed with 8pi of 5x Fragmentation Buffer (Affymetrix 
Clean-Up module) the mixture was incubated for 35 min at 94°C.
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The fragmentation was checked on a mini gel (Experion, Bio-Rad) able to distinguish very 
small bands.
3.2.4 Hybridization, Scanning and Analysis
For each gene chip (mouse genome 430 2.0m array, Affymetrix) 20pg of fragmentated 
biotin-labelled cRNA was used.
The hybridization, scanning and further analysis was performed by the Scientific Support 
Services, Wolfson Institute for Biomedical Research, UCL, UK
The gene abbreviation obtained was identified further using the online software, SymAtlas 
version 1.2.4 from © Genomics Institute of the Novartis Research Foundation 
(http://svmatlas. gnf.org/SvmAtlas/about. i sol which provides a description of the function 
of the gene, tissue distribution and links to pubmed (NCBI) for any reported scientific 
involvement of the gene.
3.3 Q u a n t it a t iv e  (r e a l t im e ) PCR
Primers were designed using Netprimer (PREMIER Biosoft International) and PearlPrimer 
(SourceForge.net) and used with iQ™ SYBR® Green Supermix (Biorad 170-8882. All 
reactions were prepared on ice and run using a Biorad iCycler PCR machine. iQ™ SYBR® 
Green Supermix (Biorad 170-8882
Primers:
Navl.8
ScnlOa s 5 -TGCAGATGCCTACACTGAGAAA-3'
ScnlOa as 5 -AGTGAGCTAAGGATCGCAGAAA-3'
P-Actin
qActb s 5’-TTCTTTGCAGCTCCTTCGTT-3’
qActb as 5’-CGATGGAGGGGAATACAGC-3’
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TrpCô
TRPCô s 
TRPCô as
5’-ATTGATAAGGAGAGCGATGAGG-3’ 
5 -AGGTCTTCTGTGTTCTGTGATTTC-3 ’
Edg7
Edg7 s 
Edg7 as
5’-TCCCATGAAGCTAATGAAGACAG-3’ 
5 -TTCATGACGGAGTTGAGCAG-3 ’
TrpV,
TrtpVi s 
TtrpVi as
5’-CATCATCAACGAGGACCCAG-3’ 
5 -AACCAGGGCAAAGTTCTTCC-3 ’
TrpMg
TrpMg s 
TrpMg as
5 ’-CGTATCATTTAGGAAGAAACCCA-3 ’ 
5’-GAGGAAGGCGATGTAGAAGAC-3’
Programme:
Step 1 3 min 95°C
Step 2 30 sec 95°C
Step 3 30 sec 60°C
Step 4 For ever 4°C
Step 2-3 repeated 40 times.
Programme (melt curve)
Step 1 1 min 95°C
Step 2 1 min 55°C
Step 3 10 sec 55°C (increasing by 0.5°C per cycle)
Step 4 For ever 4°C
Step 3 repeated 80 times.
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3.4 iMMUNOfflSTOCHEMISTRY
3.4.1 Perfusion-protocol
After deep anaesthesia with Euthatal (150 mg/kg, i.p., Rhone Merieux), animals were 
transcardially perfused with 10 ml heparinized saline (0.9% w/v NaCl) followed by 25 ml 
of freshly prepared 4% w/v paraformaldehyde in 0.1 M phosphate buffer (PB) pH 7.4. The 
DRG were post-fixed in the same fixative solution for 2 hours at 4°C and then 
cryoprotected overnight in 30% w/v sucrose containing 0.02% sodium azide in 0.1 M PB at 
4 °C. These perfused DRG were embedded in OCT embedding compound (BDH) on dry 
ice and stored at -80 C.
For dissection of the spinal cord, the vertebrae were cut to access the intact spinal cord. The 
axons entering the spinal cord were further cut before the spinal cord was removed and 
treated in the same way as DRG described above. For the freezing in OCT the spinal cord 
was placed to make cross sections possible.
When using fresh tissue, the dissected DRG were frozen down in blocks of OCT and kept 
at -80°C.
3.4.2 Sectioning
DRG was sectioned using a cryostat (Bright, UK). The 8-11 pm sections were mounted on 
electrostatically charged slides (Superfrost Plus, BDH) and left to dry for around 30 min at 
RT. For non-fixed sections, the slides were placed in ice-cold 4% PFA for 5-10 min.
Spinal cord was sectioned at 20pm and placed on Superfrost slides ad described above.
3.4.3 Staining
Slides were washed three times for 5 min in IxPBS and placed in an 
immunohistochemistry perspex tray. For each slide, 200 pi blocking solution (PBS/10% 
Goat serum (Gibco BRL)) was added and left at RT for 1-2 hours. The blocking solution 
was replaced by 200 pi of the primary antibody diluted in PBS containing 0.1% triton- 
XIOO (PBST) and left at RT over night. The slides were then washed 3-6 times in IX PBS.
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To each slide 200|il of secondary antibody diluted in PB ST was added and left in the dark 
room at RT for 1-3 hours. A further three washes in IX PBS were carried out before a drop 
of Aqueous Mounting solution (Sigma) or Citiflour (Citiflour Ltd, UK) was used to mount 
the coverslip (BDH).
The slides were analysed using a Leica epifluorescent microscope and Openlab software. 
The pictures were opened and merged using GIMP (Version 2.2.12.) software.
Primary antibodies
Antibody Tissue Dilution
IB4 -  Isolectin B4 biotin labelled (Sigma, UK, Perfused 1/200
L2140)
CGRP (Sigma, UK) Perfused 1:5000
Peripherin, IgG mouse monoclonal anti peripherin No perfusion 1:800
(Sigma, UK, P-5117)
Neurofilament, IgG Rabbit anti neurofilament 200 No perfusion 1:1000
(Sigma, UK, N4142)
N52, Sigma Perfused 1:1000
Navl.8, SNSl 1 (Okuse et al., 1997) No perfusion 1:1000
Substance P, IgG Rabbit anti-SP Perfused 1:500
Secondary antibodies
Streptavidin conjugated Alexa488 (Sigma, UK) 
Alexa594, monoclonal goat anti rabbit IgG 
(Invitrogen, UK, 11037)
Alexa488, Alexa flour 488, goat anti mouse IgG 
(Invitrogen, UK, A 11017)
1:1000
1:1000
1:1000
3.4.4 Counting
Intact L4, L5 or L6 DRG from non-perftised WT and KO were sectioned at 11pm thickness 
as described above. They were labelled with anti-peripherin and neurofilament primary
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antibodies. The secondary antibodies, goat anti mouse Alexa 488 and goat anti rabbit Alexa 
594 were used for detection of primary antibody binding and after mounting the number of 
stained cells was quantified for each 8 sections. The result was expressed as the mean 
number of positive cells for each of the lumbar levels.
3 .5  B e h a v io u r  p r o t o c o l s
3.5.1 Animal Breeding Strategy
Mice were housed and bred at the Biological Services Unit animal facility at University 
College London under conditions complying with the Animals (Scientific Procedures) Act 
1992. Homozygous DTA-mice (DTA -/-) were crossed with heterozygous Navl.8Cre (Cre 
+/-) mice to generate a 50/50% mix of DTA-CRE (DTA +/-, Cre +/-) mice and DTA- 
control (control littermates) (DTA +/-, Cre +/+). Throughout this thesis the DTA-CRE and 
DTA-control will refer to each genotype.
3.5.2 Injections of drugs
Compounds injected were diluted to the desired concentration using sterile saline (Sigma, 
UK). A Hamilton syringe (1710 TLL, lOOpl) with disposable needles (Gauge 32, BD 
Microlance) was used for all injections of formalin, CFA, Carrageenan, Capsaicin and 
NGF. The PhlTxl was injected using XX . Saline was used for all dilutions.
3.5.3 Rotarod Protocol
Before any nociceptive testing was performed both DTA-CRE and DTA-control mice were 
tested to ensure their motor function and co-ordination were intact using the Rotarod test 
(Ugo Basile).
The rod was accelerated up to 20rpm before placing the mouse on the rod. After 60 sec. at 
20 rpm the rod was accelerated further until reaching a maximum of 36 rpm within a 
further 90 sec. The total length of time each animal spent on the rod was measured, having 
a cut off time of 300 sec.
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The result was expressed as the mean time each group of mice spent on the rod ± the 
standard error of the mean (S.E.M.).
3.5.4 Weighing Protocol
As a further pre-nociceptive testing the weight of each mouse was monitored to identify 
any difference in weight gain between DTA-CRE mice and DTA-control mice.
Each mouse was placed in a bowl on a scale and the weight monitored. The result was 
expressed as the mean weights for each group of mice ± the standard error of the mean 
(S.E.M.).
3.5.5 von Frey Protocol
The mice were tested in groups of 12 and acclimatised in elevated perspex chambers with a 
metal mesh floor for 60-90 min or until any exploratory behaviour had stopped.
The von Frey filaments (Scientific Marketing Associates, UK) were applied using the 
Chaplan “up and down paradigm” (Chaplan et a l, 1994). Measured response to a hair 
filament would be the withdrawal of the paw from the applied hair. In general, the lack of 
response to the application of one hair-fllament would lead to the application of a thicker 
hair. Likewise, a response would lead to the next application being of a thinner size. The 
experiment would stop when 6 responses had been monitored around the 50% threshold.
All experiments were initiated using filament 7 (0.6g).
The 50% threshold were calculated using DIXON method and the result expressed as the 
mean value± the standard mean error (S.E.M.) (Dixon, 1980).
3.5.6 Randall Selitto Protocol
This test was carried out working with one mouse at a time. The mouse was placed in a 
perspex restrainer and left to settle for 5-8 min. The tail was gently placed under the probe 
of the Randall Selitto instrument (Ugobasile, Italy) before an increasing weight was applied 
to the tail. The weight for which the mouse would withdraw its tail was monitored. The test
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was repeated three times on three different locations of the tail, at % and % down the tail 
starting from the root with around one minute between each measure. The cut-off for all 
Randall Selitto testing was 500 g.
The result was expressed as the mean withdrawal latency in grammes for each group ± the 
standard error of the mean (S.E.M.).
3.5.7 Hargreaves’ protocol
The mice were tested in groups of 12 and acclimatised in perspex chambers with a glass 
floor for 30-60 min until no exploratory behaviour was observed.
The Hargreaves heat source (ETC Life Science, Woodland Hills, CA, USA) was placed 
with the guide light pointing towards the plantar surface of the left hind paw and the 
thermal beam was turned on. A paw withdrawal would stop the test and the time recorded. 
The cut-off time for all testing using the Hargreaves instrument was determined at 20 sec. 
The test was repeated three times for each animal allowing at least 5 min. between each 
test.
The result was expressed as the mean withdrawal latency time for each group ± the 
standard error of the mean (S.E.M.).
3.5.8 Hot plate Protocol
Each of the mice from one cage of mixed genotype was acclimatised separately on the Hot 
Plate instrument (Ugo Basile, Italy), but without any power supply, for 15 min. The Hot 
Plate was heated until 50°C or 55°C and each mouse placed individually on the plate until 
lifting of the hind paws was observed and the latency thereof monitored.
The result was expressed as the mean withdrawal latency for each group ± the standard 
error of the mean (S.E.M.).
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3.5.9 Noxious cold stimulation
3.5.9.1 Cold plate protocol
An incremental hot cold plate analgesia meter (ETC Life Science, Woodland Hills, CA, 
USA) was used to assess noxious cold sensitivity on the plantar surface of the paw as 
previously described (Kwan et a l, 2006;Zimmermann et al., 2007). Mice were placed on a 
cold surface maintained at 0 ± 0.5°C, and pain was assessed by counting the number of 
hind paw lifts or jumping during a 5 min period. The mean of the nociceptive responses 
was determined in two separate trials taken at 60 min intervals to obviate thermal 
sensitization and/or behavioural interferences.
Results were expressed as the mean nocifensive responses for each group ± the standard 
error of the mean (S.E.M.). The results for the two groups were compared using an 
unpaired 2 -tailed /-test
3.5 9.2 Acetone protocol
Mice were placed in the von Frey set-up and acclimatised for 1-2 hours. A drop of acetone 
(Sigma, UK) was applied using a 33 gauge needle inverted and connected to the syringe 
holding the acetone by a thin tube. The drop was applied to the plantar surface through the 
mesh and licking and biting behaviours were measured for 1 minute.
Results were expressed as the mean responses for each group ± the standard error of the 
mean (S.E.M.). The results for the two groups were compared using an unpaired 2-tailed /- 
test
3.5.10 Inflammatory protocols
Each mouse was used for only one inflammatory experiment and was culled afterwards 
according to the Animals (Scientific Procedures) Act 1992.
3.5.10.1 Formalin protocol
Before the injection of Formalin, a tissue was used to restrain the mouse. After the mouse 
had been gently restrained the left paw could be isolated and injected. 20 pi of 5% formalin 
(37% formaldehyde (BDH) in 0.9% saline (Sigma)) was injected subcutaneously into the
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plantar surface of the left hind paw using a Hamilton micro syringe (1710 TLL 50pl). The 
mouse was observed in a perspex cage for the fbllovying 60 min monitoring pain behaviour, 
licking and biting of the injected paw.
The results were expressed in two different ways. First, the results were expressed as the 
mean time spent licking/biting in a 0-10 min interval and a 10-60 min interval. For each 
group ± S.E.M. The results for the two groups were compared using an unpaired 2-tailed t- 
test.
Secondly, the results from each 5 min. interval were expressed as the mean time spent 
licking/biting for each group ± S.E.M. and visualised in a graph showing the development 
in pain behaviour over the 60 min. Each time point was compared using an unpaired 2- 
tailed t-test. The data was also compared using a two-way repeated analysis of variance.
3.5.10.2 Carrageenan protocol
Baseline recordings of responses to thermal stimulation using the Hargreaves instrument 
were obtained before injecting each mouse with 20 pi of 2% Carrageenan in Saline (Both 
from Sigma, UK) into the plantar surface of one of the hind paws. Thermal thresholds were 
subsequently recorded using the Hargreave’s instrument. The injected paw was measured 
after 30 minutes and every hour thereafter up to the 6^ hour.
For each time point of the experiment the data would be analysed as described for 
Hargreave’s and compared with the baseline data using unpaired student t-test.
3.5.10.3 NGF protocol
Baseline recordings of responses to thermal stimulation using the Hargreave’s instrument 
were obtained before 50ng of human recombinant NGF was injected into the plantar 
surface of the hind paw. Using the Hargreave’s test, thermal responses were measured after 
20,40 and 60 minutes and for each hour until the 7* hour.
For each time point of the experiment the data would be analysed as described for 
Hargreave’s and compared with the baseline data using unpaired student t-test.
58
3.5.10.4 CFA protocol
Baseline responses for mechanical and thermal stimulation were obtained according to the 
protocols for von Frey and Hargreave’s methods.
Mice were restrained and injected as described in the formalin protocol. 20 pi of Freund’s 
Complete Adjuvant (Sigma F-5881, UK) was injected into the plantar surface of one of the 
hind paws. On day 1, 2, 5 and 8 mechanical (von Frey) and thermal (Hargreave’s 
instrument) responses were obtained.
For each day of experiments the data would be analysed as described for von Frey and 
Hargreave’s and compared with the baseline data.
3.5.10.5 Capsaicin protocol
Capsaicin was resuspended in DMSG and diluted in saline to obtain a working 
concentration of 0.05 pg/pl. The mice were acclimatised in small enclosed spaces (the 
Hargreave’s set-up) for 1 hour before injecting one mouse at the time with 10 pi (O.Spg) 
capsaicin. The mouse was immediately observed for up to 5 minutes measuring licking and 
biting of the injected paw.
Results were expressed as the mean responses for each group ± the standard error of the 
mean (S.E.M.). The results for the two groups were compared using an unpaired 2-tailed t- 
test
3.5.11 Surgical procedures
The surgical procedures were performed in a designated theatre using a stereo zoom 
microscope (Olympus SZ40, on base SZ-STUl). After the procedure the animals were left 
to recover in separate cages and monitored for any adverse reactions before being moved 
back to their original room.
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3.5.11.1 Chung protocol
Baseline responses for mechanical and thermal stimulation were obtained according to the 
protocols for von Frey and Hargreave’s methods.
Animals were anaesthetised using Halothane (REF). A midline incision was made in the 
skin of the back at the L2-S2 levels and a further incision through the left paraspinal muscles 
was made to access the transverse processes at the L4 -S 1 levels. The L 5 transverse process 
was removed using a blunt fine forceps and the left L5 spinal nerve was cut. The muscle 
tissue was closed with 4-0 mersilk sutures (Ethicon, UK) and clips were used to close the 
skin (Michel suture clip, 7.5 mm, EST, UK).
Responses to mechanical stimulation were assessed according to the protocol for von Frey 
filaments at 3, 5, 7,10, 13, 17, 24 and 31 days after surgery. Responses to thermal 
stimulation were tested on day 4, 11, 18 and 25 according to the protocol for Hargreave’s.
Results fi’om the responses to thermal stimulation were expressed as the relative change in 
the latency at each time point after surgery (test/baseline) for each group ± S.E.M. The 
results for the two groups were compared using a two-way repeated measures analysis of 
variance test (ANOVA).
Results ft"om the responses to mechanical stimulation were expressed as the relative change 
in the 50% threshold at each time point after surgery (test/baseline) for each group ± S.E.M. 
The results for the two groups were compared using a two-way repeated measures analysis 
of variance test (ANOVA).
3.5.11.2 Seltzer protocol
Baseline recordings were obtained as described in the Chung protocol.
Animals were anaesthetised using Halothane. An incision was made in the skin of the upper 
left leg and blunt scissors were used to part the muscle layers to access the sciatic nerve. A 
tight ligation of between V2-V3 of the nerve was made using 6-0 mersilk suture (Ethicon, 
UK). The skin was closed using 4-0 mersilk sutures (Ethicon, UK).
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After at least 3 days of recovery the mice were tested and analysed as described for the 
Chung protocol.
3.5.12 Spontaneous pain
Each mouse was restrained as described in the protocol for formalin. 20 pi of Freund’s 
Complete Adjuvant (Sigma F-5881, UK) was injected subcutaneously into the paw. For the 
second injection, the fur to the side of the knee joint was shaved off and another 2 0 pl of 
CFA was injected subcutaneously at the side of the right knee. On day 1, 2, and 4 each 
mouse was acclimatised for 10-30 minutes in a perspex cage and observed for 2 times 5 
minutes and the number of spontaneous paw lifts monitored.
The result was expressed as the mean number of behaviours for each group ± the standard 
error of the mean (S.E.M.) for each day.
3.6 C a lc iu m  im a g in g
3.6.1 DRG culture
DRG fix)m DTA-control and DTA-CRE mice were dissected and incubated in an enzyme 
digestion mixture (PBS, Collagenase, Dispase, Glucose) for 30 min at 37°C. The DRG 
were washed twice in culture medium and titurated using a Gilsson PI000 pipette to 
separate the cells before being passed through a 100 pm pore cell-strainer (Falcon, UK). 
The cells were pelleted by spinning the suspension for 5 minutes at IK rpm. The cells were 
resuspended in 300-600 pL medium and drops of 30 pi cell suspension were cultured on 
poly-L-lysine and laminin coated cover slips in 35 mm petri dishes. After 60 minutes the 
cover slips were flooded in Dubecco’s modified Eagle Medium (DMEM) containing 10% 
heat-inactivated foetal bovine serum (FBS/Gibco) and 10.000 lU/ml 
penicillin/streptomycin (Gibco). The cultures were used two days after preparation.
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3.6.2 Imaging
Intracellular free calcium was measured using dual excitation fluorescence of the calcium 
sensitive probe Fura-2. Fura-2 was loaded into the cell using the acetoxymethy 1-ester form 
of the probe (Fura-AM, 5uM, 30min, 37°C). Images of cells were recorded using a 12-bit 
grey-scale camera (Hammamatsu 8480) controlled by OpenLab acquisition software. 
Images were obtained at excitation wavelengths of 360 and 380 nm and emitted light 
captured at 520 nm. Exposure times were normally within the range 250 to 2500 msec. Post 
acquisition analysis was undertaken also using OpenLab where 360 and 380 nM images 
were ratioed after background subtraction. In single-cell high-resolution experiments the 
360/380 ratio images were subjected to a calibration procedure using the equation [Ca^^]i = 
Kd* (R-Rmin) / (Rmax-R). the parameters Kd* (1055), Rmin ( .33) and Rmax (1.99), 
determined in separate experiments (Winks et al, 2005). More often the 360/380 ratio data 
was utilised; this was estimated from within defined areas of the cytoplasm (>25 um^).
Prior to any imaging, the cultures were loaded with 1 pL of the membrane permeable 
acetoxylmethyl-ester form of the Ca^  ^sensitive dye Fura-2 (2 pM in 0.1% pluronic F-1278, 
Molecular Probes, Eugene) and incubated for 60 min at RT. Following incubation, the cells 
were rinsed in isotonic external solution, ECF, (145 mM NaCl, 5 mM KCl, 10 mM HEPES, 
2 mM CaCli, 1 mM MgCb, 10 mM glucose, pH 7.4 with NaOH) and allowed 10-20 min to 
de-esterify the dye. The Fura-2-loaded neurons were exposed to a constant flow of ECF. 
Capsaicin, IpM (Roche, UK) was applied for 30 seconds before being washed 
continuously using the ECF. When activating with Menthol, lOOpM (Sigma, UK) was 
applied for 1 min before washed continuously in ECF.
Using a lOX objective, groups of neurons were observed on an inverted microscope (Zeiss 
Axiovert 200). Neurons were exposed to epifluorescence illumination using a Polychrome 
IV system (T.I.L.L. Photonics GmbH, Grafelfing, Germany) with a 150 W xenon lamp 
with light of alternating excitation wavelengths (340 and 380 nm). Emission fluorescence 
(F) was led to an IMAGO CCD camera through a dichroic filter and a 440 nm longpass 
filter. Fluorescent image intensities were expressed as the ratio F340/F380 to allow 
quantitative estimates of changes in intracellular calcium levels. F340 and F380 represent 
the fluorescence intensity elicited by 340 nm emission light (for Fura—Ca^^) and 380 nm
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emission light (for Fura without respectively. All experiments were performed at 
room temperature (23-25 °C).
All data were normalised and expressed as the mean number of Capsaicin (XX) responding 
cells for each group ± the standard error of the mean (S.E.M.).
3.7 E l e c t r o p h y s io l o g i c a l  in v e s t ig a t io n s
3.7.1 Whole cell patch clamping recordings
Voltage-clamp recordings fiom cultured DRG neurons were carried out at a holding 
potential of -60 mV using an Axopatch 200B amplifier (Axon Instruments, Inc.). Pipettes 
were pulled fromborosilicate glass capillaries with a P-97 puller (Sutter Instrument Co.) 
and exhibited resistances of 1-3 MO. Currents were digitized with a Digidata 1322A data 
acquisition system (Axon Instruments, Inc.).
Data was recorded and stored using Clampex 8.1 (Axon Instruments, Inc.). Currents were 
low pass-filtered at 2 kHz and sampled at 11 kHz. Capacity transients were cancelled, and 
series resistance was compensated by 80% minimum. Voltages were not corrected for 
liquid junction potentials. Recordings were performed at room temperature. Off-line 
analysis and statistics were performed using Clampfit 9.0 (Axon Instruments, Inc.), 
SigmaPlot 8 (Systat Software Inc.) and QuickCalcs (GraphPad software). Values were 
expressed as means ± S.E. The standard pipette solution contained 140 mM KCl, 5 mM 
NaCl, 2 mM MgCb, 5 mM EGTA and 10 mM HEPES (pH 7.3). The standard external 
solution contained 140 mM NaCl, 4 mM KCl, 2 mMCaCb, 1 mM MgCb, 10 mM HEPES 
(pH 7.4).
3.7.1.1 Mechanical stimulation of DRG
The probe used to stimulate the neurons mechanically was a heat-polished glass pipette (tip 
diameter ~5-6 pm) positioned at an angle of ~ 60° to the surface of the culture dish. The 
probe was connected to a computer-controlled piezo-electric crystal drive (Burleigh) and 
positioned such that a 10 pm movement did not visibly contact the cell but an 11 pm 
stimulus produced an observable membrane deflection. A 1 pm stimulus was attributed to a 
probe movement of 11 pm stimulation, a 2 pm stimulus to a 12 pm movement and so on. 
The probe moved at a speed of 0.5 pm/ms and the stimulus duration was 200 ms. The
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correlation between action potential properties and DRG neuronal phenotype that exists in 
adult animals was used to distinguish between mechanoreceptive (low threshold) neurons 
and nociceptive (high threshold) neurons. IB4 staining was used to distinguish between 
peptidergic and non-peptidergic IB4^ small neurons.
3.7.2 Mouse spinal cord electrophysiology in vivo.
Intact anaesthetised male and female mice (8 -1 0  weeks) were used in all experiments, in 
accordance with the requirements of the United Kingdom Animals (Scientific Procedures) 
Act (1966). After briefly inducing anaesthesia with 3 % halothane (66  % N2O and 33 %
O2), mice were injected with urethane (240 mg/kg). Animals were placed in a stereotaxic 
frame and a laminectomy was performed to expose the L3 -  L6 spinal segments. 
Extracellular recordings were made from single wide dynamic range (WDR) neurones 
using parylene-coated tungsten electrodes (A-M Systems, USA). Neurones were visualized 
on an oscilloscope, and were isolated and discriminated by spike amplitude and waveform. 
All neurones had receptive fields over the hind paw. Depth of the neurone was measured 
from the surface of the spinal cord.
Electrical stimulation was administered by inserting two needles into the receptive field. A 
train of 16 stimuli was given (2 ms pulse duration, 0.5 Hz at three-times the C-fibre 
threshold). The neuronal responses evoked were superimposed and separated on the basis 
of fibre conduction velocity and latency into total A-fibre-evoked (0 -  50 ms), and C-fibre- 
evoked (50 -  250 ms) action potentials. Neuronal responses occurring after the C-fibre 
latency band (250 -  800 ms) were classed as post-discharge. The ’input’ (non-potentiated 
response) and the ’wind-up’ (potentiated response, shown by increased neuronal excitability 
to repeated stimulation) were calculated as follows: Input = (action potentials (50 -  800 ms) 
evoked by first pulse at 3 times C-fibre threshold) -  total number of pulses (16). Wind-up = 
(total action potentials (90 -  800 ms) after 16 train stimulus at 3 times C-fibre threshold) -  
Input.
A wide range of natural stimuli including brush; von Frey filaments (Scientific Marketing 
Associates, Bamet, UK) in ascending order (1, 6 , 8 , 15, 26 and 60 g) and heat (35, 40, 45 
and 50°C water jet), were applied to the receptive field for 10 seconds per stimulus. Data 
was captured and analysed by a CED 1401 interface (Cambridge Electronic Design,
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Cambridge, UK) coupled to a Pentium computer with Spike 2 software (post-stimulus time 
histogram (PSTH) and rate functions).
Data was analysed from a total of 17 wide dynamic range (WDR) neurones in DTA-CRE 
mice (n=8) and DTA-control littermate controls (n=9). All neurons selected responded to 
innocuous and noxious stimuli.
Statistical analysis was conducted using unpaired t-tests to compare evoked responses of 
DTA-CRE and their DTA-control.
3.8 General  reagents
All general reagents were obtained from Sigma or BDH.
All tools for surgery and dissections etc. were obtained from Fine Science Tools, UK
The Diphtheria toxin fragment A floxed transgenic mouse line was a kind gift from 
Professor Andy Kopp, UCL Institute of Child Health.
The Tarantula spider toxin, PhlTxl was a gift from Dr Pierre Escoubas, University of Nice 
-  Sophia Antipolis, Institute of Molecular and Cellular Pharmacology, Valbonne, France.
The behavioural work on the transgenic PAP IN mouse line was performed at the University 
of Hong Kong, Department of Biochemistry, Faculty of Medicine Building, Hong Kong.
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4 DELETION OF NAyl.8-EXPRESSING NEURONS
4.1 INTRODUCTION -  DIPTHERIA TOXIN
Historically, the toxicity of diphtheria has been exploited in scientific studies by direct 
micro injections into tissues to introduce nerve lesions. Harrison et al. used injections of 
diphtheria toxin (DT) into cats to study remyelination in the CNS (Harrison et al., 1972). 
Another example of the early use of Dipththeria toxin is described in the paper by Baker 
and Bostock using intrathecal injections of DT into rats to investigate Ectopic discharges 
after demyelination (Baker and Bostock, 1992).
This chapter describes how a transgenic mouse line is generated to target the expression of 
diphtheria toxin to the Navl.8 specific population of sensory neurons. The deletion in tissue 
is confirmed and characterised using immunohistochemistry and responses to different 
painful stimuli are assessed. Finally, the changes in the expression of genes in DRG are 
investigated using microarray on RNA isolated from DRG.
4.1.1 Diphtheria toxin mechanism of action
Diphtheria toxin is a two-fiagment toxin consisting of an A-fiagment and a B-ffagment.
The B-fragment binds to a specific cell surface receptor and enables the toxin to insert into 
the phospholipid bilayer. This facilitates transfer of the enzymatic A-fiagment across the 
membrane. The A-fiagment catalyses the transfer of the ADP-ribose moiety of 
Nicotinamide adenine dinucleotide (NAD) to Elongation factor-2 (EF-2), thus inhibiting 
protein synthesis (Collier, 2001). Sensitivity to Diphtheria toxin differs between species 
owing to the lack of cell surface receptors in some species. In rat and mouse in particular 
the sensitivity is very low, around 10,000 fold less than, for example; humans and monkeys 
(Eidels et al., 1983).
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Figure 9. The mechanism for diphtheria toxin cell death.
Diphtheria toxin catalyses the ADP-ribosylation of the 
elongation factor (EF-2) resulting in inactivation of EF-2.
Diphtheria toxin has been used in varying ways to investigate the deletion of specific cell 
populations. In recent years several mouse lines have been generated with the aim of 
expressing Diphtheria toxin fragment A (DTA) linked to a tissue-specific promoter. In 
some cases deletion occurred successfully, but examples of incomplete deletion giving rise 
to insignificant phenotypes have been reported (Breitman et al., 1987). It has been mooted 
that random integration was the cause due to the pronucleus microinjection, leading to the 
deletion of unrelated cells (Ivanova et a l, 2005).
4.1.2 The use of Diphtheria toxin in the mouse
For decades diphtheria toxin has provided a platform for research studies, in recent years 
more sophisticated techniques have been developed to target specific cells. The breeding of 
transgenic mice to target specific cells has been used extensively. One example is the study 
from Chen et al. which exploited the lack of sensitivity of DT in mice to study the olfactory 
sensory neurons after controlled ablation. By introducing the human diphtheria receptor 
under the control of the olfactory marker protein promoter, subsequent injections of 
diphtheria deleted the olfactory neurons (Chen et al., 2005). Another method by which 
specific cells can be targeted is the Cre//ojcP system as described below.
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4.1.3 The DTA floxed mouse lines
A number of transgenic mouse lines have been generated using the CrdloxV system in 
recent years. Researchers from the Institute of Child health. University College London 
generated the ROSA-eGFP-tpA-DTA mouse (Ivanova et a l, 2005) using homologous 
recombination to introduce an eGFP-tpA-DTA (enhanced Green Flourescent Protein - 
Diphtheria Toxin A fragment) construct into the ROSA26 locus which is expressed 
ubiquitously. As fragment A of the Diphtheria toxin will be expressed inside the cell, only 
this fragment is necessary to inhibit the protein synthesis. The construct of the transgenic 
line is based on the insertion of two loxP sites flanking a sequence consisting of an eGFP 
and strong transcriptional termination sequence (tpA), followed by the DTA cassette -  see 
fig. 10. This will keep the expression of DTA silent until the flanked sequence has been 
excised by Cre. The ROSA-eGFP-tpA-DTA mouse was tested using two different Cre lines 
to confirm the successful use of Diphtheria toxin to delete cells in a tissue-specific way.
At least two other transgenic mouse lines have been generated with the ability to express 
DTA in a tissue-specific manner using the CidloxP system (Collier, 2001;Ivanova et a l, 
2005;Sato and Tanigawa, 2005)
4.2 D eletion  of  NAvI.S-expressing  neurons
Navl.8 is expressed in the sensory neurons (nociceptors) and a Cre-expressing mouse line 
has been generated with Cre expression linked to the promoter of Nayl.S. By crossing the 
Nayl.8Cre mouse (section 2.S.2.3) with the floxed DTA mouse a tissue-specific deletion of 
the Nayl .8 positive neurons was possible.
The effect of the deletion of the Nay 1.8-expressing sensory neurons was characterised 
functionally by using a host of nociceptive behaviour assays. Using immunohistochemistry, 
the efficiency of the deletion of Nay 1.8 expressing neurones on the DRG neurons were 
characterised. Finally, single cell electrophysiology was applied to investigate what effect 
the neuron ablation had centrally.
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Overview of the DTA and Nayl.SCre mouse lines. 
From top to bottom:
Insertion of the DTA-construct into the genomic ROSA 
sequence and the PGK-DTA cassette for negative 
selection.
Targeted ROSA-DTA sequence before deletion. 
Targeted ROSA-DTA sequence after deletion.
Nayl.8 genomic sequence -  exon 1-3.
Targeted Nayl.SCre sequence.
(Ivanova et a l, 2005;Stirling et a l, 2005)
4.2.1 Results
4.2.2 Breeding and genotyping
Pairs of homozygous DTA floxed mice and heterozygous Nayl.SCre mice were bred. The 
genotype of the offspring was tested by PCR using primers for the floxed strong 
transcriptional termination sequence tpA (fig. 11) and for the Cre transgene (fig. 12) with 
frequencies following the Mendelian ratios.
The heterozygous floxed DTA mouse expressing Cre will throughout this chapter and 
discussion, be referred to as DTA-CRE. The heterozygous floxed DTA mouse not 
expressing Cre will be referred to as DTA-control.
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Figure 11. DTA floxed genotyping.
Marker (lane 1+12)
Floxed DTA band (250 bp, lane 2-5) 
Floxed DTA band negative control (lane 6) 
Wild type DTA band (600 bp, lane 7-10) 
Wils type DTA negative control (lane 11)
1
CRE genotyping.
Cre-positive band at 450 bp (lane 1+3)
When Cre is not expressed the PCR does not generate 
any band (lane 2 )
4.2.2.1 Motor function and weight
Before any experiments were performed on the mice, differences in weight gain or motor 
function and coordination were investigated to ensure that the mice developed normally. 
None of the mice showed any overt differences in appearance or general behaviour. Their 
vital signs appeared unimpaired and were fertile generating litters of between 6 and 11 
mice.
A group of 14 DTA-CRE mice and 9 DTA-control mice were tested on the rotarod to 
control the motor function.
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No significant difference in the time spent on the rotarod was found with the DTA-CRE 
spending 171±14.55s and DTA-control 158±17.18s on the rod respectively (fig. 13 right).
9 DTA-CRE mice and 9 DTA-control mice of mixed gender were weighed (fig 13. left). 
No significant difference in the weight was found. The DTA-CRE weighed on average 
23.74±1.57g and the DTA-control 22.05±0.56g.
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Figure 13. Motor function and weight for DTA mice 
Rotarod (left) and weight (right).
■ DTA-CRE, □ DTA-control
4.2.3 Immunohistochemistry
Several experiments were performed to quantify and characterise the sensory neurons after 
deletion of the Nay 1.8-expressing neurones.
A quantification was done by counting the small sensory neurones labelled with anti- 
peripherin and the larger neurones labelled by anti-neurofilament. Antibody against Nay 1.8 
was used to detect any remaining Nay 1.8 positive neurons to test for complete deletion.
A further characterisation of the remaining neurons was performed to identify the 
subpopulations of the small sensory neurones, the peptidergic and non-peptidergic, to 
observe what populations were present after deletion.
To check for unspecific binding of the secondary antibody, control of the secondary 
antibody without any primary antibody was carried out for all antibodies used.
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4.2.3.1 88% reduction in peripherin positive cells in DTA-CRE mouse
The Peripherin/neurofilament staining of the small and large neurons respectively, from 
every 8 section from each Lumbar DRG L4, L5 and L6 , were quantified from a DTA-CRE 
and a DTA-control mouse (fig. 14 and fig. 15). Two individual sets of sections were 
counted fi*om each DRG. By counting every 90pm, a representative picture of the 
expression of the cells was obtained. Theoretically no cells would be counted more than 
once (large cells are <90pm) and even though a lot of small cells would not be counted, the 
same procedure were performed for both DTA-CRE and DTA-control mice.
The percentage loss of neurons in the DTA-CRE was calculated by dividing by the DTA- 
control and multiplying by 100 .
Neurofilament Peripherin
WT KO WT KO
L4-1 405 310 648 64
L4-2 368 381 595 96
Mean 387 345.5 622 80
KOAVT*100 89.27% 12.89%
Neurofilament Peripherin
WT KO WT KO
L5-1 364 332 708 105
L5-2 371 419 748 115
Mean 367.5 375.5 728 110
KOAVT*100 97.87% 15.10%
Neurofilament Peripherin
WT KO WT KO
L6-1 414 265 837 60
L6-2 367 321 907 62
Mean 414 293 872 61
KOAVT*100 70.77 7.00
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Pooled L4-L6
Pooled L4-6 86.77% 11.30%
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Peripherin-WT Peripherin-KO Neurofilament-W T Neurofilament-KO
Figure 14. Cell comparison of DTA-control and DTA-CRE DRG
The counting between the DTA-CRE and DTA-control was tested using an unpaired t-test 
with the data pooled from the Peripherin staining and the neurofilament staining 
respectively.
In the DTA mice the number of neuro filament positive neurons was 86.77% of the DTA- 
control (P<0.05), whereas the majority of the peripherin positive neurons were deleted 
leaving only 11.30% (P<0.001) positive neurons compared with the DTA-control. This 
strongly indicates a very effective deletion of small sensory neurons in the DTA-CRE 
mouse by using the Nayl.Sere crossed with the DTA mouse.
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Wild Type L4 DRG DTA-KO L4 DRG
Figure 15. Visualisation of Diphtheria toxin deletion.
Neurofilament (red) and peripherin (green).
4.2.3 2 All Nayl.S-expressing neurons ablated by Diphtheria toxin
A further control of the efficiency of the Nayl.SCre was to stain for the Nayl .8 channel.
The N ayl.S antibody SNSl 1 (Djouhri et a l, 2003) was used on lumbar DRG tissue sections 
from DTA-CRE and DTA-control mice.
In the figure (Fig. 16) the SNSl 1 antibody is co-stained with peripherin. Peripherin will 
label all the small neurons and N ayl.S is expressed in around S5% of these (Djouhri et a l, 
2003). In the DTA-control the N ayl.S is, as expected, co-localised with a large majority of 
the peripherin positive cells and a few large cells as well. Looking at the DTA-CRE 
sections, around SS% of the peripherin positive cells have been deleted. Of greater 
importance is the result that N ayl.S expression in the DTA-CRE mouse is almost 
completely ablated.
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Figure 16. Nay 1.8 staining
DRG sections were stained with anti-Nayl.S (red) and 
anti-peripherin (green).
4.2.3 3 The majority of non-peptidergic neurons are deleted in the DTA-CRE
The small sensory neurons can be divided into two subpopulations. The peptidergic 
neurons express neuropeptides such as CGRP and Substance P and terminate centrally in 
lamina I and outer lamina II. The non-peptidergic population is characterised by binding of 
Isolectin B4 and does not synthesise any neuropeptides.
To characterise the remaining neurons further following deletion of the Nay 1.8-expressing 
neurons, sections were stained for the non-peptidergic (IB4) and peptidergic (CGRP) 
subtypes.
Staining with anti-Isolectin B4 (Fig. 17) revealed a complete absence of non-peptidergic 
neurons at DRG level suggesting that Nay 1.8 is expressed in all non-peptidergic neurons.
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Figure 17. IB4 staining of DRG sections
DRG sections were stained with anti-neurofilament 
(green) and anti-IB4 (red).
4.2 3.4 Some peptidergic neurons remain in the DTA-CRE
To investigate if any peptidergic neurons were left in the DTA-CRE mouse, sections of 
DTA-CRE DRG were stained with an antibody against CGRP (Fig. 18).
The staining showed that in the DRG the majority of the CGRP positive neurons had been 
deleted in the DTA-CRE, but around 11% of remained present in the DTA-CRE when 
compared with the DTA-control mice. This suggests that at least some of the peptidergic 
neurons do not express Nay 1.8 .
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Figure 18. CGRP staining of DRG sections
DRG sections were stained with anti-neurofilament 
(green) and anti-CGRP (red).
4.2.3 5 Residual Substance P positive neurons in DTA-CRE
To investigate the characteristics of the remaining DRG neurons, in more detail, sections 
were stained with anti-substance P antibody (Fig. 19). In the DTA-control a large 
proportion of cells stained positive for the antibody. Interestingly, in the DTA-CRE only a 
very small number of cells, around 3%, indicated positive for substance P.
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Neurofilament SP/Neurofilament
Figure 19. Substance P staining of DRG sections
DRG sections were stained with anti-neurofilament 
(green) and anti-SP (red).
4.2.3 6 Spinal cord staining
To investigate differences in dorsal horn termination of the small sensory neurons after 
ablation of the Nay 1.8-expressing neurons, spinal cord sections were stained with markers 
for the peptidergic (CGRP) and non-peptidergic (IB4) sensory neurons (Fig. 20).
In the DTA-control a very clear labelling of CGRP positive fibres was recorded. From the 
DTA-CRE sections a significant reduction in staining was observed. For the IB4 staining a 
complete absence of staining is seen in the DTA mouse when compared with a thin layer of 
staining in the DTA-control. This observation confirms the results from the DRG staining, 
that the non-peptidergic neurons have been deleted, but some peptidergic still remain in the 
DTA-CRE mouse.
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Figure 20. Dorsal horn staining
Cross-sections of spinal cord were stained with anti- 
CGRP (red) and anti-IB4 (green).
DTA-control (left) and DTA-CRE (right).
4.2.4 Calcium imaging
4.2.4.1 TrpV| positive neurons strongly reduced in DTA-CRE
DRG neurons from DTA-CRE and DTA-control mice were cultured and prepared for 
calcium imaging. By applying IpM capsaicin for 30 seconds TrpVi positive cells were 
activated allowing influx of calcium. An infrared detectable fluorescent complex was 
formed between the calcium and the calcium dye FURA2 which made it possible to 
identify TrpVi positive cells (Fig. 21).
From the DTA-control 47.87±3.89% of the cells responded by an influx of calcium, 
confirming response to capsaicin, compared with only 9.28±2.33% in the DTA-CRE 
(P<0.001). The very low number of TrpVi positive cells in the DTA-CRE suggests a very 
close relationship between expression of Nay 1.8 and TrpV,.
The result suggests that if TrpVi performs a role in acute thermal sensation and thermal 
hyperalgesia after induction of inflammation a behavioural phenotype is expected.
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Figure 21. Calcium imaging -  Capsaicin activation
Representative photo of the calcium imaging experiment. 
DTA-control: before (a) and after (b) activation 
DTA-CRE: before (a) and after (b) activation
4 2.4.2 Menthol positive neurons remains in DTA-Cre
For investigation of the TpmM8 responses in the DTA-CRE mouse, DRG cultures were 
prepared as above, but activated with lOOpM Menthol for 1 min (Fig. 22).
Interestingly, a large proportion of the remaining small cells in the DTA-CRE mouse 
responded to menthol. Approximately 75% of the menthol positive cells seen in the DTA- 
control remained in the DTA-CRE mouse. This suggests that the majority of TrpMg is not 
co-local ised with Nayl.S.
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Figure 22. Calcium imaging -  Menthol activation
Representative photo of the calcium imaging experiment. 
DTA-control: before (a) and after (b) activation 
DTA-CRE: before (c) and after (d) activation
4.2.5 Pain behaviour
4.2.5.1 Mechanical stimulation
4.2.5.1.1 von Frey filaments
The responses to mechanical stimulation using von Frey hairs were tested on 14 DTA-CRE 
and 13 DTA-control mice (Fig. 23A). No significant differences between the two groups 
were found. The DTA-CRE mice recorded a 50% threshold of 0.73±0.05g and the DTA- 
control mice a 50% threshold of 0.89±0.08g (P= 0.142).
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As von Frey hair in this range applies a non-noxious stimulus, the result suggests that there 
is no difference in the non-noxious response between the DTA-CRE and DTA-control 
mice.
4.2.5.1.2 Randall Selitto apparatus
A noxious pressure is applied using the Randal Selitto apparatus (Fig. 23B).
The response to mechanical stimulation using the Randall Selitto apparatus was tested on 
13 DTA-CRE and 8 DTA-control mice. A significant difference in the applied weight 
resulting in withdrawal of the tail was found, 381.67±48.65g for the DTA-CRE and 
69.48±5.00g for the DTA-control, (P<0.001). As a further note of the 13 DTA-CRE mice, 7 
reached the cut-off point of 500 g for all 3-4 measures.
The latter results suggest that noxious mechanical responses are conveyed through Nay 1.8 
as these neurons have been ablated in the DTA-CRE mouse. The data also suggests, that 
the response obtained using the von Frey filaments is mediated through either Ap-fibres or 
through a subset of A8 and C-fibres not containing Nayl.8.
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Figure 23. Mechanical responses.
A: von Frey, B: Randall Selitto 
■ DTA-CRE, □ DTA-control
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4.2.5 2 Cold, but not heat affected in the DTA-CRE
Two different models for testing thermal responses were used, Hargreave’s instrument and 
the Hot plate.
Hot plate differs from Hargreave’s in the nature of response. In hot plate a supra spinal 
response is measured whereas Hargreave’s produces a withdrawal reflex. Interestingly, 
both thermal tests showed no differences between the DTA-CRE and DTA-control. From 
the immunohistochemistry and calcium imaging we know that not only are the large 
majority of the small sensory neurons ablated, but the TrpVi, reportedly involved in acute 
heat sensation has also been strongly affected by the deletion. This suggests that other 
proteins must be involved in the transduction of heat, located either in the remaining 
Nayl.8-negative small sensory neurons or in the Aô/A^-fibres.
4.2.5.2.1 Hargreave 's instrument (Fig. 24A)
The acute response to radiant heat using Hargreave’s instrument was tested on 6 DTA-CRE 
and 7 DTA-control mice. No significant difference was found between the two groups with 
latencies of 8.48+0.7Is for the DTA-CRE and 6.55+1.21 for the DTA-control, (P=0.22).
4.2.5.2.2 Hotplate (Fig. 24B)
Mice were tested at 50°C and 55°C. For the lower temperature a total of 10 DTA-CRE and 
5 DTA-control mice were tested showing no significant difference in response, 14.42+1.43s 
and 14.26±1.75s respectively, (P=0.96).
At 55°C 13 DTA-CRE and 7 DTA-control mice were tested and no significant difference 
was found. 36.35±3.66s and 31.93±5.06s are the data for the DTA-CRE and DTA-control 
respectively, (P=0.49).
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Figure 24. Thermal responses to heat.
Hargreaves’ (A), Hot plate (B). 
■ DTA-CRE, □ DTA-control
4.2.5.2.3 Cold plate (Fig. 25)
In total 7 DTA-CRE and 7 DTA-control mice were tested on the cold plate. A very 
significant phenotype was recorded for the DTA mice showing an average of 3.5712.82 
paw lifts compared with 44.74318.71 paw lifts for the DTA-control group. (P<0.001).
The results show that without N ayl.8-expressing neurons, the sensation of noxious cold is 
almost completely removed.
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Figure 25. Responses to cold plate (0°C) 
■ DTA-CRE □ DTA-control 
***: P<0.001
84
4.2.5.2.4 Acetone (Fig. 26)
Acetone activates TrpMg and gives rise to a cold stimulation due to the evaporation.
In total 5 DTA-CRE mice and 6 DTA-control mice were tested for responses to acetone. 
No difference was found between the two groups showing an average of 6.26±0.64 and 
5.8910.99 sec of licking and biting measured for 1 min.
The cold produced from the evaporation of acetone is less cold than the cold plate and 
suggests that a different mechanism is in place for this response involving neurons not 
expressing Nayl .8.
Figure 26.
o 7.0
c 5.0
:P 4.0
.5 3.0
1.0 
0.0
Responses to acetone 
■ DTA-CRE □ DTA-control
4.2.S.3 Inflammatory responses dramatically reduced in DTA-CRE
Responses to inflammation are affected by the host of mediators released due to tissue 
damage. For this reason the DTA mouse was analysed by using different inflammatory 
models.
4.2.5.3.1 Formalin (Fig.27)
Responses from 8 DTA and 6 DTA-control mice were recorded and the results occur in two 
observable phases. For the first phase (0-10 min.), the DTA mice displayed 60.00±8.77s of 
pain behaviour compared with 49.00±4.50s for the DTA-control. This does not translate to 
any significant difference when compared using an unpaired 2-tailed t-test (P=0.25).
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The results from the second phase (10-60 min.) showed a very strong difference. The DTA- 
CRE mice spent 55.13±26.72s on licking and biting whereas the DTA-control mice spent 
197.5+20.3Is (P =0.0015).
A more detailed visualisation of the behaviour is made by expressing the number of 
behaviours recorded over consecutive 5 minute intervals. In the second phase the DTA- 
control mouse behaviour peaks between 15 and 35 minutes after the formalin injection and 
a highly significant difference is calculated for the intervals from 15-20m (P<0.001), 20- 
25m (P<.001), 25-30m (P<0.001).
Very interestingly, the measurements from the first phase, reportedly a direct chemical 
stimulation of the sensory neurons, were not different between the DTA-CRE and the 
DTA-control. When looking at the data from the second phase, an almost complete ablation 
of responses was measured. This indicates that different neurons are involved in the 
different phases and most likely is the Nay 1.8-expressing neurons responsible for the 
second phase.
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Figure 27.
20 30 40
Time (min)
Responses to formalin:
■ DTA-CRE □ DTA-control
Phase 1 (chemical) and phase 2 (inflammatory) (left).
Inflammatory pain visualised over time (right).
50 60
4.2.5.3.2 Freund's Complete Adjuvant (CFA) (Fig. 28)
Thermal and mechanical responses were recorded from mice injected with CFA and 
compared to baseline recordings made prior to the injections. The same groups of mice, 6
86
DTA-CRE and 10 DTA-control mice were observed for both thermal and mechanical 
responses.
When exposed to thermal stimulation, a significant difference was seen for the DTA-CRE 
mice when compared to the DTA-control measurements, for all the days of recording 
except for day 2 due to variance between the DTA mice. (P-values: Day 1=0.0062, Day 
2=0.103, Day 5=0.0042, Day 8<0.001).
For the DTA-control mice a much more classical hyperalgesic phenotype was recorded, a 
strong initial hyperalgesic response converging with the baseline level at day 8. (P-values: 
Day 1 <0.001, Day 2=0.035, Day 5=0.009, Day 8=0.132).
For the response to the mechanical von Frey stimulation a strong difference between the 
DTA-CRE and the DTA-control mice was recorded for all the days measured. The DTA- 
CRE mice produce a hypo-algesic response (P-values: Day 1 <0.001, Day 2=0.035, Day 
5=0.009, Day 8=0.132), and the DTA-control develops an increased sensitivity, (P-values: 
Day 1= 0.001, Day 2=0.035, Day 5=0.009, Day 8=0.132).
The result confirms what was measured in the second phase of the formalin test, that 
inflammatory pain must largely be mediated by Nay 1.8-expressing neurons.
20.0
16.0
8.0
4.0
0.0
0 1 2 3 4 5 6 7 8
^ 1.0
B  0.8 
■o
I  0.6 H
I 0. 4
g  0.2
in
0.0
Days
I I  I I r  I I
0 1  2 3 4 5 6 7 8
Days
Figure 28. Responses to CFA
■ DTA-CRE □ DTA-control
Thermal responses using Hargreave’s instrument (left),
and mechanical responses using von Frey (right).
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4.2.5.3.3 Nerve growth factor (NGF) (Fig. 29)
NGF is released after tissue damage. It activates the TrkA receptor and is also involved in 
the release of other compounds such as CGRP and substance P.
To test for responses to injected NGF 5 DTA-CRE and 6 DTA-control mice had NGF 
injected into the plantar surface of their left hind paw. A baseline for thermal responses 
using Hargreave’s instrument was recorded prior to injections. At 20, 40 and 60 minutes 
post injection, and after 2,4, 7 and 24 hours again the thermal responses were tested. The 
DTA mice did not develop any increased sensitivity when exposed to the heat. (P-values: 
20m<0.001,40m=0.004, lh<0.001, 2h=0.006, 4h=0.006, 7h=0.02, 24h=0.07).
A very strong phenotype developed for the DTA-control mice with strong hyperalgesic 
responses lasting until the final measurement after 24h where the DTA-control mice again 
showed baseline responses. (P-value=0.34). (ANOVA for 20m-7h: P<0.05)
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Figure 29. Thermal responses to NGF
■ DTA-CRE □ DTA-control
4.2.5.3.4 Carrageenan (Fig. 30)
Using the Hargreave’s instrument thermal responses were tested before and after injection 
of Carrageenan into the plantar surface of 5 DTA and 6 DTA-control mice. The thermal 
responses were tested at 1, 2, 3,4, 5 and 6 hours post injection. The DTA mice did not 
develop any significant changes in response compared with the DTA-control mice which 
showed a very strong increase in sensitivity to the thermal application lasting until the end
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of the assay. (P-values: 30m=0.008, lh=0.011, 2h=0.004, 3h=0.016, 4h=0.017). (ANOVA: 
P<0.05)
<D
C
Î
E
P
2.0
1.8
1.6
1.4
1.2
1.0
0.8
0.6
0.4
0.2
0.0
2 3 4
Time (hours)
Figure 30. Thermal responses to Carrageenan 
■ DTA-CRE □ DTA-control
4.2.5.3.5 Capsaicin (Fig. 31)
TrpVi is activated by Capsaicin. To test for responses to capsaicin injections of O.Spg of 
capsaicin were delivered to in total 5 DTA-CRE and 5 DTA-control mice with immediate 
pain behaviour (licking and biting) recorded for up to 5 minutes per mouse after each 
injection.
The DTA-control mice showed on average of 26.67±7.14 sec compared with the DTA-CRE 
that showed an average of 1.33+0.93 sec pain behaviour. This suggests that the TrpVi 
neurons, normally responding to capsaicin, have been ablated.
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Figure 31. Behavioural responses to Capsaicin
■ DTA-CRE □ DTA-control
4.2.5 4 Spontaneous pain
The development of spontaneous pain is a phenomenon particularly experienced in 
different pain states. By injecting CFA into two different places an inflammatory response 
is generated giving rise to spontaneous pain which can be assessed by observing the mouse 
and count numbers of paw-lifts (Fig. 32).
On day 0, 20 pL of CFA was injected into the plantar surface and to the side of the knee in 
8 DTA-CRE and 5 DTA-control and observations made on day 1, 2 and 7.
A strong significant difference was observed on day 1 with the DTA-CRE mice showing an 
average of 2.0±0.78 spontaneous paw lifts compared with the DTA-control mice showing 
9.6±1.06 paw lifts. (P-value< 0.001).
No significant difference was observed from either day 2 (DTA-CRE: 1.0±0.42, DTA- 
control: 1.8±0.73, P-value=0.323) or day 7 (DTA-CRE: 0.13±0.13, DTA-control:
0.40±0.34, P-value=0.399).
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Figure 32. Spontaneous pain behaviour.
■ DTA-CRE □ DTA-control
4.2.S.5 Neuropathic pain
Together 13 DTA-control and 8 DTA-CRE mice underwent Chung surgery to induce 
neuropathic pain. Pre-surgery baselines had been measured for responses to mechanical 
(von Frey) and thermal (Hargreaves’ instrument) stimulation. The mice were tested for 
mechanical hyperalgesia using von Frey on days 3, 5, 7, 10, 13, 17, 24 and 31 (Fig 33A). 
The mice were tested further for thermal hyperalgesia on days 4, 11,18, 25 and 31 (Fig. 
33B).
Responses to von Frey filaments and Hargreaves’ instrument were not significantly 
different between the DTA and the DTA-control mice. Using a two way measured ANOVA 
no difference was calculated over the time interval for both responses to von Frey filaments 
and Hargreaves’ instrument (P>0.05). The results suggest that neuropathic pain affects 
other sensory neurons than Nayl .8-expressing.
von Frey Hargreaves’
Day P-value Day P-value
3 0.32205 4 0.4957704
5 0.207492 11 0.6170667
7 0.938007 18 0.6739001
10 0.739494 25 0.5743557
13 0.433298 31 0.7224760
17 0.057228
24 0.504248
31 0.444475
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Figure 33. Responses to Neuropathic pain.
■ DTA-CRE □ DTA-control
von Frey filaments (left) and thermal responses (right).
4.2.6 Single unit electrophysiology
The following data was collected by Mr. Curtis Asante.
Electrophysiology from the deep dorsal horn of the spinal cord allows the investigation and 
characterisation of wide dynamic range neurons activity after peripheral stimulation.
Peripheral nerves can be stimulated in the following two way to gather different data. 
Electrical stimuli were used to investigate thresholds and prolonged stimulation. Physical 
stimuli such as pinch, brushing etc. were applied to mimic the thermal or mechanical 
stimulation used when assessing the behavioural responses.
Recordings were made from 17 Wide Dynamic Range (WDR) neurons, (DTA-CRE: n=8, 
DTA-control: n=9) with a mean depth of 517.5±29pm for the DTA- and 471.3±36pm for 
DTA-control, a depth equivalent with the deep laminae of the dorsal horn (Fig. 34 left).
The electrical thresholds for A-fibres were not different between the DTA-CRE and DTA- 
control, but a strong significant difference was measured for the C-fibre threshold (P<0.05) 
(Fig. 34 right)
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Figure 34. Electrical stimulation of WDR neurons
Depth of electrode (left)
A-and C-fibre thresholds to electrical stimulation (right) 
■ DTA-CRE □ DTA-control
Following identifying the thresholds from electrical stimuli a number of noxious stimuli 
were applied and single-unit responses recorded.
Strong deficits in the responses to noxious mechanical stimulation of the paw were 
measured for the DTA mice when exposed to both pinch (P<0.05) and von Frey 
filaments>l gram (P<0.05 for filament 15g, 26g and 60g) (Fig. 35). In contrast when 
lighter mechanical stimuli were applied using a brush, no differences were recorded 
between the DTA-CRE and the DTA-control mice (P=0.839). The results confirm the 
general division of noxious information being conveyed through small sensory neurons, 
largely ablated in the DTA-CRE mouse and non-noxious information largely conveyed 
through the large sensory neurons, remaining in the DTA-CRE-mouse.
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Figure 35. Spikes generated after mechanical stimulation, 
von Frey filaments (left)
Pinch and brush (ri^ t)
■ DTA □ DTA-control
When water at different temperatures (1°C-50°C) (Fig. 36) was applied to the paw no 
significant differences were found between the DTA-CRE and DTA-control mice. The data 
compliments the behavioural data obtained fi’om Hargreave’s instrument and the Hot plate.
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Figure 36. Spikes generated after thermal responses 
Warm temperatures (left)
Cold (1°C) (right)
■ DTA-CRE □ DTA-control
After administering a train of electrical stimuli -  16 stimuli at 3x threshold -  the response 
evoked was divided on the basis of conduction velocity and generated spikes and used to
94
investigate post-discharge and wind up. Wind up — the total spikes after 16 stimuli minus 
input which is the number of spikes h"om one stimuli multiplied by 16.
An accumulation of the post-discharge after each of the 16 stimuli showed a significant 
difference indicating that less activity was conveyed. For both phenomenons the DTA-CRE 
mice showed a significantly reduced response when compared with the DTA-control mice.
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Figure 37. Electrophysiology recordings from WDR neurons 
From left to right; C-fibre activity (P<0.05), A-fibre 
activity (P=0.044), Wind up (P=0.043), post-discharge 
(P=0.0106) and input (P=0.204).
■ DTA-CRE □ DTA-control
4.2.7 Microarray
From the investigation of the regulation of transcripts between the DTA-CRE and DTA- 
control using microarray it is possible to identify possible transducers involved in different 
pain modalities. If a transcript is strongly downregulated it suggests involvement in the 
transduction of noxious mechanical pain, inflammatory pain or cold pain. Likewise for the 
upregulated transcripts, these might be responsible for some of the remaining modalities 
such as thermal pain and light mechanical sensation.
DRG from 6 male DTA-control and 6 male DTA-CRE mice were dissected and the total 
RNA was extracted and pooled together in pairs giving, in total, 3 DTA-control samples 
and 3 DTA-CRE samples, one pair for each gene chip. From each mouse, one DRG cell 
body was sectioned and stained with anti-peripherin and anti-neurofilament to double-
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check the genotype. For certainty, a second PCR genotyping procedure was carried out and 
a neurofilament/peripherin staining. This was performed as a precursor to the microarray as 
the microarray experiment is very expensive. Both the second genotyping and the 
immunohistochemistry confirmed the genotype was correct.
The amount of total RNA was tested on a 1.2% agarose gel before the first and second 
strand cDNA synthesis, cRNA synthesis and biotin labelling were performed and 
quantified. Finally the labelled cRNA was fragmented before it was loaded on gene chips.
4.2.7.1 Total RNA
Sample ng/pL 260/280 260/230
DTA-control 752.76 2.09 2.29
DTA-control 1148.5 2.07 2.28
DTA-control 972.31 2.09 2.29
DTA-CRE 177.12 2.05 2.28
DTA-CRE 252.54 2.05 2.06
DTA-CRE 277.96 2.05 1.80
4.2.T.2 cRNA
Sample ng/pL 260/280 260/230
DTA-control 152.34 1.95 2.63
DTA-control 141.78 1.95 2.57
DTA-control 132.02 1.96 2.26
DTA-CRE 126.07 1.98 1.68
DTA-CRE 165.04 1.98 2.39
DTA-CRE 130.13 1.95 2.32
1 2 3
Figure 38. Control of Fragmentation
Biotin labelled RNA was fragmentated and 
checked on a mini-gel.
Lane 1 : Marker 
Lane 2: DTA-CRE 
Lane 3: DTA-control
Figure 39. Total RNA 
From left; Lane 1 : size marker. 
Lane 2-4 DTA-CRE 
Lane 5-7 DTA-control.
3 4 5
96
Finally, the hybridisation, scanning and analysis were performed by the Scientific Support 
Services, Wolfson Institute for Biomedical Research, UCL, UK.
4.2.T.3 Regulation of several genes after deletion of nociceptors
From a list of around 10,000 genes with a P-value<0.05 a list with the largest gene changes 
was generated, categorising the genes into groups depending on their functionality; Sodium 
channels. Calcium channels, Trp-channels etc.
Voltage Gated Sodium Channels
Gene ID Fold change P-value
Nay 1.1 Scnla +1.8 3.99E-05
Nay type IQ, beta subunit Scn3b -2.9 4.75E-08
Nay 1.7 Scn9a -2.2 2.03E-05
Nay type Q, beta subunit Scn2b -3.7 6.59E-04
Nayl.8 ScnlOa -37.6 5.96E-07
Nay 1.9 Scnlla -23.32 5.04E-08
Voltage Gated Calcium Channels
Gene ID Fold change P-value
Beta-3 subunit Caen lb -1.56 1.18E-05
Beta-3 subunit Cacn3b -1.5 0.000061
L-type Alphe-lC subunit Cacnalc -2.96 l.OlE-6
N-type Alpha IB subunit Cacnalb -3.18 1.18E-06
o2ô -1 subunit Cacna2dl -3.38 1.14E-06
Trp-Channels
Gene ID Fold change P-value
TrpV, Trpvl -3.5 4.66E-06
TipC3 Trpcl -6.4 1.22E-08
TipCe Trpc3 -8.6 9.57E-09
TrpAi Trpal -13.5 5.01E-05
Growth factor receptors
Gene ID Fold change P-value
cRET Ret -1.47 -1.86E-05
TrkC Ntrk3 +1.3 0.008
TrkB Ntrk2 +1.25 0.00098
NGF receptor Ngfr -1.15 0.015
TrkA Ntrkl -8.9 9.83E-06
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GDNF receptor alphal Gfra4 +1.2 0.002
GDNF receptor alpha2 Gfra2 -4.9 2.62E-09
GDNF receptor alpha3 Gfra3 -2.7 3.56E-05
Transcription factors
Gene ID Fold change P-value
Runxl Runxl -4.1 9.27E-08
Runx3 Runx3 +2.37 1.57E-06
Neuropeptides
Gene ID Fold change P-value
BDNF Bdnf -1.8 0.00051
Substance P Tael -2.87 8.22E-06
CGRP beta Caleb -3.6 1.02E-07
CGRP alpha Calca -4.26 0.00076
Kinases
Gene ID Fold change P-value
PKA -3.07
PKA regulatory subunit 2 -2.6
PKA anchoring subunit 2 -3.98 3.92E-06
PCK delta -9.39 8.99E-08
PCK theta -8.14 7.46E-07
Others
Gene ID Fold change P-value
P2X 3 P2rx3 -11.93 7.10E-10
5-HT4 Htr4 -15.96 1.41E-08
NPY-Y2 receptor Npy2r -20.9 9.79E-08
Edg7 LPA receptor Edg7 -43.8 3.33E-12
MrgA2 Mrgpra2 -10.77 2.75E-07
MrgA3 Mrgpra3 -18.03 5.44E-06
Table 1. Altered transcripts in DRG from the DTA-KO.
4.2.8 Quantitative RT-PCR confirming microarray data
Total RNA from the same mice used for the microarray study, as well as total RNA from a 
new set of mice (DTA-CRE and DTA-control), was converted to cDNA using reverse 
transcriptase and used for qRT-PCR. p-Actin was used to normalise the data.
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A complete deletion of N ayl.8  was expected and primers for qPCR of N ayl.S  and four 
other regulated genes, Edg7, TrpCô, TrpVi and TrpMg were constructed.
After normalisation, the level of mRNA for N ayl.8  in the DTA-CRE mouse was only 
1.68±0.69% compared with mRNA from DTA-control mice. For the TrpCg, mRNA levels 
were down to 4.33+0.58% and Edg7 were down to 3.35±0.42% compared with DTA- 
control. TrpVi levels in the DTA-CRE mouse were 28.4±3.63% of DTA-control levels and 
no significant difference between DTA-CRE and DTA-control were found for TrpMg 
mRNA levels.
As mentioned, two different cDNA preparations were used. The first utilised the original 
RNA extracted and used for the microarray experiment. The second preparation was 
prepared later to test if there would be any difference between the first and a later 
preparation. For the qRT-PCR both cDNA preparations were used and there was no 
difference between them, validating the first RNA extraction which was used for the 
microarray experiment.
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Figure 40. An example for testing primers for qRT-PCR 
A: Melting curve for the primers for P-Actin 
B: PCR quantification for standard curve 
C: PCR standard curve
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Figure 41.
Trpvl
Quantitative RT-PCR.
qRT-PCR were tested for Nay 1.8 TrpCô and Edg7, 
TrpMs and TrpVi.
■ DTA-CRE □ DTA-control
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Figure 42. qRT-PCR curves for the tested RNA,
A: p-Actin, B: Nayl.8, C: TrpCe and D: Edg7 
(DTA-control: blue lines, DTA-CRE, red lines).
E+F (TrpVi): E: p-Actin, F: TrpVi.
G+H (TrpMg): G: P-Actin, H: TrpMg.
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4.3 Sum m ary
Successful deletion of the Nayl.8 positive neurons was obtained using the Nayl.SCre 
mouse. The loss of the Nayl .8-expressing neurons decreased the peripherin positive 
neurons by 88% and further immunohistochemistry and calcium imaging showed the 
remaining sensory neurons in the DTA-CRE mouse belonged to the peptidergic 
subpopulation of small sensory neurons (CGRP positive) with some testing positive for 
substance P, TrpVi and TrpMg.
Behavioural analysis of the DTA-CRE mouse showed that several pain modalities were 
affected by the deletion of the Nay 1.8-expressing neurons -  see table 2, page 102. 
Thresholds to non-noxious mechanical stimulation were not affected, whereas responses to 
noxious mechanical stimulation were almost completely ablated. Thermal acute thresholds 
were unaffected by the deletion. After introduction of inflammation both thermal and 
mechanical responses were significantly reduced. Responses to cold were ablated when 
using the cold plate, but no difference were measured when cold from the endothermie 
reaction of evaporating acetone was invoked. Spontaneous pain was also ablated, but no 
differences in thermal or mechanical responses were measured after introduction of 
neuropathic pain
The DTA-CRE mouse was further characterized using extracellular electrophysiology 
recording from WDR neurons at the dorsal horn showing a significant loss of activity 
conveyed to the WDR neurons after peripheral stimulations of the paw.
Finally, the use of microarray made it possible to identify the genes affected by the deletion 
of the Nay 1.8-expressing neurons. Among the regulated genes were several already 
reported to be involved in some of the affected pain modalities, noxious mechanical 
mechanosensation, inflammatory pain and cold pain. A number of genes, not previously 
reported to be involved in nociception were strongly downregulated suggesting that they 
possibly also could be involved in some of the modalities that were lost.
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Modality DTA-KO
Cold pain Lost
Mechanical pain Lost
Inflammatory thermal pain Lost
Inflammatory mechanical pain Lost
Spontaneous pain after inflammation Lost
Thermal pain Retained
Neuropathic thermal pain Retained
Neuropathic mechanical pain Retained
Table 2. Modality characterisation of the DTA-CRE mouse
A number of pain modalities were lost whereas other 
remained in the DTA-CRE mouse
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5 PAPIN AFFECTS THE SENSATION OF TOUCH
5 .1  In t r o d u c t i o n  t o  t o u c h
The ability to sense touch is vital in life -  nevertheless, it is still not completely understood 
how touch - light mechanical stimulus - is translated into an electrical signal for 
transmission to the brain.
Mechanoreceptor terminals are different from those responding to noxious mechanical 
stimuli as they are closely associated with specialised end organs and not free nerve 
endings. There are four classes of mechanoreceptors generating different currents 
depending on their end organ; Merkel cells, Meissner cells. Pacinian cells and Rufflni 
corpuscle -  see fig. 43.
Glabrous
skin
Merkel’s
disk
Epidermal- 
Dermal border
Free nerve 
ending
Meissner’s 
corpuscle
Hair follicle 
Receptor
Pacinian 
, corpuscle
Ruffini’s 
ending
Epidermis 
A
Dermis
Figure 43. Overview of the skin layers
Free nerve endings responding to noxious insults and end 
organs responding to light mechanical stimulation.
Merkel cells slow adapting type 1 (SAl) responsive to low frequency vibration 
and low intensity constant pressure.
Meissner corpuscles rapidly ad#apting and responsive to skin deformation which triggers
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a train of action potentials that will ease quickly and recommence 
again when the deformation returns to normal.
Pacinian corpuscles very rapidly adapting to indentation of the skin, they can detect 
changes in strength of the stimuli.
Ruffini corpuscles detect skin stretch. Their response is slowly adapting type 2 (SA2), 
adapting more slowly that than Merkel cells.
Table 3. Mechanoreceptors
Each class has different response properties and patterns 
of action potentials depending on their adaptation to 
stimulation
5.1.1 Investigation o f mechanosensation
In general, there are not many ways to investigate mechanisms of touch as it is a very subtle 
response. In vitro^ different electrophysiology techniques have been used. In vivo testing is 
based on differences in responses to light mechanical stimulation.
5.1.1.1 Behaviour
The use of von Frey filaments to test sensitivity to non-noxious mechanical stimuli is 
known from behavioural assessment of mechanical hyperalgesia.
The graded von Frey filaments apply an increasing punctuate pressure depending on the 
thickness of the filament. In general, it is accepted that for testing on mice the von Frey 
filaments bending at a low weight applied are non-noxious, whereas thicker filaments are 
noxious (Hogan, 2002). The assembly and protocol for the use of von Frey filaments are 
described in section 2.4.1.1.
Another more recent and innovative test is the ‘sand paper tesf. The commercially 
available MoTil system (TSE Systems, Germany) uses infrared tracking of the mouse to 
monitor the movements of the mouse in a small enclosed area. Inside the cage different 
tactile cues (sandpaper of different grades) have placed. The data from WT mice showed 
that they were able to recognise different tactile cues and spend more time on the rough 
than on the smooth area. A transgenic mouse line, the stomatin null mouse spent the same
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amount of time on both the rough and the smooth area suggesting that the mice could not 
distinguish between the differences in surface texture (Wetzel et al., 2007).
5.1.1.2 Electrophysiology
The skin-nerve preparation described by (Reeh, 1988)) makes recordings from teased single 
nerves possible using nerve fibres from the saphenous nerve. In this set-up the nerve is still 
attached to the skin and physical or electrical stimulation can be applied. 
Electrophysiological recordings from cultured DRG neurons have been reported by a 
number of groups. The techniques of mechanical stimulation of the cells have varied 
between groups, but in general either a pressure or a physical glass probe has been applied 
(Drew et a l, 2002;Cho et a l, 2002).
5.1.2 Proposed mechanisms for touch
Several mechanisms for mechanotransduction have been hypothesised over recent years. 
Stretch activation, where changes in the lipid bilayer stretch ion channels to change 
conformation; or the tethered model, where links between the extracellular or cytoskeleton 
proteins and the ion channels conduct the force for a conformational change; thirdly, an 
indirect activation model where a second messenger protein generates a signal that enforces 
the conformational change (Kung, 2005).
In the epidermis several cell types contribute to provide a physical barrier of the body, but 
they could also perform other functions. The Kératinocytes are the predominant cell type 
and different hypotheses have been suggested for their involvement in 
mechanotransduction. Merkel cells are another component of skin and they are known to be 
part of a complex that mediates a subset of responses to touch, but there is so far no direct 
evidence that merkel cells are activated by touch (Haeberle et al., 2004).
5.1.3 Papin
In a yeast two hybrid screening using the neural Plakophilin-related Armadillo repeat 
Protein (NPRAP)/ô-catenin as bait the Plakophilin-related Armadillo repeat Protein- 
Interacting PDZ protein (PAPIN) was identified (SOOkDa) (Deguchi et a l, 2000). The PDZ
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domain is a common structural domain of 80-90 amino-acid found in signalling proteins 
and helps anchor transmembrane proteins to the cytoskeleton and hold together signalling 
complexes (Harris and Lim, 2001). The armadillo repeat is a repeated njotif of about 40 
amino acids found in a number of proteins such as P-catenin, plakoglobin, adenomatous 
polyposis coli gene product, a regulatory protein for, a small G protein known as smg GDP 
dissociation stimulator and smg GDP-dissociation stimulator-associated protein. Papin 
distributed ubiquitously and co-localised with p0071 in epithelial cells. The p0071-protein 
also has armadillo repeats and is believed to play a role in organization of cell-cell 
junctions (Deguchi et al., 2000). Papin has four PDZ domains in the N-terminal region and 
two PDZ domains in the C-terminal region. The Papin protein is processed by proteolytic 
cleavage to generate a secreted peptide containing two PDZ domains (Yeung et al., 2003). 
(Papin has since then been renamed as PDZD2 (PDZ-domain-containing 2).
A paper suggests that Papin plays a role in the regulation of the glucose homeostasis 
affecting the development of diabetes. In the Papin knock out mouse increased levels of 
insulin were observed after injections of glucose, suggesting that Papin is required for 
normal glucose-stimulated insulin secretion (Tsang et al., 2008)
Papin’s possible relation to nociception was originally discovered after using the 
intracellular domains of Nay 1.8 as bait in a yeast-two-hybrid screening. Papin was, together 
with several other proteins such as annexin II light chain (PI 1), identified as an N ayl.8  
interacting proteins (Malik-Hall et a l, 2003). Previously, it had been shown that N ayl.8  
expressed in cells on its own did not express strongly in the membrane, but adding PI 1 
proved to increase the functional expression of N ayl.8  (Okuse et al., 2002). A  tissue- 
specific mouse line deleting PI 1 in the Nay 1.8-expressing neurons was generated and tested 
in different pain models. For the PI 1 KO mouse no highly significant nociceptive 
phenotype were measured for inflammatory pain of acute thermal sensation., but a 
significant, but not substantial change to mechanical and neuropathic pain was recorded 
(Foulkes et a l, 2006).
The functional effect of Papin on N ayl.8 currents were investigated by Dr. Kenji Okuse’s 
lab. They found that by using microinjections of siRNA to knock down Papin in cultured
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DRG neurons, the Nayl.S current was reduced by more than 50% (unpublished data from 
Kenji Okuse).
5.1.4 The Papin Knockout mouse
A Papin knock out mouse was recently generated by researchers at Hong Kong University. 
The mouse was generated using an embryonic stem cell line with the PDZD2 (Papin) locus 
disrupted. The cell line was produced using the genetrap technique ROSAFARY.
Using this technique, genes were randomly disrupted when a promoterless reporter was 
introduced into embryonic stem cells to tag and mutate genes randomly (Chen et al., 2004). 
Dr. Kwok-Min Yao, Hong Kong University, obtained the stem cell line and injected them 
into blastocyts for the generation of chimeras The disruption of PDZD2 transcription was 
confirmed by RT-PCR (Tsang et al., 2008) (Unpublished).
5.1.4.1 Analysing the Papin null mouse
In the following, the Papin null mouse will be referred to as PAPIN-KO and the Papin 
control littermates will be referred to as PAPIN-control.
The PAPIN-KO/control mice were generated by crossing heterozygous mice to generate a 
25:50:25 ratios of PAPIN-KO, PAPIN-heterozygous and PAPIN-control. By using the 
breeding regime described, both PAPIN-KO and PAPIN-control mice were generated from 
the same parents.
5.1.4.1.1 Electrophysiology
Electrophysiological recordings of DRG were made to investigate changes in currents after 
mechanical displacement using whole cell patch clamping as described.
5.1.4.1.2 Immunohistochemistry
To investigate any differences in the pattern of cells in DRG, immunohistochemistry was 
used to identify the myelinated cells using anti-neurofilament and the small cells using anti- 
peripherin.
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5.1.4.1.3 Behaviour
For behavioural assessment the Papin mouse was investigated with the hypothesis that the 
PAPIN-KO mouse might exhibit different pain thresholds compared with the PAPIN- 
control mouse. Responses to mechanical stimuli using von Frey filaments and the Randal 
Selitto apparatus were tested. For responses to thermal stimuli, the Hargreave’s instrument 
was used, and finally formalin injected to assess inflammatory responses.
5.2 R e s u l t s
5.2.1 Genotyping of PAPIN mice
DNA extraction, PCR and gel electrophoresis were used to genotype the litters from 
PAPIN heterozygous breeding pairs (Fig. 44).
B
i .
Figure 44. Genotyping the PAPIN litters.
PAPIN-control (WT) band at 420 bp. (A) 
PAPIN-KO PCR with positive bands at 570 bp. (B)
5.2.2 The PAPIN-KO mouse shows increased thresholds to light touch
5.2,2.1 von Frey
The response to mechanical stimulation using von Frey hairs were tested on 9 PAPIN-KO 
and 12 PAPIN-control mice (Fig. 45). A highly significant difference was recorded. The 
PAPIN-KO mice had a 50% threshold of 1.55±0.17g compared with the PAPIN-control 
which exhibited a 50% threshold of 0.60±0.11g (P<0.001).
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Figure 45.
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von Frey thresholds.
■ PAPIN-KO, □ PAPIN-control
S.2.2.2 Randall Selitto
The response to noxious mechanical stimulation was also tested using the Randall Selitto 
apparatus (Fig. 46). 6 PAPIN-KO and 6 PAPIN-control mice were tested without any 
significant difference found. The response for the PAPIN-KO was 113±11.64g and 
128.33±12.07g for the PAPIN-control (P>0.05).
160
E 100
Figure 46. Acute response to noxious pressure 
■ PAPIN-KO, □ PAPIN-control
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S.2.2.3 Hargreave’s
Responses to thermal stimulation were tested using the Hargreave’s instrument (Fig. 47). In 
total 10 PAPIN-KO and 14 PAPIN-control mice were tested without finding any significant 
differences. An average latency time of 9.55±0.90s was recorded for the PAPIN-KO with 
9.84±0.71s for the PAPIN-control (P>0.05).
Figure 47. Acute pain responses to thermal heat. 
■ PAPIN-KO, □ PAPIN-control
S.2.2.4 Formalin
Formalin was injected into the hind paw to record inflammatory responses (Fig. 48). Seven 
of each PAPIN-KO and PAPIN-control mice were tested showing no significant difference 
in responses respectively. The PAPIN-KO showed an overall second phase response of 
142±42.42s compared with 133.30±28.64s for PAPIN-control mice (P>0.05).
Also, no significant difference was recorded during the first phase (P>0.05).
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Figure 48.
Phase 1 Phase 2
Responses to formalin
Responses divided into phase 1 (0-10 min and phase 2 
10-60 min).
■ PAPIN-KO, □ PAPIN-control
5.2.3 Electrophysiology
77ie electrophysiology was investigated by Dr. Francois Rugiero.
Whole cell patch clamping was performed on DRG cultures prepared for both PAPIN-KO 
and PAPIN-control littermates; in total 61 large neurons and 15 small neurons were 
clamped.
To characterise the cells, electrical stimulation was used to distinguish between Low 
Threshold Mechanoreceptors (LTM) and High Threshold Mechanoreceptors (HIM) -  see 
fig.48.
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Figure 49. Membrane potentials for mechanoreceptors
The LTM is characterised by a narrow action potential, 
no shoulder, a small sag and fast repolarisation. One 
group of HTM generates a wider action potential, no 
shoulder, large sag and a slower repolarisation. Finally, 
the second group of HTM generates a very wide action 
potential, a shoulder, a very slow repolarisation and very 
large sag.
When analysing the data from the narrow AP, LTM, 21.5% of the PAPIN-KO cells were 
identified as non-responders compared with 0% from PAPIN-control. Further, the rapidly 
adapting cells were reduced from 85% in the PAPIN-control to 57% in the PAPIN-KO.
100
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Figure 50. Characterisation of the LTM neurons.
Interestingly, 20% were non-responding in the 
PAPIN-KO.
■ PAPIN-KO □ PAPIN-control
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When looking at the group HTM no differences were identified for the C-type. For the 
medium/large type, the number of non-responders was reduced from 69% in the PAPIN- 
control to 33% in the PAPIN-KO giving rise to a greater proportion of responding cells. 
This suggests that a phenotypic change or compensatory mechanisms are in place to adjust 
the balance as non-responding LTM cells were identified.
5.2.4 Comparison of cell expression
Sections were stained with anti-neurofilament and anti-peripherin to label large cells and 
small cells for comparison of cell expression between the PAPIN-KO and PAPIN-control. 
Interestingly, the PAPIN-KO (n=2) showed a lower expression of the neurofilament stained 
large neurons compared with the PAPIN-control mice (n=2). The average neurofilament 
positive cell count was 218±23 cells for the PAPIN-KO and 280±14 cells for the PAPIN- 
control (P<0.05). No difference was found for the peripherin positive cells, PAPIN-KO: 
498±36 cells and PAPIN-control: 479±56 cells (P>0.05).
. ■
Figure 51. Papin staining for cell comparison
PAPIN-KO (left) and PAPIN-control (right), 
Peripherin (green) and Neurofilament (red).
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Figure 52. Cell comparison of the large and small neurons. 
■ PAPIN-KO, □ PAPIN -control
5.2.5 Loss of neuronal connection in PAPIN-KO
Skin tissue from PAPIN-KO and PAPIN-control were stained for Merkel cells and Ap- 
fibres (neurofilament).
The staining o f skin was performed by Dr. Min Liu, Queen Mary University o f London.
ê
:
Figure 53. Lack of merkel cells and neuronal connection in PAPIN-KO 
■ PAPIN-KO, □ PAPIN -control
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5.3 Sum m ary
The nociceptive behavioural assessment of the PAPIN-KO mouse was initially founded 
upon the observation that it was identified in a yeast two-hybrid screening using parts of the 
N avl.8 channel as bait (Malik-Hall et a l, 2003). N ayl.8  has been proven to be involved in 
nociception, so a pain phenotype for the PAPIN-KO mouse was hypothesised.
Surprisingly, the only difference from the assessment of acute thresholds was in responses 
to mechanical stimulation using von Frey filaments. Responses to noxious thermal 
stimulation and noxious mechanical stimulation did not show any significant differences 
between the PAPIN-KO and PAPIN-control. Further comparison of responses after 
induction of inflammation also did not show any differences.
This suggested an involvement of Papin in low threshold mechanotransduction rather than 
previously hypothesised, in nociception.
To investigate the involvement of Papin in low threshold mechanosensation, patch clamp 
electrophysiology was performed. Cells were divided on the basis of characteristics to 
electrical stimulation before a blunt glass probe was applied, stretching the cell membrane. 
Interestingly, of all the LTM cells which normally respond to mechanical stimulation 21% 
did not respond.
Furthermore, the testing of the medium/large HTM group a higher percentage than normal 
responded to mechanical stimulation, suggesting some form of compensatory activity.
An observation from the cultures of DRG was that the number of large neurons was 
reduced in the PAPIN-KO, leading to an immunohistochemistry comparison of 
neurofilament and peripherin positive cells, labelling the large/medium cells and small cells 
respectively. Interestingly, the analysis confirmed the observation from the DRG cultures. 
The number of neurofilament positive cells in the PAPIN-KO was reduced with around 
20% compared with the PAPIN-control.
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6 NAyl.7 INVOLVEMENT IN PAIN
6.1 In t r o d u c t io n
The voltage gated sodium channel, Nayl.7 is highly expressed in the small sensory neurons 
(Toledo-Aral et a l, 1997) and several lines of research have highlighted its importance as a 
possible drug target for the treatment of pain.
6.1.1 Congenital indifference to pain (CIPA)
Historically it has been reported that some humans are capable of withstanding immense 
stimuli of pain without displaying any sensation of pain. Congenital indifference to pain 
(CIPA) is a rare inheritable disorder, which is characterised by an absence of pain 
perception, but normal sensation to light touch (Swanson, 1963). It belongs to a group of 
rare clinical and genetic neuropathies of the peripheral sensory and autonomic nervous 
system. Along with insensitivity to noxious input, due to a severe loss of C-fibres, patients 
also suffer from moderate to severe mental retardation and anhidrosis (Shatzky et al.,
2000). The disorder has been linked to mutations in the gene encoding the receptor for 
NGF, TrkA being responsible for the lack of survival of nociceptors (Indo et al., 1996).
More recently, a number of individuals were identified with a similar phenomenon of 
inability to perceive pain. Interestingly, compared with CIPA, under examination the 
subjects seemed to exhibit a completely normal physiological and mental development. The 
only physiological reason for their inability to feel pain is a distinct homozygous nonsense 
mutation in the gene encoding the N ayl.7  eliminating expression of any functional N ayl.7  
channels (Cox et a l, 2006).
6.1.2 Nayl.7 and Pain
The chronic inflammatory dominant human condition primary eiythermalgia has been 
mapped to the Nayl.7 gene and several different mutations described (Yang et al, 
2004;Waxman and Dib-Hajj, 2005;Cheng et a l, 2008). Another mutational study showed 
involvement in the inherited condition. Paroxysmal extreme pain disorder (PEPD, first
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described as familial rectal pain). Different mutations in the sequence encoding the Nayl.7 
resulted in the painful condition characterised by paroxysms of rectal, ocular, or 
submandibular pain with flushing (Fertleman et al., 2006). A third painful and disturbing 
condition. Urge Faecal Incontinence (UFI) has also been linked to Nayl.7. Around half of 
patients suffering from UFI also suffer from rectal hypersensitivity. In a small study it has 
been reported that the expression of Nayl.7 nerve fibres was increased in all layers of the 
rectal tissue (Yiangou et al., 2007). The reason for this is uncertain, but it has been 
suggested that an increase in NGF could be responsible as it regulates Nayl.7 and TrpVi 
which is also reported upregulated in UFI (Yiangou et a l, 2007;Chan et al., 2003).
6.1.3 The Nayl.7 knockout mouse
In contrast to the above-mentioned human observations^ a study generating a mouse 
Nayl.7 knockout was found to die shortly after birth (Nassar et a l, 2004). When the 
knockout was directed to the DRG using the tissue-specific Nayl.SCre mouse, the 
behavioural assessment showed a strong involvement of the Nayl.7 in acute and 
inflammatory pain (Nassar et a l, 2004). When tested for responses to neuropathic pain, no 
differences were found between the knockout and control (Nassar et a l, 2005).
6.1.4 Pharmacological blockers of Nuyl.7
One way to manipulate the function of proteins is using pharmacological blockers. This 
has, for many years, been a tool to investigate blockage of proteins as it is inexpensive and 
faster than generating transgenic mice. In the pharmaceutical sector, the synthesis of 
selective blockers has also been high on the agenda for development of potential drugs. 
Unfortunately, compounds have often turned out less specific than first expected. The 
recent discovery of the involvement of N ayl.7  in nociception has not impeded the desire to 
generate a selective blocker for N ayl.7 . Several non-specific sodium blockers already exist, 
but a N ayl.7  specific blocker could be potentially very beneficial.
6.1.5 Pharmacological agents
New structures have been synthesised and one of the new classes of blockers is the 1- 
benzapin-2-ones. They have been characterised and found to be both more potent and more
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selective than compounds tested previously. More importantly, they have showed good 
bioavailability and efficiency when tested in neuropathic pain models on rats (Hoyt et al., 
2007;Williams et al., 2007).
6.1.6 Venom derived agents
An interesting source of compounds with potential for drug use is toxins from spiders, 
scorpions, snails and snakes amongst others. The toxins consist of a mixture of up to 
several hundred different peptides, targeting many different receptors simultaneously, 
optimising methods of prey capture and protection. After isolating and purification and 
further characterisation using mass spectrometry some of the toxins have proven useful for 
treatment of several conditions, some types of pain and also as lead structures in the search 
for new drugs.
6.1.7 Conotoxins
Conotoxins are isolated from marine cone snails and have proven useful in the inhibition of 
voltage gated ion channels (Ekberg et al., 2007). The first approved “toxin” drug on the 
market was the Voltage Gated Calcium Channel (VGCC) N-type blocker, the œ-conotoxin 
MVnA (Ziconotide, Priait™) for the treatment of intractable pain (Lyseng-Williamson and 
Perry, 2006).
6.1.8 Spider toxins
In particular two different families of compounds are represented in the venoms from 
spiders: acylpolyamines and peptides. A host of both peptides and acylpolyamines have 
been isolated and described for blocking abilities for several ion channels (for review, 
(Estrada et al., 2007)).
Decade of studies into spider toxins have identified a number of venoms from tarantula 
spiders belonging to the Theraphosidae family (Escoubas and Rash, 2004). Several of the 
toxins characterised affect different ion channels. The Psalamopoeus Cambridgei toxin 1 
(PcTxl) was isolated and characterised. It blocks the ASIC la ion channel activating the 
endogenous enkephalin pathway. The results from pain models exhibit a remarkable
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antinociceptive effect in both acute and inflammatory models as well as in the CCI model 
of neuropathic pain (Mazzuca et al., 2007). Several other toxins have been isolated and 
shown to modulate voltage gated sodium channels (Escoubas and Rash, 2004;Bosmans et 
al, 2006).
6.1.8.1 The Tarantula toxin PhlTxl
More recently Phlotoxin 1 (PhlTxl) isolated from the genus Phlogiellus was reported as a 
potent blocker of the Nay 1.7 ion channel showing great selectivity for the Nayl.7, IC50 
value: 260nM. All other VGSC failed to respond at ICso-values of up to 2.0pM. In the 
formalin test PhlTxl produced a strong analgesic effect (Escoubas et al., 2006)
6.2 I n  v iv o  in v e st ig a t io n s  o f  t h e  NAv1.7 b l o c k e r  Ph l T x I
Responses to acute thermal and mechanical stimulation were tested using Hargreave’s 
instrument and von Frey filaments. Mechanical responses to long term inflammatory 
stimulation were tested by using CFA to induce an inflammatory response and test for 
hyperalgesia using von Frey filaments. Finally, investigations of mechanical responses to 
neuropathic pain were tested inducing neuropathic pain by partial ligation of the sciatic 
nerve (Seltzer) then testing for hyperalgesia using von Frey filaments.
6.3 R e su l t s
C57/BL6 mice (WT) were used for testing the toxin. The toxin was diluted in saline to a 
final concentration of 1.0 nmole/lOpL. As control saline was injected without any toxin.
All experiments were performed blind to the injected substance.
6.3.1 Acute thermal sensation not affected by PhlTxl
12 WT mice were injected with either 1.0 nmole (lOpL) of toxin or saline (10 pL) into the 
left plantar surface of the hind paw before testing.
No differences between the two injected groups were observed with latency in response for 
the saline group of 7.43±1.17s and 8.03+1.43s for the toxin group. (P>0.05).
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Figure 54. Responses to thermal stimulation. 
■ Toxin, □ Saline
6.3.2 PhlTxl significantly affects response to light mechanical stimuli
Responses to non-noxious mechanical stimulation were tested using von Frey filaments 
(Fig. 55). 12 WT mice were injected as described above before the von Frey test was 
performed.
When 1.0 nmole PhlTxl was tested, a strong significant difference was monitored between 
the two groups. The saline group showed a 50% threshold of 1.68±0.39g compared with the 
WT group that showed a 50% threshold of 0.32+0.1 Ig. (P=0.0114).
As a preliminary experiment, 0.2 nmole PhlTxl was also tested on a small number of mice 
(n=4), only 1 mouse was injected with saline and 3 mice received the toxin. The result 
showed a 50% threshold for the toxin group of 0.88+0.12 g compared with 0.40 g for the 
control mouse. (For the graph, WT data from the original experiment was included).
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Figure 55. Responses to von Frey filaments 
1.0 nmole PhlTxl (left)
0.2 nmole PhlTxl (right)
■ Toxin, □ Saline
6.3.3 Complete Freund’s adjuvant
10 mice were used for the CFA test over a period of 4 days.
On day 0 baselines were recorded for responses to thermal (Hargreave’s instrument) and 
mechanical (von Frey) stimulation, before injecting 20pL CFA into the plantar surface of 
the left hind paw.
On day 2 the mice were tested again and on day 3 the mice were injected with either toxin 
or saline as described above and tested again. Day 4, the mice were tested for a final time -  
see fig.54.
6.3.3.1 CFA -  thermal thresholds
After treatment with CFA the mice tested on day 2 exhibited an increased sensitivity to heat 
compared with the baseline recordings, (baseline: 8.66±1.14s, Day 2: 4.86±0.58s). On day 
3 the saline group still showed high sensitivity with a latency time of 5.15±0.49s compared 
with the toxin treated group that showed an average latency time of 8.26±0.81s. When 
tested again on day 4 both groups showed a high sensitivity (saline: 4.42±0.63s and toxin: 
5.23±1.00s).
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6.3.3 2 CFA - von Frey
After introduction of inflammation the mice showed a strong decrease in mechanical 
sensitivity when measured on day 2 (50% threshold, baseline: 0.8±0.05g, Day 2: 
0.43±0.17g). Day 3, the saline mice were still more sensitive than baseline (0.66±0.19g) 
compared with the toxin group which showed a 50% threshold of 1.97±0.33g. When tested 
on day 4 both groups showed responses of higher sensitivity than compared with baseline 
values (saline: 0.44±0.08g, toxin: 0.27±0.07g).
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Figure 56. CFA - inflammation
Responses to von Frey filaments (left). 
Responses to Hargreave’s instrument (right). 
■ Toxin, □ Saline
6.3.4 Neuropathic pain -  Seltzer model
To test the effect of the PhlTxl after neuropathic pain, 10 wild type mice underwent Partial 
Nerve Ligation (PNL). Thresholds to von Frey filaments were recorded before surgery and 
after surgery, the latter testing for mechanical hyperalgesia. At day 14 after surgery 9 mice 
were again tested before injections of either saline (5 pL) or toxin (0.5 nmole in 5pL) were 
injected. The mice were left for around 30 minutes before being retested.
Baseline data before surgery showed an average 50% threshold of 0.63±0.09g (n=10). On 
day 14 the 50% threshold was 0.15±0.02g (n=9) and after injections the response was 
0.39±0.06g (n=4) for saline and 0.71±0.13g (n=5) for the toxin group.
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Figure 57. Mechanical responses after PNL.
■ von Frey baseline pre-surgery.
■ von Frey measurements after surgery.
□ von Frey measurements for saline-group.
■ von Frey measurements for toxin-group.
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6.4 Su m m ary
After the discovery of the enormous impact a functional mutation of the Nay 1.7 has on the 
development and sensation of pain, the search for a selective blocker began. Historically, 
venoms from snails, spiders, snakes etc. have proven useful for the treatment of several 
conditions and a toxin from the Tarantula spider genus Phlogiellus, PhlTxl was isolated 
and found selective for N ayl.7 .
The toxin was tested on mice for responses to mechanical and thermal stimulation, testing 
for both acute responses and to mechanical stimulation after introduction of inflammation.
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The results showed that using PhlTxl increased the acute mechanical thresholds, but not 
thermal. Furthermore, after induction of inflammation the group treated with PhlTxl 
exhibited a reversal of thermal thresholds and the mechanical thresholds were reversed 
beyond the baseline recording.
Finally, mechanical responses were tested after inducing neuropathic pain. As seen in both 
acute pain testing and after inflammation, PhlTxl reversed mechanical hyperalgesia.
Even though most of these data are to be considered preliminary, due to the low n-numbers, 
there is a clear indication that PhlTxl has a strong impact on the development of acute 
mechanical sensitivity, thermal and mechanical sensitivity after inflammation and to 
mechanical sensitivity after neuropathic pain.
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7 DISCUSSION
Three different ways to investigate mechanisms of nociception have been approached in 
this thesis. First of all, the deletion of the Nayl .8-expressing neurons revealed that this 
population is essential for transmission of mechanical, cold and inflammatory pain, but not 
neuropathic pain or heat sensation. Secondly, the ubiquitously expressed protein Papin was 
demonstrated to be involved in touch. Finally, pharmacological blockage of Nay 1.7 proved 
efficient in preventing mechanical hyperalgesia after neuropathic pain.
7.1 A ssig n m e n t  o f  p a in  m o d a l it ie s
Throughout the years hypotheses attributing particular pain modalities to specific plasma 
membrane cell receptors or ion channels have been studied as it is clear that the sensory 
neurons responsible for carrying the information about tissue damage (nociceptors) are 
polymodal (Perl, 2007). Some of the most extensively studied ion channels are the Trp- 
channels, TrpVi being the first cloned followed by other Trp-channels assigned to the 
sensation of heat. The attribution has been hypothesised partly on the background of 
electrophysiological studies, but when transgenic mice were generated a more complex 
picture emerged as in the case TrpVi.
Another way to investigate and assign pain modalities to neuronal subtypes is by using 
some of the markers for specific subpopulations of sensory neurons such IB4 (non- 
peptidergic) and CGRP (peptidergic).
Over a decade ago, when the division of nociceptors was discovered due to their 
responsiveness to neurotrophic factors, studies suggested the NGF-dependent 
subpopulation (the peptidergic) was responsible for conveying inflammatory information as 
NGF was released following inflammation and the increased release of substance P and 
BDNF (Snider and McMahon, 1998). Furthermore the peptidergic neurons showed a 
significantly higher responsiveness to each of protons and capsaicin compared with IB4- 
positive neurons, but in contrast, after exposure to protons the response of EB4-positive 
neurons to capsaicin was more pronounced, and that of the peptidergic neurons less 
pronounced (Cunha et a l, 2005a). Later on, another study from Cheryl Stucky
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demonstrated that this change in sensitivity is partly due to an upregulation of TrpVi in the 
IB4-positive neurons, when exposed to protons, and is partly the reason why IB4-positive 
neurons also contribute to inflammatory nociception (Breese et al., 2005). Together, these 
few examples demonstrate that it has not so far been proven that specific subpopulations of 
nociceptors can be assigned to specific pain modalities.
In this PhD thesis I have investigated the functional changes in nociception after ablation of 
the Nayl .8-expressing neurons, a large population of the small sensory neurons and further 
identified a number of small sensory neuron specific genes that could be new targets in 
future treatment of several pain modalities.
To direct the ablation, the CxdloxP system was used express diphtheria toxin tissue 
specifically in the Nay 1.8-expressing population (Ivanova et a l, 2005;Stirling et a l, 2005) 
as Nayl.8 is expressed mainly in the small sensory neurons (Djouhri et al, 2003).
7.1.1 Successful generation of the DTA-CRE and DTA-controI mouse
Before any experiments were performed in vivo or in transgenic tissue, mice were assessed 
for any obvious differences in weight gain, motor function, fertility and general behaviour. 
No differences in weight gain and motor function were observed between the DTA-CRE 
and DTA-control; litters were all within expected sizes and the overall ratio of male/female 
progeny was close to 1:1. During the study a few mice had to be culled due to injuries. As 
recorded during the behavioural assessment, the DTA-CRE mice were insensitive to some 
pain modalities and tissue damage due to fighting or caressing could occur. To keep the 
experimenter blind to genotype and also to keep the experiments within ethical boundaries, 
these mice were culled.
The expression of Cre, mediating the expression of diphtheria toxin fragment A in the 
DTA-CRE mouse proved an efficient method of deletion of around 88% of nociceptors. 
Immunohistochemistry showed almost complete deletion of the Nay 1.8-expressing neurons. 
This accords with the results of previous experiments using the same floxed DTA-mouse, 
where cell ablation was shown to follow the pattern of Cre expression (Ivanova et a l,
2005).
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One problem experienced previously from the use of diphtheria toxin is leakage of the toxin 
into the surrounding tissue. By using only fragment A of the diphtheria toxin no further cell 
death will occur when the targeted cells die and DTA leaks from the cytoplasm into the 
extracellular matrix. Diphtheria toxin is a two-fragment toxin and in the DTA mouse only 
fragment A is present. The absence of fragment B, the part responsible for internalisation 
upon binding to its receptor, prevents further inhibition of the protein synthesis in DTA- 
CRE mouse (Collier, 2001;Ivanova et a/., 2005).
7.1.2 No eGFP fluorescence detectable in the DTA-CRE or DTA-control 
mouse
From the immunohistological analysis, one important observation was the lack of 
fluorescence from the DTA-CRE and DTA-control mouse. The generation of the DTA 
mouse DNA construct included an enhanced Green Fluorescence Protein (eGFP) cassette 
that was inserted into the floxed part of the construct to detect and confirm the expression 
pattern. From any tissue expressing the modified gene (the floxed DTA construct, see Fig. 
10, page 69), green fluorescence should theoretically be detectable after exposure to UV- 
light at wavelength 488nm. Any cells exposed to Cre would have lost the DNA fragment 
flanked by loxP sites including the eGFP cassette and the stop-signal preventing DTA 
expression. When any other tissue from the DTA-CRE or DTA-control mice was exposed 
to UV-light from the green spectrum, no visible fluorescence was detected.
The reason for lack of green fluorescence thus detected is probably due to the signal being 
too weak for detection as reported from other studies (Gusella et a l, 2002). Only by 
staining with an antibody against eGFP would it be possible to visualise the GFP. In this 
project it was not of any importance to see the eGFP fluorescence and I did not try in any 
way to check if the eGFP was detectable. In fact, if fluorescence had been detectable from 
the eGFP cassette it would have conflicted with the IHC analysis when antibodies against 
neuronal subtypes or proteins were used and in some cases detected using green fluorescent 
secondary antibodies.
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7.1.3 Efficient deletion of Nayl.8 positive neurons
Staining of DRG sections using an anti-Nayl.8 antibody was used to show an almost 
complete loss of Nayl.8 positive cells in the DTA-CRE mouse, confirming the complete 
expression of Cre in the Nay 1.8-expressing cells using the Nayl.8Cre mouse.
After this crucial experiment, validating the experimental model, deletion of the total 
population of small sensory neurons was investigated. Markers for peripherin, labelling the 
small unmyelinated C-fibres (Goldstein et al., 1991), showed that around ~88% of the 
peripherin positive neurons had been ablated. It has previously been shown that Nayl.8 is 
expressed within a similar percentage of the small sensory neuron population (Djouhri et 
a l, 2003). Staining with anti-neurofilament labelling the myelinated sensory neurons 
further revealed a more subtle deletion of a subset of the medium/large sensory neurons. It 
has been shown that Nayl.8 is expressed in a small subset of medium sensory neurons 
(Akopian era/., 1996).
In conclusion, the use of the floxed diphtheria toxin fragment A mouse in combination with 
the Nayl 8Cre mouse has proven effective in generating progeny with the Nayl .8- 
expressing neurons ablated.
7.1.4 Only peptidergic neurons left in DRG of the DTA-CRE mouse
Further IHC analysis of the DTA-CRE mouse, using markers for the peptidergic and non- 
peptidergic subpopulations of C-fibres, revealed that the large majority of the non- 
peptidergic neurons were deleted with a small group of peptidergic neurons remaining.
The results show that the two sub-populations of small sensory neurons, divided according 
to their expression of neuropeptides, have different co-expression of N ayl.8 . All of the non- 
peptidergic neurons express N ayl.8 , but a small subset, ~ 12% of the peptidergic neurons, 
does not express N ayl.8.
Of the remaining peptidergic neurons, substance P was showed to be expressed in very few 
cells in the DTA-CRE mouse compared with DTA-control.
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7.1.5 Only peptidergic neurons remain at the central terminal in the DTA- 
CRE mouse
The central terminals of the primary sensory neurons have been described clearly n 
previous studies (Snider and McMahon, 1998). To investigate if any central changes could 
be attributed to deletion of the Nay 1.8-expressing neurons, sections of the spinal cord dorsal 
horn were characterised for expression of peptidergic and non-peptidergic neurons.
The results showed that the staining reported in lamina I and outer lamina II of the dorsal 
horn using anti-CGRP (Snider and McMahon, 1998) were strongly reduced in the DTA- 
CRE mouse compared with DTA-control spinal cord sections supporting IHC observations 
from DRG sections.
The lack of IB4-positive neurons in the spinal cord also supported the results from the 
DRG. No IB4-positive neurons, designated to the inner lamina II, were identified from 
sections of spinal cord from the DTA-CRE mouse.
7.2 N A v I . S - e x p r e s s i n g  n e u r o n s  c o n v e y  n o x i o u s  m e c h a n i c a l
INFORMATION
Behavioural responses to noxious mechanical stimulation were considerably disrupted in 
the DTA-CRE mouse. Previously published works have suggested a number of transducers 
involved in noxious mechanical detection. In a separate study using the Nayl.8Cre mouse, 
Nayl.7 was deleted tissue specifically in the majority of the small sensory neurons and 
responses to noxious mechanical stimuli were greatly reduced (Nassar et a l, 2004). Also, 
when Nayl.8 was deleted, a similar, but not as strong phenotype was identified (Akopian et 
al, 1999) and finally a Nay 1.7/Nay 1.8 double knockout further confirmed this observation 
suggesting that both ion channels were involved in noxious mechanosensation (Nassar et 
al, 2005;Nassar et a l, 2004)
The modification in the DTA-CRE introduced not only deletion of Nay 1.7 and Nayl.8 in 
the Nay 1.8-expressing neurons, but the whole neuron was ablated and as hypothesised, a 
strong phenotype to noxious mechanical stimulation was recorded.
130
TrpAi has been reported by several groups to be involved in noxious mechanosensation and 
is exclusively expressed in the small sensory neurons (Kwan et ah, 2006;Petrus et ah,
2007). Recently, a subtype-specific TrpAi pharmacological blocker was developed and 
shown to reverse mechanical nociception after inflammation (Petrus et al., 2007), further 
indicating some involvement in mechanosensation.
The microarray analysis also highlighted a number of transcripts which, being selectively 
expressed, are possibly involved in mechanotransduction. Nay 1.7 was found to be only 
slightly reduced, but as this sodium channel is expressed across the DRG the actual 
reduction in the small DRG neurons may have been masked (Sangameswaran et ah, 1997). 
Nay 1.7 is important in mechanosensitive neurons, but is unlikely to be the transducer. 
Transcripts for TrpAi was strongly downregulated suggesting that TrpAi could play a role 
in the conveyance of information about mechanical tissue damage, possibly that of 
mechano-transducer.
Finally, electrophysiological data obtained from WDR neurons confirmed further a clear 
difference after noxious mechanical stimulation of the periphery between the DTA-CRE 
and DTA-control mice. Recordings from the DTA-CRE mouse showed that only a fraction 
of electrical impulses was conveyed after stimulation.
In conclusion, the result strongly suggests that Nay 1.8-expressing neurons are responsible 
for detecting noxious mechanical stimuli.
7.2.1 No phenotype for light mechanical sensation
Sensation from light stimuli has for long been an area of great interest. From a pain 
perspective, light mechanical stimuli can turn into a very painful and debilitating 
experience in particular after nerve injury where allodynia can develop.
The large AP-fibres, responding to non-noxious mechanical stimulation (Almeida et al., 
2004) were not affected by the introduction of diphtheria toxin and when tested for 
responses to light touch the DTA-CRE mouse did not show any differences compared with
131
the DTA-control mouse. The result confirms that Nayl.8-expressing neurons are not 
responsible for light mechanical sensation.
IHC showed a 13% reduction in the number of myelinated sensory neurons as Nay 1.8 is 
expressed in a small subset of medium sized neurons ((Djouhri and Lawson, 2004)), but 
this small reduction in the number of Aô-fibres was not detected from the behavioural 
analysis for light touch responses. Furthermore, the WDR electrophysiology confirmed the 
behavioural result as both brush and application of non-noxious von Frey filaments did not 
give rise to any differences in central input. The WDR recordings using thicker von Frey 
filaments did show a strong phenotype for the DTA-CRE muse, but only for filaments over 
1 g. When such thick filaments are applied a noxious mechanical and not a non-noxious 
stimulus is applied.
7.2.2 No involvement o f Nayl.S-expressing neurons in acute heat sensation
Responses to thermal stimulation were tested using two different models, the Hot plate and 
the Hargreaves’ instrument. Several reports on possible transducers of noxious heat have 
been reported with many of them expressed either partly or exclusively in the small sensory 
neurons. By investigating the DTA-CRE mouse further information about subsets of 
sensory neurons involved in thermal sensation would emerge.
The response to the hot plate revealed minimal differences between the DTA-CRE and the 
DTA-control. The hot plate exposes the mouse to supra-threshold heat and the responses 
are considered to be supra spinal involving voluntary rather than involuntary behaviour 
(Jensen and Yaksh, 1984).
A more specific exposure to heat comes from the radiant heat delivered by the Hargreaves 
instrument and results in a reflex withdrawal (Hargreaves et a l, 1988). Interestingly, no 
significant difference between the DTA-CRE and DTA-control mice was recorded from the 
Hargreaves instrument. A trend in the responses to Hargreaves’ instrument did suggest 
increasing resistance to heat in the DTA-CRE mouse, but the difference was not 
statistically significant. Previously, similar findings of a non-significant trend of increased
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heat resistance were reported from the PI 1-KO, the Nayl.7-KO and the Nayl.S-KO 
(Foulkes et a l, 2006;Akopian et a l, 1999;Nassar et a l, 2004) suggesting that several 
proteins expressed in Nayl.S-expressing neurons could influence thermal sensation. 
Surprisingly, from the Nayl.7/Nayl.8 double KO a pronounced resistance to heat was 
reported when using the Hargreaves instrument (Nassar et a l, 2005). This result was not 
reproduced testing the DTA-CRE mouse.
For long time several ion channels belonging to the Transient Receptor Protein family have 
been reported as the main transducers for noxious heat (Patapoutian et a l, 2003). TrpVi 
had been shown, using calcium imaging and electrophysiology, to be sensitive to capsaicin, 
heat and protons (Hek293 and Oocytes) (Caterina et a l, 1997). A few years later in 2000, 
two groups published in vivo data from TrpVi KG mice. One of the TrpVi KO showed 
similar results to the data previously obtained from electrophysiological recordings from 
transfected HEK293 cells and oocytes. Furthermore, the transgenic mouse showed a 
pronounced difference, compared to control, indicating a much suppressed response to heat 
in the hot-plate and immersion of the tail in hot water, but using the Hargreaves test no 
strong difference was found (Caterina et a l, 2000). After induction of inflammation using 
either CFA or mustard oil the subject again recorded a suppressed thermal response, but no 
phenotype was recorded when tested to mechanical stimuli (Caterina et a l, 2000). Also, no 
difference, thermal or mechanical, was observed after nerve injury (Caterina et a l, 2000). 
Data from another TrpVi KO ratified the inhibited response to heat and protons using 
electrophysiology (Davis et a l, 2000). Exposure to acute thermal stimulation using Hot 
Plate or Hargreaves’ elicited indifferent response from the transgenic mouse compared with 
control. Only after introduction of inflammation, using carrageenan, was again a marked 
difference in response to heat noted (Davis et a l, 2000).
A more detailed analysis was performed by Woodbury et al. The study reported a strong 
difference in co-expression of TrpVi and IB4 (marker of the non-peptidergic neurons). In 
rat subjects, 50-55% of IB4-positive neurons also co-stained for TrpVi. In contrast the 
number in mouse was found to be much smaller with only around 4% of the IB4-positive 
neurons co-staining for TrpVi (Woodbury et a l, 2004)
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Using a skin-nerve preparation, heat sensitive fibres in the TrpVi KO mouse were 
identified and tested for responses to heat. With 57% of the WT and 78% of the KG fibres 
exhibiting a positive heat response, the data proved different to data published previously. 
The IB4-negative neurons were tested and overall there was no notable difference in heat 
responses when testing with and without TrpVi expression (Woodbury et al., 2004). To 
investigate further if TrpVi could be responsible, the heat responsive fibres from the TrpVi 
KG were stained with anti-TrpV2. Gnly one out of twelve fibres tested positive for TrpV: 
further suggesting no involvement of TrpVi in the physical detection of noxious heat.
As TrpVi is strongly expressed in the Nayl.S-expressing neurons my results do not support 
a role for TrpVi in acute noxious thermal sensation. Even though around 4.5% of the cells 
in the DTA-CRE mouse did respond to capsaicin compared with DTA-control using 
calcium imaging, it seems improbable that such a small number of positive cells would 
convey a normal response. The behavioural data from injections of capsaicin confirmed a 
lack ofTrpVi.
Data from the microarray experiment shows that TrpVi transcripts were downregulated 3.5 
fold. The calcium imaging suggests the downregulation of TrpVi was greater. If the 
calcium imaging result is correct, a reason for the low expression of TrpVi in the DTA- 
CRE mouse could be caused by developmental changes after the ablation of the N ayl.S- 
expressing neurons. Quantitative RT-PCR of TrpVi in the DTA-CRE was shown to be 
downregulated around 4-fold compared with DTA-control, similar to that measured in the 
microarray experiment.
In conclusion, the results indicate that Nayl.S-expressing neurons may only contribute to 
sensation of noxious heat; arguably other non-Nay 1. S-expressing neurons are involved. Gne 
possible transducer reported to detect noxious heat is TrpV: (Dhaka et a l, 2006). The ion 
channel is expressed in medium and large neurons, is therefore not affected by the induced 
deletion by diphtheria toxin (Caterina et a l, 1999) and could contribute to heat sensation in 
the DTA-CRE mouse. In the microarray gene analysis TrpV2 is neither down nor
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upregulated, indicating that only minor regulation has occurred. No TrpVi KO transgenic 
data have been published to ratify in vivo involvement in thermal sensation.
7.2.3 S elec tive  b lo c k a g e  o f  Nayl ?  d oes  n o t  a f fe c t n o x io u s  th e rm a l  s e n sa tio n
The tissue-specific deletion of Nay 1.7 in the Nayl.S-expressing small sensory neurons gave 
rise to a trend towards thermal resistance, though non-significant when tested using 
Hargreaves’ instrument (Nassar et a l, 2004). When a selective blocker of the Nay 1.7, 
PhlTxl, delivered locally to the paw, was tested using Hargreaves’ instrument no 
differences in thermal sensation were recorded. Collectively, the data suggests that Nay 1.7 
is not involved in the sensation of noxious heat.
7.3 L a c k  o f  s e n s a t io n  t o  n o x i o u s  c o l d  i n  DTA -CRE c o n f i r m s  a
ROLE FOR N A vI .8  IN COLD RESPONSES
Recently, Zimmerman et al reported that N ayl.8  is essential for the sensation of noxious 
cold (Zimmermann et a l, 2007). As Nayl .8-expressing neurons have been deleted in the 
DTA-CRE mouse it could validate this observation. Interestingly, the DTA-CRE mouse did 
show a strong resistance in response to noxious cold using the cold plate. The data suggests 
that it is Nay 1.8-expressing neurons that convey noxious cold information.
When the DTA-CRE mouse was exposed to non-noxious coolness generated by the 
evaporation of acetone no difference was observed. TrpMg has been investigated for 
involvement in sensation of cold as it is located in the sensory neurons, expressed 
exclusively in a small subset of small neurons and activated by cold and menthol (Story et 
a l, 2003). When the TrpMg KO mouse was exposed to a range of temperatures, results 
showed enhanced resistance to cold below 15°C, suggesting that it does not detect 
innocuous cold, but noxious (Bautista et a l, 2007;Dhaka et a l, 2008)
In the microarray experiment, TrpMg was surprisingly not found to be up- or 
downregulated. To validate this result, qRT-PCR was performed and as with the microarray 
and functional behaviour, no difference was found versus control. A final investigation of
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the TrpMg expression in the DTA-CRE mouse was performed using calcium imaging. 
Activation by menthol demonstrated that only a small proportion of the small sensory 
neurons in the DTA-control mouse are activated by menthol and this subset is almost intact 
even after deletion of the Nayl.S-expressing neurons in the DTA-CRE mouse, suggesting 
that the TrpMg population is not co-localised with Nayl.8.
Electrophysiological recordings from WDR neurons were performed and a range of 
temperatures applied to the paw. The temperature stimuli were applied using a syringe 
filled with water at the chosen temperature. This form of application elicits not only a 
thermal response, but also a mechanical response from the water-jet.
The results from the WDR electrophysiological analysis reproduced the behavioural 
observations showing no differences between DTA-CRE and DTA-control to any 
temperature applied. When 1°C water was applied in the WDR electrophysiology, no 
difference was found, but this is not comparable to the cold plate as the latter exposes the 
mouse to constant cold for 5 minutes. A more scientifically comparable behavioural assay 
is the acetone test, where evaporation of acetone applied for a short period cools the paw. 
On performing this test no difference was found between the DTA-CRE and DTA-control.
Contradicting the results from the DTA-CRE mouse in the above tests, results from WDR 
recordings from the Nayl.8 null mouse did report a significant difference when responses to 
1°C were measured (Matthews et al., 2006).
In conclusion, the results suggest that Nay 1.8-expressing neurons do not contribute to the 
acute thermal sensation, but are involved strongly after induction of inflammation. Also, 
Nay 1.8-expressing neurons are necessary for the detection of noxious cold.
7.4  NAv1.8-EXPRESSING n e u r o n s  a r e  r e s p o n s i b l e  f o r  INFLAMMATORY 
PAIN
The neuronal response to tissue damage is a very complex situation. Inflammatory 
mediators sensitise the sensory neurons resulting in hyperalgesia and allodynia.
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Some of the transducers expressed at the termini of the primary sensory neurons convey 
inflammatory pain. Deletion of Nayl.S-expressing neurons was hypothesised to result in a 
reduction in responses to inflammation.
When the DTA-CRE mouse was injected with formalin, the measure of response was 
reduced significantly during the second phase, the phase believed to be inflammatory 
(Tjolsen et al., 1992). When the DTA-CRE mouse was exposed further to long term 
inflammation, mechanical and thermal responses were measured for several days eliciting a 
strong resistance to both stimuli.
Of transducers involved in the sensation of inflammatory pain. Nay 1.7 is a strong candidate. 
In a previous study, Nayl.7 was selectively deleted in the Nayl.S-expressing neurons using 
the Nayl.SCre mouse. The result was a significantly reduced response in the second phase 
of the formalin test (Nassar et a l, 2004). This was confirmed further in responses to CFA, 
NGF and Carrageenan (Nassar et a l, 2004). Also, a delay in onset of inflammatory pain 
were measured in the Nayl.8 KG (Akopian et a l, 1999). Finally, in the double knock out of 
both Nayl.7 and Nayl.8 the responses to inflammation were almost completely ablated 
(Nassar et a l, 2005). Both Nayl.8 and Nayl.7 expressed in the Nayl.8-expressing neurons 
were deleted in the DTA-CRE mouse, ratifying previous observations.
TrpVi is another ion channel heavily involved in the development of inflammatory pain 
and is expressed in the sensory neurons (Davis et a l, 2000). The two sets of data published 
on TrpVi knockout mice show the response to heat after induction of inflammation were 
significantly reduced (Davis et a l, 2000;Caterina et a l, 2000).
TrpV2 is also reportedly involved in the development of inflammatory pain. In wild type 
mice injected with either carrageenan or CFA, Probenocid, a selective activator for TrpV2 
induced a stronger licking and biting behaviour compared with wild type mice injected with 
placebo (saline) (Bang et a l, 2007). This suggests that activation of TrpV2 affects the 
development of inflammatory pain. Interestingly, the TrpV2 is mainly in the populations of 
medium and large sensory neurons and should not be affected by the diphtheria expression 
linked to N ayl.8  expression. Therefore the data from the DTA-CRE mouse suggests that 
TrpV2 is not involved in development of inflammatory pain. As previously mentioned, data 
from a TrpV2 KG mouse has yet to be published.
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One ion channel expressed in the small sensory neurons and reported involved in 
inflammatory pain is TrpAi (McNamara et a l, 2007). In the microarray gene analysis of 
the DTA-CRE mouse TrpAi is the most greatly downregulated Trp-channel (13.5 fold) so 
some involvement of TrpAi in inflammatory pain is very possible.
Among other ion channels of interest, P2X3 has been showed to be upregulated after 
inflammation and to contribute to mechanical sensitisation (Dai et al., 2004). It was 
downregulated almost 12 fold in the DTA-CRE mouse, thus similar to TrpA] a role in 
inflammatory pain can not be excluded.
From the results, no specific receptor can be identified as responsible for the hyperalgesia 
observed after inflammatory pain, but for possible new drug treatment of inflammatory 
pain, receptors expressed in the Nayl.S-expressing neurons should be targeted specifically 
as opposed to receptors such as TrpVi which are not expressed in Nayl.S-expressing 
neurons. Finally, from the microarray list of regulated transcripts, a number of novel genes 
were found to be strongly downregulated in the DTA-CRE mouse, suggesting a possible 
role in the inflammatory pain seen in the DTA-control mouse.
7.5 NAv1.8-e x p r e ssin g  n e u r o n s  a r e  n o t  r e spo n sib l e  fo r  
N e u r o pa t h ic  pa in
Neuropathic pain mechanisms are not fully understood. The receptors, channels and 
sensory neuron populations that are involved in neuropathic pain pathogenesis have still not 
been characterised fully. Microarray experiments have been used to investigate changes in 
gene expression and have suggested the involvement of several hundreds of genes, in the 
DRG, spinal cord and surrounding tissue (Griffin et a l, 2007;Costigan et a l, 2002).
In the DTA-CRE mouse, no differences in mechanical or thermal thresholds were measured 
after introduction of nerve injury compared with DTA-control. In previous studies using the 
Nayl.SCre mouse to delete receptors in a tissue-specific manner similar results were 
obtained. Nayl.S-expressing tissue-specific knockouts of Nayl.3, Nay 1.7, Nayl.S (each 
individual, and the latter two together) as well as PI 1 and BDNF (Zhao et a l, 2006;Foulkes
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et al., 2006;Nassar et al., 2004;Nassar et al., 2006;Nassar et al., 2005) demonstrated no 
involvement in neuropathic pain thresholds.
The data from the DTA-CRE mouse, together with previous data, suggests that sensory 
neurons other than Nayl.S-expressing neurons are arguably responsible for the development 
and maintenance of neuropathic pain.
When transgenic mice have been tested for development of neuropathic pain, the gene 
modification has often been performed in a non-specific way. The Nayl.SCre mouse only 
deletes the target gene in neurons expressing Nayl.S, leaving most medium and large 
primary neurons unchanged. This difference suggests further that fibres other than those 
expressing Nayl.S are required for the development of neuropathic pain.
Recently spinal cord slices were investigated using Calcium imaging to establish whether 
Ap-fibre information could spread from lamina III to more superficial laminae after 
neuropathic pain (SNI) (Schoffhegger et al., 200S). The results showed that activation of 
only Ap-fibres gave Ca^  ^transients in superficial nociceptor specific laminae in 67% of the 
neuropathic rats compared with 12% for the control rats. Also, chemical and electrical 
stimulation of the deep dorsal horn resulted in activation of superficial laminae. Together 
with the previous observations and the in vivo data fmm the DTA-CRE mouse it seems 
very likely that Ap-fibres play a very important role in the development and maintenance of 
debilitating allodynia and hyperalgesia seen with neuropathic pain.
7.6 NAvI .7  s p e c i f i c  b l o c k e r  r e v e r s e s  NEUROPAXinC PAIN
The Nay 1.7-specific blocker, PhlTxl, delivered locally to the paw, was demonstrated to 
reverse the development of neuropathic pain. As reported, the Nay 1.7 KO, limited to the 
Nayl.S-expressing neurons, did show a strong development of hyperalgesia after nerve 
injury suggesting that blockage of Nay 1.7 in neurons other than those expressing Nayl.8 are 
responsible for neuropathic pain.
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7.6.1 Nayl.S-expressing neuron specific transcripts
Total RNA from DRG dissected from DTA-control and DTA-CRE mice was used for a 
microarray gene analysis to distinguish which transcripts had been either up- or 
downregulated. As the Nayl.S-expressing neurons had been ablated, the microarray 
experiment would make it possible to identify transcripts enriched or specifically expressed 
in the Nayl.S positive neurons. Transcripts strongly enriched in the DTA-KO could mean 
an involvement in some of the remaining pain modalities and likewise strongly 
downregulated transcripts are possibly responsible for the suppressed modalities.
Whilst around half the probes on the gene chip are used for controls, the regulation of 
several transcripts also acted as controls as they are co-localised with Nayl.8 e.g. Nay 1.9 
(downregulated 23-fold) (Fang et al., 2002). Nayl.8 itself should obviously be strongly 
downregulated and fortunately, this was the case (downregulated 37-fold).
Using microarray in this way will not identify all regulated genes. If the transcripts are 
expressed widely across the DRG some down-regulation can be expected. If the expression 
of a transcript is limited to only the small DRG a large down-regulation would be expected. 
Finally, an up-regulation would be expected if the transcript was expressed only in the large 
neurons. Further, for the microarray platform I used any splice variants of transcripts will 
not be detected. Also, the proportion of mRNA is not identical to the proportion of protein 
translated.
Sodium channels other than N ayl.8 and Nay 1.9 are also regulated according to the 
microarray analysis. Nay 1.7 is only downregulated 2.2 fold, but this could be due to its 
expression in the large sensory neurons (Sangameswaran et a l, 1997). The widely 
distributed Nay 1.1 (upregulated 1.8-fold) has not been linked to nociception.
Two different p-subunits are regulated. The Nay-type II P-subunit (downregulated 3.7-fold), 
modulates channel gating, assembly and expression and is expressed in all subtypes of 
DRG neurons (Chahine et a l, 2005). Nay-type HI p-subunit (downregulated 2.9-fold) is 
expressed in the small and medium DRG neurons (Chahine et a l, 2005), but has not been 
linked to nociception.
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Several ion channels belonging to the Trp-family showed a reduction in transcript levels. 
TrpAi, TrpVi and TrpVi and their involvement in nociception have been described 
previously. TrpCs and TrpCe (downregulated > 6  fold) are each expressed in the small 
sensory neurons, but neither has been shown to be involved in nociception.
Of the calcium channels (and subunits) the transcript most downregulated in the microarray 
analysis is the a2Ô-l subunit (downregulated 3.4-fold), predominantly expressed in the 
small sensory neurons (Yusaf et al., 2001) and is involved in neuropathic pain rather than 
acute pain (Li et a l, 2004). The calcium channel a-subunit. Cay 1.2 (L-type) (downregulated 
3-fold) has not been linked to pain. Of calcium channels involved in nociception, mostly 
belonging to the N-type (Cay2) or T-type (Cay3) families of VGCC (Gribkoff, 2006), only 
Cay2.2 was downregulated (3.2-fold) in the microarray experiment. Of the VGCC subunits 
the P3-subunit was downregulated 1.5 fold. From the study of the p3-subunit knock-out 
mouse it was shown that p3 was strongly involved in inflammatory pain, but only 
moderately involved in acute nociception (Murakami et al., 2002).
The G-Protein coupled receptors MrgA2 and MrgA3, both expressed in nociceptors (Dong 
et al., 2001) and possibly involved in modulating sensory information (Liu et al., 2008), 
were both downregulated (11-fold and 18-fold respectively) in the DTA-CRE mouse.
Transcripts for prostaglandin receptors, involved in inflammation (Matsuoka and 
Narumiya, 2007), were downregulated between 2- and 4-fold. P2X3 (downregulated 11.9- 
fold) is involved in inflammatory responses due to the release of ATP and possibly in 
thermal sensation (Souslova et a i, 2000). As P2Xg is exclusively expressed in small 
neurons a strong downregulation was expected in the DTA-CRE mouse (North, 2004). This 
would support the observation from the immunohistochemical characterisation showing 
that the non-peptidergic neurons had been ablated, as the P2X] channel is exclusively 
expressed in IB4-positive neurons (Burgard et al., 1999).
The serotonin receptor, 5-HT4 (downregulated 16-fold) is expressed throughout the sensory 
neurons, with its highest content in the small C-fibres (Nicholson et al., 2003), but without 
any direct links to nociception. Interestingly, 5-HT3 which is distributed in a similar way as 
5-HT4 and involved in several pain modalities was found to be downregulated 2.1-fold in
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the experiment. The 5-HTia receptor (downregulated 2.9-foid) has no reported influence on 
peripheral nociception, but is involved in several psychiatric disorders (Sharp et al., 2007). 
CGRP-R2 (downregulated 3.6-fold), one of the receptors for the neuropeptide CGRP, 
released upon a host of stimuli in the periphery and activates and sensitise nociceptors, is 
expressed in both central and peripheral neuronal tissue (Benemei et al., 2007).
Several of the markers for neuron subtypes are regulated in the DTA-CRE mouse. RET, the 
tyrosine kinase receptor for GDNF (Molliver et a l, 1997) is expressed in the IB4-positive 
non-peptiodergic neurons, but also in some large neurons (Bennett et al., 2000). RET is 
only downregulated 1.5-fold, but this could be partly due to the fact that it still is expressed 
in some large neurons and also possible compensation from an upregulation in the large 
cells. Another marker is the transcription factor RunXl, shown to be involved in the 
transition of a subpopulation of sensory neurons changing from expressing TrkA to RET 
with a distribution within the DRG appearing to be restricted to nociceptors (Molliver et 
a l, 1997;Theriault et a l, 2004). In the DTA-CRE mouse RunXl is downregulated 4-fold. 
The other transcription factor regulated, belonging to the Runx-family, is RunX3 
(upregulated 2.4-fold). RunX3 is involved in the differentiation of the large neurons so an 
upregulation is expected as the large neurons represents a larger proportion of the RunX3 in 
the DTA-CRE compared with DTA-control (Inoue et a l, 2002).
Of transcripts coding for receptors involved in endogenous analgesia, the p-opioid receptor 
(downregulated 7-fold) is strongly linked to the Nayl.S-expressing neurons. A study of a 
rare polymorphism of the p-opioid receptors suggests involvement of the receptor in 
noxious mechanosensation (Fillingim et al., 2005).
Of particular interest, a group of transcripts, GPCRs, Kinases, channels and receptors has 
been identified that has not previously been associated with nociceptors, but associated 
with the Nayl.S-expressing neurons. Among these transcripts must be receptors partly 
responsible for pain modalities absent in the DTA-CRE mouse -  cold pain, noxious 
mechanotransduction and inflammatory pain.
One of the most regulated transcripts in the DTA-CRE mouse is the GPCR, GNA14 
(downregulated 37-fold) belonging to the Gq subfamily of the GPCR superfamily and has
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very recently been cloned from porchine (Chen et al., 2008). The Kelch-like 5 transcript 
(Klhl5 downregulated 17-fold) belongs to the Kelch protein super-family. Klhll is involved 
in trafficking and modulation of the VGCC currents Cav2.1 (Aromolaran et al., 2007) and 
KhlhS is likely to have similar cytoskeletal characteristics.
Edg7 is another transcript showing an almost complete co-expression with Nayl.S  
(downregulated 44-fold) (Takuwa et al., 2002), but no published links to nociception and as 
it is expressed ubiquitously it is not a potential drug target.
The data obtained from the microarray experiment is a suitable basis for further 
experiments. The Nayl.S-expressing neurons were deleted reducing the peripherin-positive 
cells by around SS percent. This suggests that e.g. the transducer for one of the remaining 
pain modalities, heat must be either expressed within the remaining subset of non-Nay l.S- 
expressing neurons or in another population of sensory neurons.
7.7 E x t r a c e l l u l a r  e le c t r o ph y sio l o g y  c o n fir m s  o b se r v a t io n s
Investigations of the information carried through to the dorsal horn could possibly validate 
some of the observations obtained from behavioural studies. However, it is important to be 
aware of a few differences between the techniques. The electrophysiological experiments 
are performed in vivo, but the mice are under deep anaesthesia enabling the measure of 
supra-threshold stimuli of the neurons compared with the behaviour where pain thresholds 
are measured.
Also, the range of stimuli differs according to the measurement techniques performed for a 
given modality. For light mechanical stimulation using non-noxious pressure, a brush is 
used for the electrophysiology, whereas von Frey filaments are used for behaviour. For 
noxious mechanical pressure, pressure applied using forceps is used for electrophysiology 
but the Randall Selitto apparatus for the behaviour.
Thermal stimulation was tested at several different temperatures, cold, warm and hot. For 
the electrophysiological analysis all temperatures were applied using water compared with 
behavioural where hot-plate, Hargreaves’, cold plate and acetone were used. These variants 
could give rise to different responses.
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No electrophysiological recordings were performed after introduction of inflammation or 
nerve injury.
7 .8  P a pin
From the discovery that the Papin protein interacts with Nay 1.8 it was believed that it could 
have an effect on pain thresholds as seen with another Nayl.8-interacting protein, PI 1 
(Foulkes et al., 2006). A Papin knock out mouse (PAPIN-KO) was investigated for acute 
pain thresholds and interestingly no differences were recorded when exposed to painful 
mechanical, thermal or inflammatory stimuli. In contrast, when tested for responses to non- 
noxious mechanical stimulation using von Frey filaments (Hogan, 2002) the 50%-threshold 
of the PAPIN-KO mouse compared with Papin control littermates (PAPIN-control) was 
more than doubled: 1.55g vs. 0.60g. This result was unexpected and not considered to be 
related to the interaction with Nayl.8.
One way to investigate this observation further was by recording electrophysiological 
changes after mechanical stimulation of cultured DRG neurons. The low-threshold 
mechanoreceptors (LTM), identified by their narrow action potential, all respond to 
mechanical stimuli whereas only around 30% of the LTM characterised by wider action 
potentials are activated by mechanical stimulation (Drew et a l, 2004).
The results showed that in the PAPIN-KO around 20% of the LTM cells with narrow action 
potential did not respond. There could be several reasons. One is that the cells are 
mechanosensitive, but when the stretch of the cell membrane exceeds 7-8 pm, the cell tends 
to die and a change in current is not identified. Another possibility is that the cells are in 
fact non-responders.
The other electrophysiologically interesting observation is the increment in the percentage 
of mechanically activated wide action potential LTM cells. Normally, around 70% of these 
cells will not respond to mechanical stretching of the membrane (Drew et a l, 2004), but in 
the PAPIN-KO mouse only 35% cells did not respond suggesting a significant change 
mechanically activation. This change can be due to a shift in phenotype of the cells to 
compensate for the difference seen with the narrow action potential LTM cells.
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An observation made while performing the electrophysiology gave rise to the suggestion 
that the number of large neurons stained by anti-neurofilament, were lower in the PAPIN- 
KO compared with the PAPIN-control. Whole DRG were sectioned and stained to compare 
both the large cells and the small cells (anti-peripherin positive).
No difference in the number of small peripherin stained cells was found, but interestingly 
the number of large cells stained with anti-neurofilament showed a significant difference 
with 22% less cells expressed in the PAPIN-KO when compared with the PAPIN-control.
This result gives another possible explanation to the observed behavioural phenotype, as 
the numbers of conducting cells are reduced in the PAPIN-KO.
Finally, immunohistochemistry of the skin demonstrated significant differences between 
the PAPIN-KO and PAPIN-control in the anatomy of the cells. Strikingly, the physical 
connection between the merkel cells and the sensory neurons was lost in the PAPIN-KO 
mouse suggesting another possible reason for the lack of response to light mechanical 
stimulation.
In conclusion, a behavioural observation found that the PAPIN-KO was deficient in 
response to non-noxious mechanical stimulation. This observation was investigated by 
electrophysiology and immunohistochemistry and a number of possible explanations were 
identified.
• A greater number of non-responding narrow action potential LTM fibres were 
found in the PAPIN-KO compared with PAPIN-control.
• More responding wide action potential medium/large fibres were found in the 
PAPIN-KO
• A lower number of medium/large sensory neurons were found in the PAPIN-KO 
compared with PAPIN-control.
• A strong reduction in the connection between merkel cells and sensory neurons was 
identified in skin from PAPIN-KO.
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7.9 N A v 1.7 BLOCKAGE USING P H L T x I
The discovery of the importance of Nay 1.7 in nociception has been a breakthrough in the 
search for new treatments of pain hence research into this specific ion channel has 
increased significantly. In mouse, a DRG tissue-specific deletion of Nay 1.7 demonstrated a 
significant role of the sodium channel in mechanical and inflammatory pain. In human, a 
functional deletion of Nay 1.7 demonstrated a remarkable ablation of the ability to sense 
tissue damage; whereas mutations of Nay 1.7 have been linked to various painful conditions.
A toxin, PlhTxl isolated from the Tarantula Spider was found to block Nay 1.7 selectively. 
Its ability to reduce responses a range of stimuli, acute, after introduction of inflammation 
and also after nerve injury, was tested in vivo.
No difference in response was found between the toxin group and control group when the 
injected paw was exposed to radiant heat. Only after inducing inflammation did the PhlTxl 
reverse the thermal hyperalgesia recorded in the saline-treated control group. Responses 
after mechanical stimulation were greatly reduced by the toxin. The acute threshold to von 
Frey filaments was increased after injection of PhlTxl and the post-inflammatory 
hyperalgesia was more than reversed.
Interestingly, mechanical hyperalgesia seen after nerve injury was also reversed in the 
group of mice treated with the toxin.
The data suggest that blockage of Nay 1.7 expressed in the sensory neurons can reverse 
several different pain modalities. Of particular interest is the observation after nerve injury 
where mechanical hyperalgesia was reversed as this debilitating condition has been proven 
difficult to treat with current drugs.
As the data collected is limited and the n-numbers small the data has to be considered 
carefully before drawing conclusions. To further investigate the role of Nay 1.7, one 
possibility would be to generate a transgenic mouse with deletion of N ayl.7 not only in the 
small sensory neurons, but also in the medium and large sensory neurons. From this 
experiment mechanical allodynia after neuropathic pain should be prevented as seen with
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PhlTxl. One transgenic mouse line expressing Cre in all the sensory neurons is the Wntl- 
cre (Danielian et aL, 1998). Unfortunately Cre is also expressed in other neuronal tissue, 
but it would still be a way to investigate further the deletion of Nayl.7 in primary sensory 
neurons.
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8 CONCLUSION AND PERSPECTIVES
The transgenic approach to delete a specific subpopulation of sensory neurons has proven 
very successful in the investigations of pain modalities attributable to the Nayl.S 
subpopulation. The study combined behavioural analysis, extracellular electrophysiology 
and microarray gene analysis to investigate the transgenic mouse. The results showed that 
noxious mechanical hyperlagesia, inflammatory pain, but not thermal hyperalgesia or 
neuropathic pain are conveyed by the Nayl.S-expressing neurons.
To investigate the data obtained further, potential candidates from the microarray data 
could be deleted using siRNA in DRG cultures and investigated using electrophysiology 
before generating a transgenic mouse line. Also, the skin-nerve preparation where the 
electrophysiological signalling from the periphery to the dorsal horn can be investigated 
could be an interesting approach to obtain more detailed information of e.g. which neurons 
in the DTA-CRE mouse is responsible for the noxious thermal sensation.
To investigate the DTA mouse line further, it could be interesting to examine the 
termination of Ap-fibres at the dorsal horn. Ap-fibres can be stained by injecting cholera 
toxin-B into the sciatic nerve. The toxin will bind to the myelinated fibres and after a 
couple of days of retrograde transport, the dorsal horn can be excised, stained and the 
termination will be visualised (Bennett et al., 1996).
8.1 T h e  u s e  o f  t r a n s g e n i c  m ice
In this Ph.D. project two different methods of interrupting gene expression and one of 
interrupting function were used. For the deletion of a subset of sensory neurons the 
CvdloxP system was used. For the investigation of Papin a conventional technique was 
used generated by random LacZ insertion (gene trap) and finally pharmacological block of 
the Nay 1.7 ion channel using a spider toxin. Interestingly, these different approaches have 
each proven useful in identifying proteins involved in nociception and pain.
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